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Temperate bacteriophage have a complex, dynamic relationship with bacteria:
parasitizing in the lytic cycle, but often increasing bacteria’s fitness as lysogens.
The phage-bacteria relationship is vast and has evolved over more than an
estimated three billion years, and there are likely many uncharacterized, intricate
events between host and phage with important impacts on bacterial pathogenesis.
This Thesis explores some of these lesser-studied phage-bacteria interactions,
describing atypical mechanisms (“conversion events”) by which phage shape the
populations of Bacillus anthracis and Staphylococcus aureus, driving their
increased diversity and likely impacting their natural behaviors.

In B. anthracis, phage contributions to virulence are largely unknown. The first
part of this Thesis describes how an induced phage from a highly virulent, B.
anthracis-like isolate affects the well-characterized strain Sterne and selects for a
phage-resistant variant with a markedly altered phenotype, but with no apparent
difference in virulence potential. In this work, we characterize this variant strain by
a variety of techniques, including whole-genome DNA and RNA-sequencing. In
addition, we connect the Sterne variant phenotype to that of the phage’s parent
strain, B. cereus Biovar anthracis CA, uncovering lytic phage-bacteria interactions

(i.e., selection by lysis) that may act to promote phenotypic diversity and shape
populations of B. anthracis and B. anthracis-like pathogenic species in the wild.

Unlike B. anthracis, S. aureus has well-characterized bacteriophage contributions
to its virulence potential, with known lysogens carrying virulence factors stably
integrated into the host chromosome. The second part of this Thesis describes an
extra-chromosomal DNA sequencing screening that uncovers the presence of
episomal prophages in a number of S. aureus clinical isolates. QPCR
characterization of one of these strains, MSSA476, reveals that the episomal nature
of one of its prophages, fSa4ms, would have been missed if sequencing wholegenomic and not specifically extra-chromosomal DNA. In addition, we find that
fSa4ms excision into the cytoplasm is a temporal event, and that the prophage does
not appear to undergo lytic cycle replication after excision—suggesting that its
excision is part of a lysogenic switch. Follow-up experiments show that fSa4ms
excision can alter expression of htrA2 and promote increased heat-stress tolerance.
This work suggests that for S. aureus, in addition to carrying important virulence
determinants, phage may also play a rather widespread role as DNA-level switches
to control virulence factor expression and/or generate distinct subpopulations. While
this Thesis discusses atypical phage conversion events, it also illustrates perhaps
the most important, universal role of phage in bacterial pathogens: tools to create
diversity and allow for bacteria’s increased infection and success under different
evolutionary selections and environmental conditions.
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CHAPTER 1. INTRODUCTION
Bacteriophage, or phage for short, are viruses that infect bacteria. They are the
most abundant “organisms” on earth, have co-evolved with their hosts, and
unsurprisingly, exert significant influence over the bacterial domain, in pathogenic
and non-pathogenic species alike. Estimates of the total phage population in the
biosphere are 1031, an order of magnitude greater than their hosts (Wommack and
Colwell, 2000), and in addition, the scale of bacteria-phage infections is also
exceedingly large. There are an estimated 1024 infections per second, and as welldiscussed by (Hendrix, 2005), biological interactions on this scale offer nearly
unlimited opportunities for genetic exchange, horizontal gene-transfer (HGT), and
evolution among phages and their bacterial hosts (Bertozzi Silva et al., 2016;
Samson et al., 2013). Research in phage biology has uncovered the numerous roles
the viruses play, of course as bacterial predators, but also as genetic elements
imparting hosts with virulence factors (Beres and Musser, 2007; Coleman et al.,
1989), promoting the bacterial colonization of animals (Schuch and Fischetti, 2009),
and even driving global nutrient cycling (Wilhelm and Suttle, 1999). While bacteria
are natural human pathogens, they and the microbiome are also positively
implicated in human health, impacting immune system development and
inflammation (Cho and Blaser, 2012), shaping the gut-brain axis (Yano et al., 2015),
and preventing the development of cancer (Zitvogel et al., 2017), and phage have
been shown to play a clear role in shaping microbiome composition and its
associated effects (Mirzaei and Maurice, 2017). With many reports suggesting that
1

bacteria may be “controlling” us and research describing phage control over
bacteria, it is intriguing to think that perhaps our ultimate “masters” are actually
bacteria’s predators—the bacteriophage—and research efforts focused on
uncovering new phage-bacteria interactions should no doubt lead to greater insights
on human health. This Thesis aims to better understand the interactions between
phage and bacteria, and explores some of the atypical ways in which phage
influence their bacterial hosts, focusing on their roles in the Gram-positive
pathogens Bacillus anthracis and Staphylococcus aureus.

1.1 A brief history and classification of virulent and temperate
bacteriophage

Bacteriophage first appeared in the literature just over a century ago, with their
independent discovery by Twort in 1915 and d’Herelle in 1917. In his seminal work,
Twort discovered that some colonies of micrococci would turn “glassy” in cultures,
that non-glassy micrococci could transform to this phenotype upon exposure to
glassy colonies, and suggested that this transformation was propagated by ultramicroscopic viruses of a lower order than bacteria (Twort, 1915). Shortly after,
d’Herelle uncovered microbes that would lyse “Shiga-bacilli”, terming the microbes
“bacteriophage” for “bacteria eaters” (D'Herelle, 2007). Earlier reports of likely
phage discovery exist in the literature as well, with one report from 1898
uncovering the phage-mediated lysis of B. anthracis (Gamaleya, 1898). The
discovery of bacteriophage however is generally credited to Twort and d’Herelle.
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The one-hundred years since these initial discoveries have found phage to exist and
exert their influence over almost all corners of the biosphere, but in addition to their
biological roles, bacteriophage were (and still are) indispensable tools in molecular
biology (well-reviewed in (Summers, 2005)), are used directly as or provide the basis
for novel antibiotics (Fischetti, 2005; O'Flaherty et al., 2009), and have numerous
other biotechnological applications. This Thesis however, focuses on the natural,
biological roles of phage.

The phages uncovered by Twort, d’Herelle, and other early researchers were likely
virulent rather than temperate phage, and a broad distinction can be made between
the two. Virulent phage are obligate predators of bacteria (existing in a lytic cycle),
while temperate phage, in addition to predating bacteria via the lytic cycle, can
associate with a bacterial host in a more “quiescent” state known as lysogeny.
(Examples challenging the notion of lysogeny as truly “quiescent” though, will be
discussed later in the text.) Virulent and temperate phage are selfish elements,
focusing on their own survival and replication, and using bacterial hosts to
accomplish these goals. Outside of their own propagation however, both also engage
in activities that serve to generate diversity in bacterial pathogens and nonpathogens alike. Though when considering the mechanisms by which phages shape
bacterial diversity, temperate phages outshine virulent phages because of their
capacity to exist in the lysogenic state. This Thesis, and the remainder of the
introduction, focus on temperate phage and discuss some of the known ways in

3

which they generate diversity among their bacterial hosts. Chapters 2 and 3
highlight research uncovering more atypical and subtle impacts of temperate phage
on Gram-positive pathogens. A brief section detailing temperate phage biology is
below, followed by a discussion of how such phage impact their bacterial hosts.

1.2 Temperate phage biology

Temperate phage were first described by Bordet in 1919, who showed that bacteria
isolated from infected mice could be induced to produce phage particles in the
laboratory, though he incorrectly predicted that such particles were a product of the
bacteria itself rather than a separate biological entity (Summers, 2005). Esther
Lederberg later uncovered phage l (Lederberg and Lederberg, 1953), a lysogenic
phage of Escherichia coli, setting the stage for fundamental discoveries in phage
biology, particularly in the factors that govern maintenance of lysogeny and the
switch to the lytic state. (Early bacteriophage work and a history of lambda are
reviewed in (Summers, 2005; Casjens and Hendrix, 2015; Ptashne, 2004).

Unlike virulent phages, temperate phages are capable of a multitude of lifestyles,
including the lysogenic and lytic cycles, as well as pseudolysogeny and chronic
infection. Briefly, they are described and distinguished. Phage replication via the
lytic cycle consists of: 1) viral adherence to a bacterial cell, 2) injection of genetic
material (typically double-stranded DNA), 3) replication of DNA and synthesis of
viral building blocks, 4) phage structural assembly and packaging of DNA into
4

heads, and 5) lytic burst from the host cell and release into the surrounding
environment (Figure 1-1a). In the lysogenic cycle, phage co-exist with the bacterial
host. Like the lytic cycle, phage 1) adhere to the bacterial cell and 2) inject genetic
material, however following this step, phage genomes integrate within the bacterial
chromosome or get maintained as cytoplasmic plasmids, but do not undergo
replication and production of progeny viral particles. These phage DNA elements,
termed prophage, divide with the host cell (Figure 1-1b). They can exit the lysogenic
cycle however, and be induced into the lytic cycle (often in times of bacterial stress
or DNA damage), executing steps 3-5 and killing the host cell. (Factors governing
the lytic/lysogenic switch in phage l will be briefly discussed in the following
paragraph.) Pseudolysogeny is an intermediate state where phage 1) adsorb to the
bacterial cell and 2) inject genetic material, however are held in a purgatory-like
state, putting off the decision to enter the lysogenic or lytic cycle until a change in
the external environment (Figure 1-1c). Lastly, chronic phage infection (not
pictured), is a state where phage stably infect the bacterial cell, but continuously
release progeny into the external environment without host cell death. Such a
phage state occurs in the filamentous phage of E. coli for example, but does not
occur in lambdoid (lambda-like) phages (Rakonjac et al., 2011).

5

Figure 1-1. The lytic, lysogenic, and pseudolysogenic cycles of
bacteriophage. A) In the lytic cycle, phage recognize a specific cellular receptor
and adsorb to the outside of the bacterium before injecting genetic material, then
begin genome replication and synthesis of viral proteins. Packaging of genetic
material into viral proteins forms functional virions, which burst from the cell in
controlled host lysis. B) In the lysogenic cycle, phage recognize specific bacteria and
inject their DNA as in A), however do not undergo a viral particle replication
program. Instead, the prophage genome either integrates into the host chromosome
or is maintained as a plasmidial element, and replicates in tune with host cellular
division. C) In the pseudolysogenic state, phage follows the first steps in A) and B),
however the prophage element is maintained in a non-replicative state, unlike the
lytic and lysogenic cycles, which remains until changes in the external environment
prompt a lysis/lysogeny decision. Reprinted from (Feiner et al., 2015) with
permission.
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1.2.1 The lytic/lysogenic switch

The molecular processes governing the lytic/lysogenic switch in l are well studied
(Casjens and Hendrix, 2015; Ptashne, 2004) (Figure 1-2). Briefly, the decision
hinges on successful repression of the lytic state by the CI repressor protein. CI
repressor protein has two core activities: 1) repression of Cro (an activator of the
lytic cycle), and 2) autoregulation of CI production. Cro and CI have opposite-facing
genes (5’ ends closest) and share operator regions in their promoters, producing the
following functional switch. CI protein binds upstream of its encoding gene,
promoting its own production while simultaneously blocking the promoter for Cro.
As long as CI is stably produced and maintained, the phage remains in the
lysogenic state. When cellular DNA damage occurs, RecA (a bacterially-encoded
protein) becomes activated and promotes the cleavage of CI, preventing CI positive
autoregulation and the repression of Cro. With CI no longer repressing Cro, the
lytic cycle activator is now produced and accumulates, binding CI operators,
repressing CI production, allowing its own production, and activating the
prophage’s lytic cycle program (Calendar and Inman, 2005). The lytic/lysogenic
decision for newly infecting phage depends upon levels of another protein, CII,
which promotes the initial production of CI (Echols, 1986; Ptashne, 2004).
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1.2.2 Prophage replication

Replication of prophage is necessary to ensure its survival. In the lysogenic cycle,
replication allows for phage dissemination to the host’s daughter cells, and for lytic
phages, the spread to new, uninfected hosts. For integrated lysogenic prophage,
this is accomplished during host chromosomal replication, with chromosomes
containing the prophage genome segregating to each daughter cell. Lysogenic
plasmidial phages must ensure their own dissemination, and encode genes for their
replication, equal segregation to daughter cells, and often, anti-curing, plasmidaddiction systems (Abeles et al., 1984; Łobocka et al., 2004).

Replication of l (and l-like) phage in the lytic cycle is well-studied and will be
briefly summarized (Enquist and Skalka, 1978) (Figure 1-2). Following induction
into the lytic cycle, the prophage excises from the chromosome into the cytoplasm as
a circular DNA element and begins bi-directional, q-replication, creating multiple
circular copies of its genome. Following q-replication, unidirectional rolling-circle
replication generates long, linear prophage concatemers, containing multiple copies
of prophage genome per DNA molecule. For l, these concatemers are cut at specific
sites, creating individual phage genomes with single-stranded cohesive ends of DNA
(cos sites). Genomes are then packaged into phage particles. Other lambda-like
phages can contain either cos sites or are packaged through an alternative
mechanism known as headful packaging. Here, a linear concatemer is recognized at
a “pac”-site, cut, and DNA injected into a phage head until it can no longer contain
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any more DNA. This is typically about 105% of the phage genome. After the second
cut, the next phage genome in the molecule is packaged in the same manner until
the phage head is full, however the resulting phage contains different DNA ends
than the first phage. This process continues until the rest of the DNA molecule is
packaged, and results in a phage population that contains terminally redundant
and circularly permuted genomes.

The discussion of phage biology thus far has not addressed host impacts of phage
carriage. Clearly, phage infection (lytic or lysogenic) does not exist in a vacuum, and
the bacterial cell should not be thought of as merely a factory for phage
propagation, but rather a dynamic organism that is drastically changed by carriage
of viruses. The following section discusses a number of the known mechanisms by
which temperate phage impact and influence their bacterial hosts.
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Figure 1-2. Overview of the l (and l-like) phage lysis/lysogeny switch and
replication in the bacterial host. 1), 2) and 3) The lytic and lysogenic cycles
begin with the same series of steps: phage adsorption to the cell surface, DNA
ejection from the phage head, and circularization of the genome (for l this is
achieved through annealing of single-stranded, complementary cos ends). 4) A
decision is made to enter the lytic or lysogenic cycle, dependent upon levels of CII
protein. If levels of CII are relatively high, the phage enters the lysogenic cycle,
typically integrating within the host chromosome via recombination between attB
and attP sites, and the state stabilized by CI production, also providing
superinfection immunity. Under inducing conditions, CI is cleaved, allowing Cro
production, phage excision and exit from the lysogenic cycle. Alternatively, phage
can enter the lytic cycle immediately following injection of DNA (2). 5) In the lytic
cycle, phage replicate their genome, first undergoing q-replication resulting in
multiple circular genome copies, followed by 6) rolling circle replication where long
linear concatemers containing multiple phage genomes are generated. Then, 7)
transcription and production of phage structural proteins occurs. Lastly, 8) single
phage genomes are cut from concatemers, packaged into phage particles, and 9)
virions released by endolysin-induced cell lysis. Figure reprinted with permission
from ViralZone and SIB Swiss Institute of Bioinformatics. Ó 2014 ViralZone and
SIB Swiss Institute of Bioinformatics.
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1.3 Temperate phage as agents of diversity and benefactors of bacteria

Temperate phage, especially within the lysogenic cycle, impart important
advantages to their bacterial hosts. This positive feature of phage infection for the
bacteria is an evolutionary trade-off: bacteria house elements that can and will
likely kill them at signs of damage or stress, but they allow better survival and
adaptation to the external environment than in their absence. The benefits of this
tradeoff are no doubt why we see so many diverse bacterial species harboring
lysogenic prophage today. Besides, it is possible that if a bacterium harbors no
phage, it will be outcompeted by related phage-harboring strains and fail to survive
regardless. This section outlines some of the ways phage impart benefits to their
hosts as “benefactors of bacteria”. While the following mechanisms discussed are
diverse, they all result in the same end goal: generating diversity within bacterial
species. Phage can drive the diversity of and benefit bacteria through a number of
mechanisms including: 1) positive (lysogenic) conversion, 2) negative conversion, 3)
genome diversity and chromosomal rearrangements, 4) lytic induction, and 5)
transduction and other DNA transfer events. Phage-driven diversity, coupled with
evolutionary selection, likely accounts for the excellent pathogens many bacterial
species are today. A discussion of each diversity mechanism follows, however the
contributions of phage to bacteria are also well reviewed in (Brussow et al., 2004;
Canchaya et al., 2004; Feiner et al., 2015; Nanda et al., 2015).
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1.3.1 Positive (lysogenic) conversion

Perhaps the most impactful role of temperate phage in bacteria is through positive
(lysogenic) conversion, or the introduction and expression of foreign genes in a
bacterial host. The genes implicated in lysogenic conversion are often termed
“morons”, for more DNA on the prophage genome than necessary for survival,
replication, or establishment of the lysogenic state (Brussow et al., 2004). Any
connotation of these genes being useless or “moronic” should however be quickly
dispensed of; as a consequence of selection, morons typically encode important
virulence determinants or other bacterial fitness factors responsible for survival or
severe invasive disease (e.g. streptococcal toxins and superantigens) (Beres and
Musser, 2007)). The term positive conversion itself denotes the bacterial phenotype
being converted by harboring prophage (i.e. non-lysogenized bacterium: phenotypeà lysogenized bacterium: phenotype+). A few important examples of lysogenic
conversion are discussed below.

The pathogenicity of S. aureus depends on an arsenal of virulence factors, many of
which are encoded on temperate prophage genomes (Thammavongsa et al., 2015;
Thomer et al., 2016). In S. aureus Newman, for example, the strain displays
severely reduced virulence in a mouse model when cured of its four resident
prophages (Bae et al., 2006). One of its prophages, fNM3, encodes virulence factors
including staphylokinase (SAK), staphylococcal enterotoxin A (SEA), chemotaxis
inhibitory protein of S. aureus (CHIPS), and staphylococcal complement inhibitor
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(SCIN), and its curing significantly reduces abscess formation. Importantly, fNM3
is a b-hemolysin (hlb)-converting phage, indicating that while it positively converts
cells for SEA, SAK, CHIPS and SCIN, it integrates within the gene for another
virulence factor, hlb, disrupting its transcription, and negatively converting cells
(i.e., Newman: hlb-/sea+/sak+/scin+/chips+ ; Newman DfNM3:
hlb+/sea-/sak-/scin-/chips-). Negative conversion will be discussed further in the next
section.

In Streptococcus pyogenes, prophages carry DNases, hyaluronidases, as well as a
number of superantigens called SPEs (streptococcal pyrogenic exotoxins), which are
non-specific T-cell activators that contribute to the symptoms of “Scarlet Fever”
(Beres and Musser, 2007). Their direct contributions to disease however, have not
been fully elucidated. Notably, The Rockefeller University was founded following
the death of John D. Rockefeller Sr.’s grandson from streptococcal disease. Whether
or not lysogenic conversion is responsible for the foundation of other universities is
unclear, but it appears we owe it to phage for the development of our home
institution.

In a distinct manner from strict virulence factor carriage, morons can also encode
fitness factors (Brussow et al., 2004), including transcription and sigma factors that
alter the activities of the cell. Lysogeny of B. anthracis by Bacillus spp.-infecting
phages was shown to alter the pathogen’s biofilm formation capacity, promote

15

earthworm colonization, promote or block sporulation, and induce
exopolysaccharide coatings on vegetative cells and spore structural changes (Schuch
and Fischetti, 2009). These phenotypes were found to be mediated by phageencoded sigma factors. Whether or not these factors are truly morons with no role in
the phage lifecycle however, is unclear. Also notable for B. anthracis and the related
species Bacillus cereus and Bacillus thuringiensis are the findings that while these
three species have highly related chromosomes, they exhibit markedly different
phenotypes (Kolstø et al., 2009). In addition, these strains have been shown to
harbor an array of inducible prophage, suggesting that positive conversion may play
a role in generating the unique phenotypes among the three species (BUCK et al.,
1963; Kiel et al., 2008).

While not encoded by morons per se, superinfection immunity (blocking of infection
by similar phage) may also be considered a feature of lysogenic conversion.
Typically, superinfection immunity occurs through the production of compatible CI
repressor, preventing infecting phage from executing a lytic cycle. In some cases,
however, prophage will encode specialized immunity genes to prevent
superinfection. E. coli fV10, for example, encodes an O157 antigen-modifying
enzyme (oac) that alters the fV10 receptor, preventing superinfection (Perry et al.,
2009).
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1.3.2 Negative conversion

Negative conversion is not quite the direct opposite of positive conversion, but
rather is a potential consequence of carrying integrated prophage. Prophage
integration occurs in various parts of the chromosome (or on resident plasmids) and
depending upon where prophage integrate, the transcription of genes may be
interrupted and cells converted to a negative phenotype. As previously mentioned,
the hlb-converting phages of S. aureus integrate within the b-hemolysin gene, and
disrupt transcription of the full-length gene product. For S. aureus, the trade-off
appears evolutionarily favorable, as the phage carries multiple virulence factors,
and strains containing hlb-converting phages are most commonly associated with
infection (Coleman et al., 1989; 1991; Goerke et al., 2006). In a similar manner,
fL54a and related phage of S. aureus integrate within the lipase (geh) gene,
shutting down its functional production. These phage however, do not appear to
code for known virulence determinants, morons, or other fitness factors (Lee and
Iandolo, 1986; Lee et al., 1985). Lipase is a known virulence factor, making the
evolutionary appeal for phage carriage and associated negative conversion as of yet,
unclear (Hu et al., 2012).

In S. pyogenes, a different type of “negative conversion” occurs with the phage-like
chromosomal island SpyCIM1 (formerly termed f370.4). This prophage-like element
integrates within the mismatch-repair (MMR) operon on the chromosome,
negatively converting cells for the loss of MMR activity, resulting in an increase of
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the cellular mutation rate approximately 200-fold (Scott et al., 2008; 2012).
Interestingly, this element displays a unique excision/integration pattern dependent
on cell density, allowing the cell to regain MMR activity while still retaining the
phage-like element. A more detailed discussion of SpyCIM1 and similarly related
events in other bacterial species is located in Chapter 3.

1.3.3 Phage as drivers of DNA sequence diversity in bacteria

Lysogeny is also a key driver of sequence diversity among strains within a given
bacterial species. Bacterial pathogens carry essential and non-essential genes, with
the latter typically involved in virulence and other fitness-associated activities.
These non-essential genes are typically different among strains, and often are the
key differences allowing strain differentiation. Fitzgerald et al. report that nearly a
quarter of the S. aureus genome (22%) encodes such non-essential genes, and it is in
fact prophage sequences that comprise the majority of these regions. Similar
patterns are also present in other pathogenic species such as E. coli and
Helicobacter pylori (Fitzgerald et al., 2001). Such differences in prophage content
may drive the pathogenicity of select strains and differences in clinical
manifestations of disease (Goerke et al., 2004; 2006). In S. pyogenes, the majority of
sequence-level differences among strains and M-types are prophage related (Beres
and Musser, 2007). M1 and M18 strains differ primarily in prophage sequences
(Smoot et al., 2002), and the enhanced virulence of the M3 strain MGAS315 is
speculated to arise from a diverse array of phage-encoded morons that all appear in
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the poly-lysogenized strain (Beres et al., 2002). The M3 strain in particular is an
example of an additional method by which prophages can introduce diversity:
serving as anchor points for chromosomal rearrangements. In the SSI-1 M3 strain
of S. pyogenes, the presence of two integrated prophage allowed a 1 Mbp
chromosomal inversion and the generation of this unique strain. The inversion itself
also resulted in a swap of phage virulence genes, and as a consequence, the strain
contains novel prophage genomes in addition to altered M3 chromosomal synteny
(Nakagawa et al., 2003).

Prophage genomes are arranged in modules, or groups of genes with specific
functions. Typically these are: lysogeny, DNA replication, transcriptional control,
DNA packaging, head/tail morphogenesis, lysis, and in some cases, accessory genes.
This structure allows the rapid swapping of modules between prophage genomes in
multiply phage-infected cells and the fast evolution of prophage genomes. Such
exchanges occur because the DNA sequences on module borders tend to be highly
homologous among phages, while the genes of the modules themselves can be vastly
different. Thus, phage can easily exchange modules via homologous recombination
and markedly change their genomes, potentially affecting both their host-range and
the virulence or fitness of their hosts. For example, if phage “A” with a broad host
range swaps accessory gene modules with a co-infecting narrow-range phage “B”
(which encodes potent virulence factors), phage B’s original morons can now rapidly
disseminate to new strains, or even species. The g-phage of B. anthracis is believed
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to have undergone such a homologous recombination, exchanging a spore-antigen
moron for a fosfomycin resistance-encoding gene from f4066 (Schuch and Fischetti,
2006). A particularly interesting case is seen in the phages SpaA1 and BceA1. These
phages are nearly identical by sequence, are a chimera of different prophage regions
from B. thuringiensis and B. cereus, and remarkably, also contain an additional
complete prophage (MZTP02) in their genomes, in what is termed a “Russian Doll”
arrangement. BceA1 has a broad host range, capable of infecting Staphylococcus
pasteuri and B. cereus/B. thuringiensis, however it is unclear if the phage carries
lysogenic conversion genes that can affect both hosts (Swanson et al., 2012).
Regardless, these phages represent the extent to which module exchange produces
novel prophage genomes, generating new elements to affect bacterial hosts.

1.3.4 Lytic induction of temperate prophage
The methods by which temperate phage drive diversity and impact hosts discussed
so far have mainly dealt with phage in the lysogenic cycle. The induction of
temperate phage into the lytic cycle however, also has a number of consequences
both on the individual cell and population levels. For individual bacterial cells,
induction into the lytic cycle likely leads to cell death, and cannot be seen as
beneficial. On the population level however, limited induction of lysogenic phage
can be beneficial, especially when the induced phage carry important lysogenic
conversion genes. Quite often, morons are carried in the late lytic region of the
prophage genome, such that when phage induction occurs, these genes are
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significantly upregulated. In S. aureus MSSA476, the hlb-converting phage fSa3ms
carries sak, sea, and scin, located adjacent to the host lysis cassette. Induction of
phage by mitomycin C increases transcription of sak and sea, from both native and
phage lytic cycle promoters (Sumby and Waldor, 2003). In an infection environment,
fSa3ms induction in a small proportion of the MSSA476 population could provide
the whole population with increased levels of SEA and SAK, and allow more
successful infection of hosts.

In a similar manner, pathogenic E. coli harboring Shiga-toxin converting phage (stx
phage, encoding the Shiga toxin) are found to be induced in mammalian hosts and
low-iron conditions. The location of the stx gene (controlled by lytic cycle promoters)
allows its increased expression during phage induction, and phage-mediated lysis of
E. coli cells allows the release of toxin into the external environment. Shiga toxin
itself liberates iron from mammalian host cells, and in this case, the sacrifice of a
few E. coli cells improves conditions for the remainder of the pathogenic bacterial
population (Nanda et al., 2015). For S. aureus and E. coli, phage induction allows
clonal populations to diversify into “toxin producing factories” and their
beneficiaries who will go on to survive. Separate from the increased transcription of
virulence genes, the controlled induction of temperate phage in Pseudomonas
aeruginosa allows for the release of DNA and other cellular debris to seed biofilms,
benefiting the rest of the population (Webb et al., 2003).
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In a distinct manner, induction of temperate phage can also alter populations for
the selection of phage-resistant variants. While not benefitting the bacteria
directly, selection for phage resistance can impart protection against other phages
present in the environment if they use similar mechanisms for adsorption, entry, or
replication. In clonal populations, phage reinfection of cells is generally blocked by
superinfection immunity, however there are reports of successful superinfection by
Bacillus-infecting phage (BUCK et al., 1963). In these cases, development of phageresistance (or keeping a small phage-resistant subpopulation) may benefit the
whole population, serving as insurance in case of exposure to superinfecting phages.
In general however, the selection of phage-resistant variants is typically associated
with negative fitness, and phage-resistant strains often show decreased virulence
(Filippov et al., 2011; León and Bastías, 2015). In S. aureus, phage-resistant strains
were found to be attenuated for virulence, and even used for successful vaccine
development (Capparelli et al., 2010). In E. coli, phage-resistant mutants can lack
antigenic capsular polysaccharides (Stirm, 1968). Some reports, mainly outside of
pathogenesis, have shown phage resistance as a potential benefit, with
Streptoccocus thermophilus resistant variants showing equivalent levels of
acidifying activity in milk cultures (Binetti et al., 2007). This benefit, however, is
likely directed toward humans using the strain in industrial fermentations, and not
bestowed upon the bacteria themselves. Chapter Two details the discovery of a
phage-resistant mutant in B. anthracis that harbors a unique phenotype without
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apparent attenuation of virulence potential, challenging the notion that
development of phage-resistance by genomic alteration results in negative fitness.

1.3.5 Transduction and other gene transfer events

Also occurring outside of the lysogenic cycle is transduction, or the transfer of nonphage DNA by phage. (Virulent phage are also capable of transduction.)
Generalized or specialized transduction (movement of any DNA versus typically
phage genome-adjacent or -associated DNA) by phage allows the rapid spread of
genes that may encode virulence determinants or other fitness factors (e.g.
antibiotic resistance). In S. aureus, for example, bacteriophage transduction was
shown to transfer mecA, encoding methicillin resistance (Chlebowicz et al., 2014).
Such activity becomes increasingly important given the present-day relative ease of
phage (and pathogenic bacteria as well) to travel to far reaches of the globe. For
bacteria, phage can serve as an easy delivery system to acquire new sequence
diversity and functional genes from related strains or species to increase survival,
fitness, or virulence.

In addition to these forms of transduction, phages can also serve as helpers for the
dissemination of other non-self, phage-like elements. One key example is found in
the phage-like chromosomal islands of S. aureus. S. aureus pathogenicity islands
(SaPIs) can fill phage heads of a “helper” phage with their own genetic material,
akin to a hijacker stealing a car. Here, the hijacker (SaPI) gets to its desired
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destination (uninfected surrounding bacteria), but the owner (the helper phage
genome) is left behind (Novick et al., 2010). SaPIs have been found to encode for
virulence factors, including those responsible for toxic-shock syndrome, and phages
allow their dissemination and generate increased diversity among S. aureus isolates
(Lindsay et al., 1998). SpyCIM1, the phage-related chromosomal island of S.
pyogenes is thought to require helper phages as well, but such potential phage
vehicles have not yet been uncovered (Nguyen and McShan, 2014).

1.4 Exploring phage contributions to the lifestyles of B. anthracis and S.
aureus

Classifications of phage and bacteria-phage interactions are often thought of in
broad strokes: virulent versus temperate, lytic versus lysogenic, and concepts of
positive and negative conversion as 100% absolute. Indeed, this introduction has
presented some major concepts in this way. Thinking in this manner is useful for
initially understanding phage biology, however it oversimplifies the vast nature of
phage and their interactions with bacterial hosts. Recent reports have illustrated
that a more complex and dynamic relationship exists between bacteria and their
phages as well as between phages themselves (Goerke et al., 2004; 2006; Swanson
et al., 2012). The phage-bacteria relationship is estimated to be greater than three
billion years old (Hatfull and Hendrix, 2011), and no doubt intricacies exist between
bacteria and phage beyond these broad strokes. The following chapters explore a
couple of these more atypical, intricate phage-bacteria interactions: the selection
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and expansion of phage-resistant subpopulations in B. anthracis, and the
excision/integration dynamics of episomal lysogenic prophage in S. aureus.

Both projects were initially undertaken to explore potential lysogenic conversion in
each Gram-positive pathogen. In S. aureus, extra-chromosomal DNA isolation and
next generation sequencing screened clinical isolates for the presence of rare,
lysogenic plasmidial phages that could be “hidden in plain sight”. Such work aimed
to uncover novel phages encoding virulence determinants and lend greater
understanding into the virulence potential of clinical strains. For B. anthracis, the
impacts of phage from non-pathogenic environmental sources are well-described
(Schuch and Fischetti, 2009), however this project sought to help understand how
lysogenic conversion of B. anthracis by phage from anthrax-endemic environments
could affect the bacteria, and whether such phage played any role in pathogenesis.
In both projects, we did not identify novel phage capable of lysogenic conversion, but
rather, uncovered more subtle, intricate mechanisms by which phage influence
bacterial hosts. In S. aureus, we find that episomal lysogenic prophage are fairly
widespread among clinical isolates, and that their excision/integration dynamics
have important impacts on the host. In B. anthracis, we discover that phageresistant subpopulations may play a role in the lifestyle of the pathogen, and
uncover a phage-resistant variant with a unique and highly unusual phenotype.
The following Chapters describe these projects, and begin with introductions
detailing relevant project- and species-specific background information.
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CHAPTER 2. SELECTION BY PHAGE LYSIS AMPLIFIES A PHAGERESISTANT BACILLUS ANTHRACIS VARIANT SUBPOPULATION WITH
UNUSUAL AND DYNAMIC PHENOTYPES

INTRODUCTION

2.1 A brief overview of B. anthracis biology, the B. cereus sensu lato group,
and the discovery of B. anthracis-like B. cereus isolates

Bacillus anthracis is a Gram-positive, spore-forming pathogen that exists as a
monomorphic species within the Bacillus cereus sensu lato (s.l.) group. This group
contains six species in total, including B. cereus and B. thuringiensis which are
highly related to B. anthracis. The three species share a conserved chromosome,
core set of genes, and an array of chromosomally-encoded virulence factors (Kolstø
et al., 2009; Radnedge et al., 2003; Zwick et al., 2012). Genomically, B. anthracis is
distinguished in the group by the presence of four chromosomally-integrated
prophages (Sozhamannan et al., 2006) and a specific nonsense mutation in the plcR
(phospholipase C regulator) gene, which encodes a transcriptional activator of
virulence factors such as enterotoxins, hemolysins, phospholipases, proteases, and
other extracellular protein-encoding genes (Kolstø et al., 2009). Phenotypically, B.
anthracis is a non-hemolytic, non-motile, penicillin-sensitive and g-phage sensitive
species with some of these phenotypes linked to PlcR transcriptional activation. B.
cereus on the other hand is typically hemolytic, motile, penicillin-resistant, g-phage
resistant, and encodes a functional PlcR protein. Despite clear phenotypic
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differences, differentiation between B. anthracis and some B. cereus strains has
become increasingly difficult with the emergence of pathogenic B. cereus strains
presenting anthrax-like disease (Brézillon et al., 2015; Hoffmaster et al., 2004;
Wang et al., 2013). One report however, distinguished B. anthracis, B. cereus, and
B. thuringiensis on the basis of csaB (cell surface anchoring) gene nucleotide
sequence analysis, finding the three B. cereus sensu lato species clustered into two
groups, with all B. anthracis and the majority of mammalian-isolated pathogenic B.
cereus in one cluster, and B. thurningiensis insect-infecting strains clustered in the
other (Zheng et al., 2013). The csaB gene itself encodes a pyruvyl-transferase
essential for Surface-layer (S-layer) and S-layer-associated protein (BSL) anchoring
to the B. anthracis secondary cell wall polysaccharide (SCWP) (Mesnage et al.,
2000). Specifically, CsaB catalyzes the addition of a ketal pyruvyl group onto the
terminal N-acetylmannosamine (ManNAc) of the SCWP, allowing the non-covalent
anchoring of S-layer proteins and BSLs via a surface layer homology (SLH) domain
(Figure 2-1a) (Anderson et al., 2011; Missiakas and Schneewind, 2017; Soufiane et
al., 2011).
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Figure 2-1. B. anthracis SCWP and S-layer structures. A) Molecular structure
of B. anthracis SCWP. The B. anthracis SCWP contains a repeating backbone of Nacetylglucosamine-N-acetylmannosamine (GlcNAc-ManNAc) linkages, with b- and
a-galactose (Gal) substitutions on GlcNAc as shown (Choudhury et al., 2006). The
terminal unit of the SCWP contains acetylated and ketal-pyruvylated ManNAc,
with the pyruvyl group serving as an anchor for non-covalent bonding of the S-layer
proteins Sap and EA1, and in addition, BSLs. B) Diagram of the B. anthracis cell
envelope. B. anthracis contains a single plasma membrane and peptidoglycan to
which the SCWP and poly-g-D-glutamic acid capsule are attached. The S-layer
proteins are attached to the SCWP by non-covalent anchoring of SLH-domains
(green) to pyruvylated terminal ManNAc (arrow). Figure adapted from (Missiakas
and Schneewind, 2017) with permission.
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The B. anthracis S-layer itself has been well-characterized (Etienne-Toumelin et al.,
1995; Mesnage et al., 1997; Missiakas and Schneewind, 2017) and is an important,
distinguishing feature for B. anthracis and B. anthracis-like pathogenic strains of
B. cereus (Figure 2-1b). Fagan and Fairweather describe the S-layer as a
modulating, functional structure allowing the cell to carry out specific activities and
interactions with its external environment (Fagan and Fairweather, 2014). For B.
anthracis, the S-layer is chiefly comprised of two proteins, Sap and EA1, which
cover the cell in a para-crystalline lattice and have demonstrated murein-hydrolase
activity (Ahn et al., 2006). Twenty-two other BSLs have been confirmed or predicted
with roles in cell-separation (Anderson et al., 2011), virulence (Kern and
Schneewind, 2008), and nutrient acquisition (Tarlovsky et al., 2010). These include:
adhesins (BslA) (Kern and Schneewind, 2008), N-acetylglucosaminidases (BslO)
(Anderson et al., 2011), amidases (BslS, BslT, BslU, AmiA) (Fagan and
Fairweather, 2014), b-lactamases (BslM) (Fagan and Fairweather, 2014), and hemescavenging proteins (BslK) (Tarlovsky et al., 2010). Clearly, the S-layer is an
important structure for B. anthracis to execute activities important to its survival
and pathogenesis (Nguyen-Mau et al., 2012; Oh et al., 2017; Schneewind and
Missiakas, 2012). Perhaps unsurprisingly, given the number of proteins that
comprise the S-layer and their total reliance on CsaB-mediated SCWP pyruvylation
for anchoring (Kern et al., 2010), mutation in csaB carries multiple downstream
effects on the cell. (Mesnage et al., 2000) describe a B. anthracis csaB knockout
harboring a phenotype of small convex colonies, clusters of cells that fall to the
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bottom of tubes in liquid culture, and long chains of twisted cells. This csaB
knockout was also unable to deposit Sap and EA1 on the cell wall (Mesnage et al.,
2000). Similarly, (Wang et al., 2013) show that BslO is not deposited on the cell
walls of a B. cereus G9241 csaB mutant. In addition, phage-resistance has also been
linked to csaB mutation (Bishop-Lilly et al., 2012; van Zyl et al., 2015), with CsaBdeficient mutants selected for by infection with AP50c phage.

In addition to the S-layer, the well-described virulence plasmids pXO1 and pXO2
are key components of pathogenic B. anthracis (Figure 2-2a). The pXO1 plasmid
encodes for the three anthrax-toxin components: protective antigen (pag), lethal
factor (lef), and edema factor (cya), as well as the regulator genes atxA and pagR,
while pXO2 encodes for the poly-g-D-glutamic acid (PDGA) capsule important for
host immune system evasion (Moayeri et al., 2015; Mock and Fouet, 2001; Young
and Collier, 2007). Previously, the presence of pXO1 and pXO2 was used to
differentiate B. anthracis from B. cereus and B. thuringiensis. It is now recognized
however, that the presence of these plasmids is not solely B. anthracis-specific
(Kolstø et al., 2009). A number of B. cereus disease-causing isolates with anthraxlike pathogenesis have been found to carry the highly homologous virulence
plasmids, pBCXO1 and pBCXO2. G9241 is one such isolate, harboring pBCXO1
with 99.6% sequence similarity over homologous regions to pXO1, and encodes pag,
lef, cya, atxA and pagR (Figure 2-2b) (Hoffmaster et al., 2004; 2006; Oh et al., 2011).
Other B. cereus isolates harbor both pBCXO1 and pBCXO2 (Leendertz et al., 2006).
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B. cereus Biovar anthracis CA harbors both plasmids and is a B. anthracis-like
strain isolated from the carcass of an ape believed to have died of anthrax infection
in Cameroon (Brézillon et al., 2015). B. cereus bv anthracis CA, herein referred to as
“CA”, straddles the classic boundaries of B. anthracis and B. cereus (Klee et al.,
2010). The strain encodes both the B. anthracis-associated PDGA capsule on
pBCXO2 as well as a hyaluronic acid capsule on pBCXO1 via functional hasA,
which is typically mutated in B. anthracis (Figure 2-2c).

(Klee et al., 2006) describe unusual phenotypes in the initial report of the CA strain,
where colonies at 24 hours growth displayed typical B. anthracis phenotypes
including: non-hemolytic, rough-edged colonies with grey-green coloring and
“Medusa heads” (curled projections at the colony edge), but after 48 hours growth,
the same colonies were found to have transitioned and displayed a smooth, shiny
phenotype with a yellow-green center, and in addition were smaller than that of
classic B. anthracis. Subclones of single CA colonies were found to repeatedly
display a mix of phenotypes, including some small, smooth colonies with bhemolytic activity (a hallmark of B. cereus) and sensitivity to g-phage (a hallmark of
B. anthracis) (Klee et al., 2006). In addition, CA cells contained twisted, corkscrewlike morphologies, atypical of B. anthracis (Figure 2-3). A summary of CA’s
characteristics is presented in Table 2-1. The CA strain represents an unusual
hybrid of B. anthracis and B. cereus, possessing phenotypic hallmarks of both
species (Kamal et al., 2017; Klee et al., 2006; 2010), while also displaying unusual
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behavior where subclones of the same colony possess different phenotypes. CA
represents a unique, disease-causing, anthrax-presenting isolate; research
described later in this Chapter details efforts to uncover the role and contributions
of phage to its unusual characteristics and lifestyle.

Table 2-1. Phenotypes of B. cereus bv anthracis CA, B. anthracis, and B.
cereus.
Microbiological
characteristic

Hemolysis

Result
B. cereus bv
anthracis CA
Primary Subculture
culture
−
+/−

B. anthracis

B. cereus

−

+

Motility

+

+

−

+

Susceptibility to g-phage

−

+/−

+

−

Penicillin G

R

R

S

R

Capsule

+

+/−

+

Absent in
vitro

S, sensitive; R, resistant; −, negative; +, positive; +/−, some subclones positive,
others negative.
Table adapted and reprinted with permission from (Klee et al., 2006).
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Figure 2-2. The plasmids and outer cell structures of B. anthracis, B. cereus
G9241 and B. cereus BV anthracis CI. A) B. anthracis harbors virulence
plasmids pXO1 and pXO2, encoding the anthrax toxin genes pag, lef, cya as well as
the regulator atxA. It contains a poly-g-D-glutamic acid capsule and functional Slayer. B) B. cereus G9241 harbors pBCXO1, highly homologous to pXO1, however it
encodes functional hasA. It does not encode for a pXO2-like plasmid. Consequently,
it produces anthrax toxin, as well as a hyaluronic acid and B. cereus-specific
capsule, but not PDGA. C) B. cereus Biovar anthracis CI is a unique African isolate
highly homologous to CA, which encodes pXO1- and pXO2-like virulence plasmids.
It produces anthrax toxin, poly-g-D-glutamic acid capsule. and via functional hasA,
hyaluronic acid capsule. Figure used with permission from (Missiakas and
Schneewind, 2017).
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A

B

Figure 2-3. Atypical cellular morphologies of B. cereus Biovar anthracis
CA. CA has unique cellular morphologies with twisted, corkscrew-like cells seen in
(A). In addition, clear cell division septa are not apparent. Typical B. anthracis (B)
contains straight, rod-like cells with clear division septa. The unique structures
seen in (A) are rarely found (arrows) on B. anthracis cells. Figures reprinted with
permission from (Klee et al., 2006).

2.2 Role of phage in B. anthracis

The roles of phage in B. anthracis are unique from those of other Gram-positive
pathogens, in that they are traditionally not associated with virulence. In S. aureus,
lysogenic conversion imparts the bacteria with factors important for pathogenicity
(Bae et al., 2006), while in S. pyogenes, prophage also encode factors thought to be
crucial to virulence (Beres and Musser, 2007), however a direct link in vivo has not
yet been made. Why a similar role for phage in the Gram-positive pathogen B.
anthracis is not seen is unclear. However, the difference could be perhaps attributed
to B. anthracis’s virulence plasmids, which may supply sufficient virulence
determinants for successful infection, rendering such a phage role unnecessary.
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Despite seemingly no role in virulence, phage have been well-studied in the B.
cereus sensu lato group (reviewed in (Gillis and Mahillon, 2014)). Such research
however, has typically focused on their host-range and structural characteristics. A
brief review of the phages of the B. cereus s.l. group (and in particular, B. anthracis)
follows.

The phages of the B. cereus s.l. group belong to the Myoviridae (large phage with
contractile tails), Siphoviridae (phage with non-contractile tailes), Podoviridae
(phage containing short non-contractile tails), and Tectiviridae (tailless phage
containing spikes) families. Many phages in the group have broad host ranges and
can infect B. anthracis, B. cereus, and B. thuringiensis, and also serve as
transducing agents for HGT (Gillis and Mahillon, 2014). Other phages however, are
specific to B. anthracis. Foremost are the chromosomally-integrated prophages
(lambdaBa01-lambdaBa04) that distinguish B. anthracis from B. cereus and B.
thuringiensis. Interestingly however, these phages cannot form viable virions and
lyse cells. Their effects on the host are to date, unclear (Sozhamannan et al., 2006).
A well-studied non-integrating B. anthracis-infecting phage is the gamma (g) phage.
The g-phage, and related phages (known as g-like phages) are virulent phages
highly-specific for B. anthracis (but also a few B. cereus strains) that are believed to
have originated from the temperate phage Wb and are used for strain typing
(Schuch and Fischetti, 2006). f20 is a plasmidial temperate phage isolated from B.
anthracis Sterne (containing the pXO1, but not pXO2 virulence plasmid), however
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its sequence is unknown as are any of its effects on the bacteria (Inal and
Karunakaran, 1996).

Some studies have examined lysogens for phenotypic changes associated with phage
carriage, however are limited in scope. One early study found capsule-producing B.
anthracis displayed no difference in a mouse model of virulence between strains
lysogenized or not lysogenized with phage b. The same strain lysogenized with the
close relative phage a however, showed decreased virulence, and the phage was
found to induce into the lytic cycle and lyse cells when exposed to sodium
bicarbonate and high CO2 levels. It was believed that the decreased virulence of ainfected cells was due to phage induction occurring in vivo (Iyanovics, 1962).
Regardless in either case, lysogeny was associated with either no change or
decreased virulence of B. anthracis, effects typically not associated with phage
carriage. In another report, the B. anthracis-infecting phage AP50 was found to
convert colonies to a flat, wrinkled phenotype (Sozhamannan et al., 2008). Recently,
a lytic variant of the phage, AP50c, was found to select for resistant mutants in a B.
anthracis population. Resistant mutants all contained inactivating mutations in
csaB, the pyruvyl-transferase encoding gene, and displayed a mucoid phenotype
associated with csaB mutation (Bishop-Lilly et al., 2012). While AP50, a, b, f20 and
lambdaBa01-04 can lysogenize B. anthracis, detailed study of their potential
impacts on the bacteria’s lifestyle has not been carried out.
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In general, the effects of phage carriage on B. anthracis are not well-described. One
recent report from the Fischetti Laboratory has however, provided examples of
phage-mediated contributions to the B. anthracis lifestyle (Schuch and Fischetti,
2009). In this report, phages isolated from soil environments were found to stably
lysogenize B. anthracis, and resulting lysogens harbored new phenotypes promoting
long-term vegetative survival. Phage promoted biofilm formation, earthworm
colonization, vegetative cell changes, and also blocked sporulation, enabling longterm vegetative cell survival outside of an animal host (an environment where cells
typically sporulate). Some phages, surprisingly however, increased sporulation.
Regardless, in both cases, phenotypes were found to be driven by phage-encoded
sigma factors (Schuch and Fischetti, 2009). For B. anthracis, lysogenic conversion
appears to be crucial in controlling outside-host vegetative cell survival, and stands
in contrast to typical virulence-associated lysogenic conversion in other pathogens
(Figure 2-4).
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Figure 2-4. Phage-mediated lifestyle changes of B. anthracis. Lysogeny of B.
anthracis by phage from soil-environments can control vegetative cell survival after
mammalian host death. Phage can promote long-term soil survival by enabling
biofilm formation, earthworm colonization, cell-surface changes, and by blocking
sporulation. Other phages however, can promote sporulation in typically
asporeagenous conditions. Both changes are driven by phage-encoded sigma factors.
Reprinted with permission from (Schuch and Fischetti, 2009).
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2.3 How do phage from anthrax-endemic areas affect B. anthracis?
While the report by Schuch and Fischetti lent critical insights into the roles of
phage for B. anthracis, it also reinforced the notion that phage do not play a major
role in the pathogen’s virulence, with phages promoting post-disease vegetative soil
survival, and the phages used in the study themselves isolated from non-anthrax
endemic areas (potting soil, earthworm guts, and fern root systems) (Schuch and
Fischetti, 2009). No studies thus far have examined how phage from anthrax
contamination zones in particular may affect the Gram-positive pathogen, and if
they play any role in the virulence of the organism. The following research explores
this question and describes how a phage induced from the unusual disease-causing
isolate B. cereus Biovar anthracis CA alters the well-characterized Sterne strain of
B. anthracis.

For this study we induced a novel phage (fBACA1) from the pathogenic strain B.
cereus Biovar anthracis CA, and exposed Sterne to the phage, finding that fBACA1
could infect B. anthracis Sterne, and that phage exposure selected for a resistant
variant which displayed unusual and distinct phenotypes surprisingly similar to
those of the phage’s parent strain, CA. In the following sections, we show that
infection with fBACA1 selects for a B. anthracis csaB mutant, a gene target with
high homology between B. anthracis and B. anthracis-like B. cereus pathogenic
strains (Zheng et al., 2013), with the mutant harboring the phenotype previously
reported including: long chains of twisted cells, small convex colonies, and clump40

like growth in liquid culture (Bishop-Lilly et al., 2012). We also describe however,
novel csaB mutant characteristics in Sterne, including hemolytic activity, small
colonies without rough edges or “Medusa heads”, the appearance of multi chain
rope-like bacilli, and altered biofilm formation capacity. In addition, we examine the
virulence of the csaB mutant and describe a growth media-induced phenotypic
switch where the csaB mutant displays markedly altered phenotypes in rich media
versus animal host or serum growth environments, and characterize these
transcriptional changes via RNA-seq. Lastly, we link the observed csaB mutant
phenotype in Sterne to that reported for B. cereus bv anthracis CA, uncovering by
deep-sequencing a subpopulation of csaB mutants in a CA genomic sample. Taken
together, this research suggests that lytic phage-bacteria interactions (in addition to
lysogeny) may be an important factor shaping populations of Bacillus anthracis and
B. anthracis-like pathogenic species in the wild.
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RESULTS

2.4 Exposure of B. anthracis Sterne to an anthrax-derived phage identifies
a Sterne variant with distinct phenotypes

This study aimed to understand the effects of induced phage from disease-causing
isolates of B. anthracis and B. anthracis-like species on the well-characterized
strain B. anthracis Sterne. B. cereus Biovar anthracis CA, a unique anthrax-like
strain isolated from an infected ape carcass in Cameroon (Klee et al., 2006), was
cultured with mitomycin C to induce potential prophage. We incubated Sterne with
an induced and purified phage from CA, termed fBACA1, and found the resulting
colonies to harbor a markedly different phenotype after phage exposure. We then
purified this variant strain, termed Sterne::fBACA1, for further phenotypic
analysis.

On BHI plates, Sterne::fBACA1 colonies were smooth, mucoid, and smaller than
Sterne, did not contain rough edges or “Medusa heads”, and were not easily
removable with pipet tips or loops; they would stick to plates before being pulled off
whole (Figures 2-5a and 2-5b). On Columbia blood agar, Sterne::fBACA1 culture
spots contained a yellow-green center, maintained their smaller size as compared to
Sterne, and after >24 hrs growth at 37°C, displayed b-hemolytic activity in the
center of the culture spots (Figure 2-5c) (Table 2-2).
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In liquid BHI culture, Sterne::fBACA1 settled to the bottom of tubes resulting in
clear supernatants, while Sterne displayed a uniform turbid culture (Figure 2-5d).
By microscopy, Sterne::fBACA1 displayed its most remarkable characteristics,
including increased chain length, a lack of clear division septa, and twisted
corkscrew-like cellular morphologies similar to structures described for CA (Klee et
al., 2006) (Figure 2-6). In addition, we observed the appearance of highly organized,
multi-chain rope-like structures. These structures were observed in static and
shaken liquid cultures. Staining with acridine orange and DAPI revealed both the
organized nature of these structures and that cellular division and partitioning of
DNA was occurring despite no visible division septa (Figure 2-6). The rope like
structures would often converge at nodes connecting the culture as one contiguous
mass (Figure 2-7).

Table 2-2. Phenotypic comparisons of B. anthracis Sterne and
Sterne::fBACA1.

Strain

Roughedged
colonies

Hemolysis

DNase
activity

g-phage
susceptibility

Penicillin
sensitivity

Motility

Sporulation

Sterne

+

-

+

+

S

-

+

Sterne::

-

+

+

+

S

-

+

ΦBACA1

(+) Positive for trait
(-) Negative for trait
(S) Penicillin sensitive
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Figure 2-5. B. anthracis Sterne exposed to fBACA1 displays atypical B.
anthracis phenotypes. A) Comparison of Sterne (left) and phage-exposed Sterne
(right) on BHI agar plates. Sterne colonies display rough edges with larger colony
size. Phage-exposed Sterne colonies display more compact and smaller colonies with
smooth edges. B) Photograph of individual Sterne (left) or phage-exposed Sterne
(right) colonies. Sterne colony contains weak borders with a dense colony center;
phage-exposed Sterne displays a tight colony border and is of uniform density
throughout. C) Culture spots of Sterne (left) and phage-exposed Sterne (right)
grown on 5% sheep blood agar at 37°C. Sterne does not display hemolytic activity,
while phage-exposed Sterne displays hemolytic activity in the middle of the colony
and yellow-green color; D) Sterne (left) and phage-exposed Sterne (right) grown in
liquid BHI culture at 30°C. Sterne culture is uniformly turbid, while phage-exposed
Sterne culture grows as one bacterial mass settled at the bottom of the culture tube,
with the surrounding media clear.
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Figure 2-6. B. anthracis Sterne::fBACA1 harbors phenotypes similar to B.
cereus Biovar anthracis CA and grows in unique, rope-like multi-chain
structures. A) B. anthracis Sterne grown in liquid culture displays chains with
clear division septa. B) B. anthracis Sterne::fBACA1 grows with an abnormal
twisted morphology. C) B. anthracis Sterne::fBACA1 grows in longer multi-cell
chains without clear division septa as compared to Sterne. D) B. anthracis
Sterne::fBACA1 grows in organized, rope-like, multi-chain structures. E) (top)
phase-contrast image of Sterne::fBACA1 rope-like structure does not show clear
division septa; (bottom) Sterne::fBACA1 stained with DAPI shows DNApartitioning and cellular division within multi-cell chains. All images captured at
1000X magnification, except C at 400X.
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Supplemental Figure 1
A

B

Figure 2-7. B. anthracis Sterne::fBACA1 displays unique growth
characteristics. A) (top) Sterne::fBACA1 robust rope-like structure with phasecontrast microscopy; (bottom) Sterne::fBACA1 stained with acridine orange reveals
clear division septa and organization of the rope-like structure (captured at 1000X
magnification). B) Representative example of a Sterne::fBACA1 “node” in liquid
culture, where multiple rope-like structures converge (captured at 100X
magnification).
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We also tested Sterne::fBACA1 for DNase activity, susceptibility to g-phage,
penicillin resistance, motility, sporulation, and biofilm formation. Sterne::fBACA1
and Sterne did not show penicillin resistance or motility as compared to the positive
control B. cereus T. Sterne and Sterne::fBACA1 were also sensitive to g-phage and
did not show qualitative differences in DNase activity nor significant differences in
sporulation (Table 2-2). Sterne::fBACA1 differed in biofilm formation capacity
compared to Sterne, with the variant strain displaying no biofilm formation at
room-temperature (RT) or 30°C until 10 weeks, whereas Sterne was capable of
forming biofilms at earlier time points. However, both Sterne and Sterne::fBACA1
formed equivalent biofilms at similar time points at 37°C with or without glucose
(Table 2-3). Sterne::fBACA1’s inability to form a biofilm at RT and 30°C may arise
from its sticky and clump-like growth, preventing sufficient cellular seeding at the
liquid-air interface.
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Table 2-3. B. anthracis biofilm formation capacities.
3 weeks

RT

RT +

30°C

glucose

30°C +

37°C

glucose

37°C +
glucose

Sterne

-

-

+

++

+++

+++

Sterne::fBACA1

-

-

-

-

++

+++

Sterne

-

+++

++

++

-

+++

Sterne::fBACA1

-

-

-

+

-

+++

Sterne

+

+++

++

+

-

++

Sterne::fBACA1

+

-

-

+++

+

+++

6 weeks

10 weeks

Biofilms were scored weekly for strength/robustness. Scoring key: (-) no biofilm; (+)
weak growth; (++) medium growth; (+++) strong growth.

2.5 Sterne::fBACA1 is not lysogenized by fBACA1

Sterne::fBACA1 had a unique phenotype, and we were curious to understand the
genomic changes, if any, responsible for its novel characteristics. Re-exposure of
Sterne::fBACA1 to fBACA1 stocks did not result in cell lysis on plates or in liquid
cultures, indicating that the variant strain was resistant to infection. Phageresistance can occur, in part, due to lysogeny, receptor modification, or other
genomic changes in the organism. To test if Sterne::fBACA1 was indeed lysogenized
with fBACA1, we first sequenced the genomic DNA of fBACA1 to allow for
construction of PCR screening primers. De novo assembly of phage DNA reads
resulted in two contigs that had a 16 base-pair overlap. RAST and PHASTER
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analysis of joined contigs predicted an intact prophage element, with Siphoviridaelike genome organization, and gene sequences commonly resembling those of other
Siphoviridae phages by BLAST analysis. We did not complete the fBACA1 genome,
however the de novo assembled contigs of the prophage element are available in
Appendix 1. We used this contig sequence to design PCR primers (phiBACA1_F,
phiBACA1_R) to probe for phage-specific sequence in Sterne and Sterne::fBACA1
by PCR. Surprisingly, no fBACA1-product was detected in Sterne or
Sterne::fBACA1, while the phage stock as positive control produced the predicted
product. Southern blots of whole genome DNA preparations from Sterne and
Sterne::fBACA1 were also negative for fBACA1 DNA (data not shown).

2.6 DNA sequencing reveals a single-nucleotide insertion responsible for
Sterne::fBACA1 phenotypes and fBACA1-resistance

Results from the PCR and Southern blot experiments indicated Sterne::fBACA1 is
not lysogenized with fBACA1 and that Sterne likely undergoes selection for phageresistant variants upon fBACA1 exposure. Separately, we were able to transiently
lysogenize Sterne with fBACA1 after repeated attempts, but the lysogens grew very
weakly on plates and in liquid culture. Restreaking these lysogenic colonies on BHI
agar often resulted in no growth or colonies that had Sterne::fBACA1-like
phenotypes. Therefore Sterne can carry fBACA1, however unstably under our
conditions, with ultimate selection for fBACA1-resistant Sterne variants.

51

To understand the genomic background of Sterne::fBACA1’s phage-resistance and
its associated phenotypes, we sequenced Sterne and Sterne::fBACA1 for direct
comparison. De novo assembly of reads from Sterne::fBACA1 did not reveal any
novel elements nor reads corresponding to fBACA1, supporting PCR and Southern
blot data that the variant strain is not lysogenized with the phage. However, two
single nucleotide insertions in Sterne::fBACA1 were uncovered by comparing read
alignments of the chromosome: a (G)4à(G)5 insertion at position 1,730,529, and an
(A)7à(A)8 insertion in position 1,710,151 of the chromosome (Table 2-4). Both
insertions were confirmed by Sanger sequencing. The A(7)àA(8) insertion is in the
3’ end of a tRNA methyltransferase, and is predicted to change the amino acid
sequence of the protein product from …KGSFSRQILVCE* to …KRIIF*. It is
unclear if or how truncation and alteration of the gene product may affect its
activity. The (G)4à(G)5 insertion lies in the 5’ region of the csaB gene, a pyruvyltransferase that acts on the SCWP. The specific (G)4à(G)5 insertion that
Sterne::fBACA1 harbors appears to be a “hotspot” of mutation in csaB as it has
previously been implicated in B. anthracis AP50c phage resistance (Bishop-Lilly et
al., 2012), with AP50c phage unable to adsorb to the csaB mutant’s cell surface.
Both the AP50c-resistant variant and the fBACA1-resistant variant from this
current study appear to encode a truncated, inactive CsaB protein (Table 2-4).

52

Table 2-4. Genomic alterations uncovered in Sterne::fBACA1 by wholegenome DNA sequencing.
Position

Change

Type

Frequency

Coverage

P-

Result

Value
1730529

(G)4 ®

Insertion

98.2%

338

0

Frameshift
mutation

(G)5

(truncation of
CsaB protein)
1710151

(A)7 ®

Insertion

97.1%

383

0

Frameshift
mutation (7 AA

(A)8

truncation of
tRNA
methyltransfer
-ase protein)

From our sequencing, Sterne::fBACA1 appears to be a csaB mutant that harbors a
number of reported phenotypes linked to CsaB deficiency, including long bacterial
chains, twisted cells, and clumping in liquid culture. However, we also report
additional phenotypes for the fBACA1-selected csaB mutant, including: rope-like
multi-chain structures, hemolytic activity with small, yellow-green culture spots on
SBA plates, and resistance to the phage fBACA1. Since no lysogeny was proven to
exist, we will refer to Sterne::fBACA1 as Sterne dcsaB for the remainder of this
Thesis. To definitively link fBACA1 resistance and the observed Sterne dcsaB
phenotypes to csaB and not the single-nucleotide insertion in the tRNAmethyltransferase, we reverted the (G)4à(G)5 mutation, while leaving intact the
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(A)7à(A)8 insertion. Successful construction of the strain was confirmed by Sanger
sequencing and the strain termed Sterne comp-csaB.

Comp-csaB phenotypes were Sterne-like and reversed those from dcsaB. By
microscopy, comp-csaB cells had short chain lengths, clear division septa, and the
absence of any twisted cells or rope-like multi-chain structures. Sterne comp-csaB
had larger colonies with rough edges and “Medusa heads” on BHI agar, and culture
spots did not display hemolytic activity (Figure 2-8). BHI liquid cultures of Sterne
comp-csaB were turbid and similar to Sterne. Biofilm and sporulation analysis of
the revertant strain did not show qualitative differences in biofilm formation
capacity, nor significant differences in sporulation (data not shown). In addition,
sensitivity to fBACA1 was regained in comp-csaB (Figure 2-8). The reversion of
distinct dcsaB phenotypes observed in comp-csaB therefore links a number of
reported (Mesnage et al., 2000) and newly discovered pleiotropic effects to the csaB
gene. The single-nucleotide insertion in the tRNA-methyltransferase does not result
in observable phenotypes different from Sterne, however we cannot rule out their
existence. Notably, B. anthracis strains resistant to AP50c phage via csaB mutation
were also shown to harbor additional SNPs in their genomes (Bishop-Lilly et al.,
2012); the roles and geneses of these mutations are unclear.
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Figure 2-8. B. anthracis comp-csaB displays Sterne-like phenotypes. A)
Sterne comp-csaB visualized under phase-contrast microscopy displays short chains
and the absence of multi-chain structures (captured at 100X magnification). B)
Sterne comp-csaB shows clear division septa (captured at 1000X magnification). C)
A single Sterne comp-csaB colony on BHI agar displays a Sterne-like rough edge. D)
Sterne and Sterne comp-csaB are sensitive to infection by fBACA1; Sterne dcsaB is
resistant. All strains grow with PBS spotted as a negative control. E) Sterne, Sterne
dcsaB, and Sterne comp-csaB grown on Columbia 5% sheep blood agar display
different growth phenotypes. F) Sterne and Sterne comp-csaB culture spots do not
display hemolytic activity, whereas Sterne dcsaB displays hemolytic activity in the
center of growth. RN4220 is included as a positive control for hemolysis.
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2.7 Sterne dcsaB does not show altered virulence potential in a mouse
model, and exhibits an altered phenotype in the infection environment

As the mutant Sterne dcsaB exhibited a distinct phenotype, we tested whether a
csaB mutation event would affect the virulence potential of Sterne. We compared
the virulence of Sterne and Sterne dcsaB in a mouse bacteremia model. Since
Sterne dcsaB had longer chain lengths than Sterne, we normalized the two strains
to ensure equivalent bacterial dosing. We determined that Sterne dcsaB chain
length was on average 5-6-fold longer than Sterne under the conditions used for this
experiment, and therefore Sterne dcsaB was injected at a 5-6-fold lower CFU/mL
dose. Normalized Sterne and Sterne dcsaB did not show a significant virulence
difference between survival curves in survival percentage or median time to death
(P = 0.3450, Figure 2-9).
Sterne (n = 12)
Sterne dcsaB (n = 12)

Figure 2-9. Survival curves of Sterne and Sterne dcsaB from mouse
infection model.
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While Sterne dcsaB did not show altered virulence potential in our animal model,
we were curious if or how the rope-like structures might contribute to disease, and
examined various mouse organs 48 hours after initial infection. GFP-PlyGBD
visualization of bacilli by microscopy surprisingly did not reveal the long chain,
rope-like structures typical of the variant grown in BHI, but rather shorter chains
and dispersed bacteria resembling Sterne (Figure 2-10a). Occasionally we observed
longer-chain rope-like structures and cells with corkscrew-like twisted
morphologies, however they did not comprise the majority of visualized Sterne
dcsaB cells (data not shown). We also passaged Sterne dcsaB directly from infected
tissues into liquid BHI culture for growth at 37°C overnight. Remarkably, these
cultures harbored the phenotype initially observed with long chains of cells, ropelike multi-chain structures, cells with a lack of clear division septa and
corkscrew/twisted morphologies (Figure 2-10b). The distinct change in growth
characteristics of Sterne dcsaB in mouse tissues as compared to BHI suggested a
phenotypic switch dependent upon the bacteria’s external environment.
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Figure 2-10. B. anthracis Sterne dcsaB displays a unique and reversible
phenotype in the infection environment. A) Sterne dcsaB extracted from
mouse kidney, labeled with GFP-PlyGBD displays Sterne-like morphology and chain
lengths (captured at 200X magnification). B) Reculturing Sterne dcsaB from the
mouse into liquid BHI reveals long-chain, rope-like bacterial structures and twisted
morphologies (captured at 100X magnification).

2.8 Sterne dcsaB grown in fetal bovine serum displays a similar phenotype
as observed in mouse tissues

Results from mouse infection experiments suggested that the animal host
environment induces a switch that alters the phenotype of the variant Sterne dcsaB
strain. To mimic this growth outside the mouse, we cultured Sterne dcsaB in fetal
bovine serum (FBS). Sterne dcsaB in FBS displayed turbidity similar to that of
Sterne, without the appearance of any bacterial clumping or masses. By microscopy,
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cells resembled Sterne: short chains with clear division septa, and the total absence
of any multi-chain or rope-like structures (Figure 2-11). While we observed
occasional disorganized clusters of cells in the Sterne dcsaB FBS culture, we
observed similar structures to the same degree with the Sterne FBS culture.

Figure 2-11. Sterne dcsaB in FBS harbors Sterne-like and similar
phenotypes to those seen in mouse infection. A) B. anthracis Sterne (left) and
Sterne dcsaB (right) grown in FBS at 37°C display similar phenotypes (captured at
100X magnification). B) (left and right) Sterne dcsaB displays clear division septa in
FBS culture and a distinct phenotype as compared to BHI growth (images captured
at 1000X (left) and 100X (right) magnifications).
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Sterne dcsaB in Figure 2-11 was grown in FBS at 37°C to mimic temperatures in
the mouse. Interestingly, when we cultured dcsaB in liquid BHI at 37°C, we
normally observed growth of the strain as a single mass, but occasionally, the
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bacteria
would disperse and grow as a turbid culture. When grown in BHI at 30°C
however, we did not observe this behavior; Sterne dcsaB cultures always remained
as one mass at the bottom of tubes with a non-turbid, clear supernatant (Figure 212). Growth in FBS at 30°C did not alter the observed serum phenotypes of Sterne
dcsaB, however 36 hours of growth was required for the entire culture to be devoid
of any bacterial clumps or masses.
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Figure 2-12. B. anthracis Sterne dcsaB displays different growth
characteristics in BHI liquid culture at 30°C versus 37°C. Labeled liquid
culture tubes of Sterne dcsaB show characteristic “clumped” growth in BHI at 30°C,
and occasionally observed turbid growth in BHI at 37°C. Sterne dcsaB grown in
FBS at 37°C, in which turbidity was always observed, is shown for reference.

61

Using this temperature-based growth characteristic of dcsaB, we examined the
minimum FBS dose necessary to observe the growth media-induced phenotypic
switch by culturing Sterne dcsaB in increasing ratios of BHI:FBS at 30°C. Cultures
showed higher turbidity with increased concentrations of FBS, with a complete loss
of the BHI-associated phenotype at a 90:10 BHI:FBS ratio, suggesting that serumderived factors are too dilute to elicit a phenotypic switch below a 10-fold dilution
(Figure 2-13).

Figure 2-13. FBS induces phenotypic changes in B. anthracis Sterne dcsaB
in a dose-response-like manner. BHI:FBS mixed media cultures of Sterne dcsaB
ranging from 100:0 BHI:FBS to 0:100 BHI:FBS. Cultures display little to no
turbidity from 100% to 90% BHI by volume, but become increasingly turbid and
uniform as % FBS increases.
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In addition, growth of Sterne dcsaB in 85°C heat-treated FBS displayed similar
phenotypes and morphologies to growth in non-heat-treated FBS, suggesting that
heat labile factors are not responsible for the observed switch (Figure 2-14).
Preliminary fractionation experiments to uncover the serum factor(s) responsible
suggested multiple components may be at play for the phenotypic switch, but we did
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not characterize these factors for this study; experiments are ongoing for their
future discovery and purification (Appendix 2).
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Figure 2-14. B. anthracis Sterne dcsaB grows in turbid culture in heattreated FBS. Sterne dcsaB was grown in heat-treated FBS and observed for
growth phenotypes and morphologies. A) Sterne dcsaB grown in heat-treated FBS
at 37°C displays short chains and the absence of multi-chain structures, with
similar growth to that of FBS culture (captured at 100X magnification). B) Sterne
dcsaB grown in heat-treated FBS shows clear division septa and short chains
(captured at 1000X magnification).
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2.9 RNA-seq reveals global gene expression differences between Sterne
and Sterne dcsaB in BHI and FBS growth environments

The distinct phenotypes of Sterne dcsaB suggested there may be large-scale gene
expression changes due to csaB mutation and the bacteria’s external environment.
In addition, we hypothesized that differential expression (DE) between Sterne and
Sterne dcsaB may be occurring to a greater degree in BHI than FBS due to the
disparate BHI-associated phenotypes observed. We designed an RNA-seq
experiment to test these hypotheses and compare gene expression patterns between
and within Sterne and Sterne dcsaB grown in BHI or FBS media, resulting in four
group comparisons: 2 of genotype (Sterne against dcsaB in BHI and FBS), and 2 of
growth condition (Sterne or dcsaB BHI against FBS). RNA-seq was carried out as
described in Materials and Methods, and a summary of the differential expression
data is presented in Tables 2-5a and 2-5b; the full data set is given in Appendix 3.

Our RNA-seq experiment revealed several changes associated with both genotype
and growth condition. Despite imparting strict limits on calling DE due to the
number of sample replicates, our 4 group comparisons yielded a percentage range of
called DE genes from 10.94 - 56.56% of the genome. CsaB mutation has a noted
pleiotropic effect on the bacterial cell (Mesnage et al., 2000); by RNA-seq, it also
appears to fundamentally alter its transcriptome.
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Table 2-5a. B. anthracis Sterne and Sterne dcsaB whole-genome
differential expression (DE) summary.
Group

# downregulated

# upregulated

% downregulated

% DE genes of

Comparison

DE genes (in A)

DE genes (in A)

/ % upregulated

all B. anthracis

genes

Sterne genes

(A vs. B)

dcsaB BHI vs.

1620

1606

50.2/49.8

56.6

828

849

49.4/50.6

29.4

1194

1106

51.9/48.1

40.3

237

387

48/62

10.9

dcsaB FBS
Sterne BHI vs.
Sterne FBS
dcsaB BHI vs.
Sterne BHI
dcsaB FBS vs.
Sterne FBS

Table 2-5b. B. anthracis Sterne and Sterne dcsaB pXO1-only differential
expression (DE) summary.
Group

# downregulated DE

# upregulated

% downregulated

% DE genes of

Comparison

genes (in A)

DE genes (in A)

/ % upregulated

all pXO1-

genes

encoded

(A vs. B)

genes

dcsaB BHI vs.

56

11

83.7/16.4

39.9

67

2

97.1/2.9

41.07

30

9

76.9/23.1

23.2

23

4

85.2/14.8

16.1

dcsaB FBS
Sterne BHI vs.
Sterne FBS
dcsaB BHI vs.
Sterne BHI
dcsaB FBS vs.
Sterne FBS
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For Sterne dcsaB, phenotypic differences are markedly pronounced between BHI
and FBS growth, and a similar gene expression pattern is reflected in the RNA-seq
data. 56.56% of Sterne dcsaB genes were DE comparing growth in BHI versus FBS.
For Sterne, this value was 29.4%. Sterne and Sterne dcsaB showed a number of
different phenotypes in BHI, but less so in FBS. This is also reflected in the
differential expression data. 40.3% of genes were DE between the two strains grown
in BHI, but this value was reduced to 10.9% for FBS. Principal component analysis
(PCA) of the RNA-seq samples shows a similar result (Figure 2-15). Sterne and
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Sterne dcsaB BHI samples are distinctly clustered from each other, as are intrastrain BHI and FBS samples. Sterne and Sterne dcsaB samples grown in FBS
however, cluster closer together in the plot.

Figure 2-15. Principal component analysis (PCA) plot of samples from
RNA-seq. Sterne and Sterne dcsaB RNA-seq sample distances visualized using
PCA. Sterne BHI and Sterne dcsaB BHI biological groups form distinct clusters
with their respective replicates clustered together. Sterne and Sterne dcsaB FBS
groups cluster both near each other and with their respective replicates clustered
together, indicating smaller sample distance between the two biological groups than
between Sterne and Sterne dcsaB BHI groups.
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For Sterne and Sterne dcsaB whole genomes, DE in BHI versus FBS environments
is equally split between upregulated and downregulated genes. Examining pXO1encoded genes only however, reveals that most of its DE genes are upregulated in
FBS (Table 2-5b, Appendix 3). In Sterne dcsaB, 67 pXO1 genes were differentially
expressed in total, with 56 upregulated in FBS growth. For Sterne, of 69 DE genes,
67 are upregulated in FBS growth. The upregulation of pXO1 virulence-associated
genes we observe is similar to reports of pXO1 upregulation in CO2/bicarbonate
atmospheres (McKenzie et al., 2014; Passalacqua et al., 2009a). Therefore, we
believe upregulation of pXO1-encoded genes in FBS suggests the media may be a
partial mimic of the infection environment. The RNA-seq data we present shows
global transcriptional changes in Sterne and Sterne dcsaB, revealing a growthmedia induced switch of the transcriptome and the dynamic nature of B. anthracis
Sterne, wild-type and dcsaB. In addition, our data highlights the pleiotropic effects
of csaB mutation and correlates the disparate phenotypes of Sterne and Sterne
dcsaB with differential expression. At this time however, we cannot describe specific
transcriptional changes that may account for the two strains’ similarities in FBS
and distinct differences in BHI growth media. Experiments to uncover key genes
involved in this event are ongoing.
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2.10 Western blot of protective antigen correlates with RNA-seq data

To validate data generated from our RNA-seq experiment, we took an orthogonal
approach, measuring levels of protective antigen (PA) in culture supernatants by
Western blot. Growth condition comparisons revealed that in Sterne, pag is
upregulated 4-fold in FBS as compared to BHI culture, while in dcsaB this
upregulation is 50-fold. Genotype comparison data showed Sterne expresses pag 10fold higher than dcsaB in BHI, while in FBS there is no significant difference in pag
expression between the two strains. Results from Western blots corroborated these
data (Figure 2-16). A combined blot (Figure 2-16a) displays normalized samples
from Sterne, Sterne dcsaB, and Sterne comp-csaB grown in BHI or FBS, as well as
negative controls of DSterne (lacking pXO1 and pXO1-encoded pag), and BHI or
FBS growth media alone. The combined blot shows equivalent detection of
protective antigen at the expected molecular mass among Sterne, Sterne dcsaB, and
Sterne comp-csaB in FBS-growth environments in agreement with our RNA-seq
data, and the absence of PA in DSterne and FBS-only samples. As FBS contains a
high level of endogenous proteins, to obtain distinct bands on a gel, dilution of
samples 1:100 in 1X PBS was required. PA protein levels were below the limit of
detection for all BHI samples at this dilution, suggesting lower levels of PA
expression in BHI culture. Therefore, an additional blot was generated using
concentrated BHI supernatants. This blot (Figure 2-16b) shows normalized,
concentrated supernatants from Sterne, Sterne dcsaB, and Sterne comp-csaB BHI
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samples, as well as DSterne and BHI-only controls. Sterne and Sterne comp-csaB
display equivalent band intensities for PA, while Sterne dcsaB displays a fainter
band. No PA is detected in DSterne and BHI-only controls. This blot indicates that
pag expression for Sterne dcsaB is downregulated compared to Sterne, and reversal
of the single nucleotide insertion in csaB (and not within in the 3’ tRNAmethyltransferase) restores pag expression to that of wild-type Sterne. Our
Western blot is in accordance with data generated from our RNA-seq, and validates
its results in an orthogonal manner.
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Figure 2-16. Western blot of protective antigen in culture supernatants
validates RNA-seq data. Western blot of culture supernatants from Sterne,
Sterne dcsaB, and Sterne comp-csaB grown as described for RNA-seq are probed for
protective antigen. Selected area of blots between 75-100 kD are shown for clarity.
A) 1:100 diluted and normalized samples in 1X PBS from strains grown in BHI or
FBS are shown. Normalized BHI samples are below the limit of detection. For FBS
samples, Sterne, dcsaB, and comp-csaB show approximately equivalent bands for
protective antigen. Negative controls DSterne and FBS-only do not show bands
corresponding to protective antigen. B) Western blot of concentrated, normalized
BHI supernatant samples shows approximately equal band intensity for Sterne and
Sterne comp-csaB, but decreased band intensity for Sterne dcsaB. DSterne and BHI
negative control samples do not show protective antigen-specific bands.
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2.11 Deep-sequencing reveals unstable carriage of fBACA1 and that csaB
mutation does not readily revert
Given the phenotypic similarities between Sterne dcsaB and B. cereus bv anthracis
CA, we were curious if a proportion of the CA population may harbor mutations in
csaB, potentially uncovering a genomic basis for the previous phenotypic
observations of CA (Klee et al., 2006). We used a deep-sequencing approach to
examine csaB variants in CA as well as several Sterne strains. Prior to carrying out
deep-sequencing of csaB amplicons however, we determined the spontaneous
resistance rate of Sterne to fBACA1 and examined Sterne dcsaB for potential
reversion to wild-type. Sterne fBACA1-resistant colonies were found to appear at
an average rate of 4.8 x 10-7 resistant colonies/CFU. We also examined if Sterne
dcsaB would revert its csaB mutation in the absence of phage selection. Potential
csaB reversion was not observed in cultures, suggesting that under our conditions
and in the absence of phage, there is not a high selective pressure for revertant
cells.

The spontaneous fBACA1 resistance rate and lack of csaB reversion suggested that
uncovering csaB variants in Sterne or Sterne dcsaB by deep-sequencing was
unlikely unless sequencing was carried out with a very high read depth and
coverage of the csaB amplicon was in excess of 2,000,000x. For CA, phenotypes
suggestive of CsaB deficiency were readily seen (Klee et al., 2006), and given that
this strain harbors fBACA1, we hypothesized that selection for csaB mutation
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might occur at a higher rate and be uncovered by deep-sequencing. We carried out
deep-sequencing of csaB amplicons from CA, Sterne and the Sterne-derived strains
dcsaB and comp-csaB. Summarized results are in Table 2-6, including percentage
variant type classified as harboring nonsense, nonsynonymous, or silent mutations.
Individual variants uncovered by deep-sequencing are listed in Tables 2-7a-d.

Table 2-6. csaB variant frequencies of selected Bacillus anthracis strains.
Strain

% Frequency of mutation type in population

Nonsense

Nonsynonymous

Silent

Sterne

0

0

0.3

Sterne dcsaB

0

0

0

Sterne comp-csaB

0

0.2

0.1

CA

1.9

6.7

0.2

We found Sterne did not contain any variants with nonsense or nonsynonymous
mutations, but 0.3% of the population carried silent mutations in three distinct loci.
Sterne dcsaB did not contain any mutations in its population, excluding the
(G)4à(G)5 insertion. Sterne comp-csaB did not contain any nonsense mutations,
however 0.2% of the population did contain a nonsynonymous AàG transition
resulting in a serine to glycine substitution. It is not clear the downstream effect of
this substitution on CsaB activity. Sterne comp-csaB also harbored silent mutations
in 0.1% of its population. While Sterne and Sterne-derived strains did not harbor
any nonsense mutations, sequencing of CA revealed nonsense, single-nucleotide
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substitutions in 1.9% of the population and nonsynonymous, single-nucleotide
substitutions in 6.7% of the population. Silent mutations were present in 0.2% of
the CA population.

We have not verified that the nonsense mutations disrupt CsaB activity, however of
the 5 nonsense mutations found, 4 (1.7% of the CA population) occur upstream of a
mutation in csaB as reported by (Bishop-Lilly et al., 2012) to inactivate the CsaB
protein. It is unclear if the C878A variant also encodes for inactive CsaB.
Nonsynonymous mutations have been reported to inactivate CsaB in addition to
truncations of the protein. The nonsynonymous mutations we uncovered were not
the same nucleotide changes as previously reported (Bishop-Lilly et al., 2012),
however they are predicted to result in similar amino acid substitutions (charged
(+/-) to noncharged, noncharged to charged (+/-)). It is possible that a number of
these nonsynonymous mutations may reduce or disrupt CsaB activity. Results from
this deep-sequencing experiment show that B. cereus bv anthracis CA has an
increased level of variation and mutation in the csaB gene as compared to Sterne
and other Sterne-derived strains. We believe this variation is likely driven by
interaction of CA with fBACA1. From PCR screening, CA appears to carry
fBACA1, however variation in csaB suggests this lysogeny is not entirely stable,
and fBACA1 may drive the selection of CsaB-deficient mutants through lytic
interactions, giving rise to CA’s unique and atypical phenotypes.
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Table 2-7. Individual variants uncovered by deep-sequencing of csaB PCR amplicons.

Sequence

Position

Change

Coverage

Variant

Variant P-

Result

Frequency

Value

(amino

Mutation

Quality

Strand

score

bias %

acid
change)

A. Sterne

T

123

T®C

237,223

0.10%

3.80E-26

N®N

silent

34

59.4

A

144

A®G

240,118

0.10%

1.60E-26

K®K

silent

32

94.6

T

1,059

T®C

175,980

0.10%

1.70E-18

S®S

silent

33

97.3
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B. Sterne
dcsaB

No variants passing cut-off filter requirements

C. Sterne
comp-csaB

A

144

A®G

214,453

0.10%

7.90E-10

K®K

silent

30

90.6

A

223

A®G

266,763

0.20%

8.40E-22

S®G

nonsynonymous

31

61.8

D. CA

75

C

48

C®A

155,561

0.30%

3.20E-191

D®E

nonsynonymous

34

71.5

C

94

C®G

218,255

0.20%

1.80E-100

P®A

nonsynonymous

34

57

C

119

C®T

200,206

0.10%

1.30E-15

S®S

silent

31

89.2

A

122

A®G

203,609

0.30%

1.80E-56

N®S

nonsynonymous

30

96.7

G

124

G®T

205,618

0.10%

2.80E-10

D®Y

nonsynonymous

31

57.8

C

127

C®A

219,922

0.20%

1.50E-76

P®T

nonsynonymous

32

65

A

144

A®G

209,668

0.10%

1.20E-15

K®K

silent

32

94.6

G

293

G®T

220,697

0.10%

8.30E-22

R®I

nonsynonymous

31

76.3

C

301

C®A

212,536

0.20%

8.70E-46

R®S

nonsynonymous

32

55

C

332

C®A

233,478

0.10%

3.10E-07

A®E

nonsynonymous

30

69.7

C

346

C®A

300,363

0.70%

0.00E+00

P®T

nonsynonymous

35

51.1

C

367

C®A

197,735

0.20%

1.90E-11

R®S

nonsynonymous

31

63.8

C

392

C®A

188,342

0.50%

0.00E+00

S®*

nonsense

32

61.2

G

400

G®T

182,960

0.90%

0.00E+00

E®*

nonsense

36

53.8

C

485

C®A

176,215

0.50%

0.00E+00

P®Q

nonsynonymous

32

56.7

C

499

C®A

204,695

0.20%

6.90E-24

Q®K

nonsynonymous

31

58.5

G

559

G®T

211,738

0.40%

0.00E+00

A®S

nonsynonymous

34

59.3

C

560

C®A

221,461

0.20%

1.10E-32

A®E

nonsynonymous

30

62.1

G

562

G®T

199,746

0.40%

0.00E+00

V®F

nonsynonymous

35

58.3

G

613

G®T

270,400

0.40%

0.00E+00

D®Y

nonsynonymous

35

57.7

C

725

C®G

236,197

0.10%

2.10E-87

A®G

nonsynonymous

36

51.5

C

776

C®A

232,652

0.10%

1.10E-09

S®*

nonsense

30

75.8

C

785

C®A

250,178

0.20%

2.80E-23

S®*

nonsense

30

74.2

G

846

G®T

223,686

0.50%

0.00E+00

M®I

nonsynonymous

35

53.7

G

862

G®T

204,780

0.20%

1.20E-102

D®Y

nonsynonymous

32

68.3

G

874

G®T

186,993

0.10%

8.40E-08

D®Y

nonsynonymous

31

55.8

C

878

C®A

203,659

0.20%

7.20E-13

S®*

nonsense

30

73.2

C

973

C®A

161,633

0.60%

0.00E+00

Q®K

nonsynonymous

34

86.1

G

999

G®T

199,199

0.40%

0.00E+00

L®F

nonsynonymous

33

82

G

1,060

G®T

126,765

0.20%

6.00E-07

D®Y

nonsynonymous

30

72.9

A

1,072

A®G

110,304

0.20%

7.50E-17

K®E

nonsynonymous

30

93.8

* = stop codon; quality scores shown as Phred values
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DISCUSSION
Previous work in the Fischetti Lab uncovered the influence of bacteriophage on the
environmental lifecycle of B. anthracis, finding that phage-bacteria interactions—
and in particular lysogeny—control and can enable phenotypes that promote longterm vegetative survival (Schuch and Fischetti, 2009). These changes were driven
by sigma factors, encoded by phage isolated from diverse land and marine
environments. For this current study, we aimed to uncover how phage induced from
disease-causing isolates may shape B. anthracis. We found that exposure of Sterne
to fBACA1, a novel Siphoviridae-like phage induced from B. cereus bv anthracis CA
(itself a strain recovered from an ape presumed to have died of anthrax in
Cameroon (Klee et al., 2006)), selects for a phage-resistant variant with a unique
phenotype.

2.12 Selection by lysis drives unique phenotypes in CA and Sterne dcsaB
Whole-genome DNA sequencing revealed that exposure of Sterne to fBACA1
selected for and expanded a csaB variant population. This variant displayed a
unique phenotype atypical of classic B. anthracis, and remarkably, a number of its
observed traits were also reported for CA (Klee et al., 2006). These included colonies
lacking “Medusa heads” that were smaller, mucoid and smooth, and in addition, the
variant also displayed hemolytic activity on blood-agar plates. Under the
microscope, we observed increased chain lengths of bacilli without clear division
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septa, and like CA, the appearance of twisted and corkscrew-like cells. The number
of characteristics shared between dcsaB and CA suggests that the same factor(s)
(likely fBACA1) drives the appearance of atypical B. anthracis traits in both
strains. In dcsaB, we also observed a novel characteristic of multi-chain and
organized rope-like growth. It is presently unclear how these structures form, as
they were observed in both shaken and static cultures, and if the individual twisted
cellular morphologies observed translate into the genesis of these macromolecular
structures.

Sterne dcsaB shared a number of characteristics with CA, but also harbored
classical B. anthracis traits different from the African strain, including penicillin
sensitivity, a lack of motility, and sensitivity to g-phage. CA is penicillin resistant
and motile, however as previously reported (Klee et al., 2006), some subcultures of
the strain display inconsistent hemolytic activity, g-phage sensitivity, and capsule
production. Why the two strains differ is likely due to the evolutionary lineage and
associated genomic background of each strain. B. anthracis is a monomorphic
lineage within B. cereus sensu lato, while CA lies at the frontier between Bacillus
anthracis and Bacillus cereus sensu stricto (Antonation et al., 2016; Brézillon et al.,
2015). Thus, it is not surprising that CA possesses a mixture of typical B. anthracis
and B. cereus phenotypes. While the exact regulation mechanism behind CA’s
dynamic phenotypes is unclear, our data suggests that for CA, hemolytic activity,
twisted cellular forms, atypical growth and the appearance of small, smooth, shiny
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and mucoid colonies could in part, arise from selection for CsaB-deficient
subpopulations. We show that the phage fBACA1, isolated from CA itself, selects
for a phage-resistant csaB Sterne mutant that harbors CA-like phenotypes. Deepsequencing revealed that selection for csaB mutation occurred at a higher rate in
CA than for other B. anthracis strains tested. Whether fBACA1 is the agent
responsible for the selection of these mutants in CA is presently unclear and should
be studied further, but is a likely candidate. The previous reports of CA colonies
transitioning from a classic B. anthracis phenotype at 24 hours growth to colonies
with a CsaB-deficient phenotype at 48 hours growth (Klee et al., 2006), coupled with
our deep sequencing data and Sterne dcsaB’s phenotype suggest that lytic
interactions may indeed be occurring between CA and fBACA1 selecting for csaB
mutants in the CA population. We cannot yet state if such phage-bacteria
interactions are happening out of the laboratory setting and in native infection
environments such as the primate, but such future study will be crucial to better
understand the influence of phage on pathogenic Bacillus spp.

A simple approach to drive at this unresolved question is through deep-sequencing
of the csaB gene region from PCR of environmental samples, i.e., PCR using a DNA
template from direct swabs of ape carcasses without any exposure to the laboratory
or other artificial environments. Amplification and sequencing of the csaB region
should reveal if a subpopulation of cells harbor csaB mutation at a frequency
greater than that of spontaneous mutation. If from these samples, mutation in csaB
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is found in a significantly higher proportion of the population than suggested by a
random mutation rate, then phage-resistance and subpopulations of phage-resistant
cells would be suggested as an important component of the B. anthracis lifecycle, in
addition to lysogeny. It is also possible however, that csaB mutation is selected for
after initial strain isolation, and laboratory culturing may actually select for csaB
mutation instead. This would suggest however the presence of a phage-stabilizing
factor for fBACA1, specific to CA’s native environment that keeps the phage in the
lysogenic cycle. Such a factor could come from the animal host, the surrounding soil
environment, or potentially even the bacteria itself. If this were the case, then it
would be in contrast to typical events reported in other bacterial pathogens, where
phage tend to induce in infection conditions. In S. pyogenes for example, a soluble
factor from human pharyngeal cells was found to induce its phage and allow the
increased expression of phage-encoded superantigens and DNase which presumably
increase bacterial fitness (Broudy and Fischetti, 2003; Broudy et al., 2001; 2002).
fBACA1 does not encode any obvious virulence factors, and any potential benefits
from its induction are unclear. Thus, it may make sense for B. anthracis to prevent
phage induction when in an animal host, and for other pathogens to induce phage
which carry virulence factors located adjacent to or within lytic cycle operons.
Indeed, CO2/bicarbonate has been shown to cause the induction of B. anthracis
phage a, and a lysogens were found less virulent than non-lysogenized strains,
presumably due to indiscriminate lytic cycle induction and B. anthracis cell death in
the animal host (Iyanovics, 1962). For CA, preventing fBACA1 phage induction
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may maximize its virulence potential in the host. Given recent reports of other
lysogenized B. anthracis derivatives and their effects on vegetative cells (Schuch
and Fischetti, 2009), it may also be worthwhile to study the virulence potential of
these lysogens and examine if/how they maintain phage in infection environments.
Such work will better illustrate the roles of phage (if any) in the virulence program
of B. anthracis. If phage are lost in these lysogens as well, or there is selection for
resistant subpopulations, then lytic phage-bacteria interactions will appear to have
a broader role in B. anthracis infection and its further study will be warranted.

2.13 csaB mutation in B. anthracis may not negatively impact fitness

As B. cereus bv anthracis CA was isolated from the carcass of an infected ape, we
were curious of dcsaB’s virulence potential as compared to wild-type Sterne in an
animal model, and found that Sterne and dcsaB did not show a significant
difference in virulence potential. To our knowledge, this is the first virulence
comparison of a csaB mutant in B. anthracis, however comparison in a mouse model
between B. cereus G9241 and its csaB knockout was performed in Wang et al.,
where the csaB mutant displayed a significantly lower virulence potential (Wang et
al., 2013). The strains and methods used in our model versus Wang et al. vary
considerably and therefore cannot be meaningfully compared. It is noteworthy
however, that while B. cereus G9241 and its csaB knockout differed in virulence
potential, a larger difference was seen in time to death rather than percentage of
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animal death. Our animal model work showed no significant difference in either
comparison, but surprisingly, we found that dcsaB’s distinct BHI-associated
phenotype was largely absent in mouse tissues. Cells from the mouse examined by
fluorescence microscopy had Sterne-like morphologies, while reculturing the same
cells in BHI regenerated the long-chain, rope-like forms. This result suggested an
environmental dependent switch that alters the dcsaB phenotype. As B. anthracis
pathogenesis involves multiple organ systems (Moayeri et al., 2015), it is likely that
the bacteria would evolve strategies to ensure its dispersal throughout an animal
host and the presence of such a phenotypic switch makes evolutionary sense. If
dcsaB were to maintain its long chain, rope-like growth, it is unclear if the bacteria
would be able to disseminate effectively throughout the host and successfully infect
(Guichard et al., 2012). That dcsaB can effectively disseminate in this context
suggests csaB mutation may not be evolutionarily disadvantageous (at least in
Sterne) as the strain can apparently overcome the downstream effects of the
genomic alteration as needed.

We successfully mimicked the phenotypic changes seen in the animal environment
by growing dcsaB in fetal bovine serum, but it is presently unclear how FBS (or the
animal environment) precipitates this switch. Sterne dcsaB grown in heat-treated
serum also displays Sterne-like characteristics, suggesting that its serumphenotype is not due to direct action by FBS but likely changes from within the
bacteria itself, and preliminary fractionation experiments suggested there may be
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multiple components of serum that induce specific phenotypic changes. In addition,
a seemingly stochastic event was observed with turbid dcsaB growth in BHI at
37°C, suggesting that temperature can induce phenotypic changes in the csaB
mutant as well. Regardless, our data suggests that B. anthracis Sterne dcsaB can
respond to different growth environments, alter its phenotype accordingly and
overcome some of the effects of csaB mutation.

2.14 How does csaB mutation and the external environment affect B.
anthracis?

Given the phenotypic differences between Sterne and dcsaB as well as the mutant’s
multiple phenotypes, we designed an RNA-seq experiment to examine the
transcriptional changes occurring in Sterne and dcsaB during BHI and FBS growth.
RNA-seq revealed large scale, whole-genome expression differences between Sterne
and dcsaB as well as within each strain in BHI versus FBS environments. Withinstrain comparisons of Sterne and Sterne dcsaB showed large differential expression
in BHI versus FBS growth environments, though the changes for dcsaB were
greater than those of Sterne. Between-strain DE observed in our RNA-seq appears
to correlate with phenotypic comparisons of the strains; Sterne and dcsaB displayed
stark differences in BHI media and more similar phenotypes in FBS, and this trend
is reflected in the transcriptome data. The close transcriptional profile of the two
strains in FBS may explain why Sterne and Sterne dcsaB exhibit similar virulence
potentials in our animal model. While csaB mutation should prevent S-layer
83

associated virulence factors such as BslA, an adhesin (Kern and Schneewind, 2008),
from attaching to the cell wall, the virulence contribution of these gene products
does not appear large enough to significantly alter virulence in our model. Other
genes associated with virulence such as lethal factor and protective antigen did not
meet the criteria for calling differential expression in comparing Sterne and dcsaB
in FBS, but were called in BHI, highlighting 1) that Sterne and Sterne dcsaB have
vastly different profiles in a “non-infection” environment but are far more similar in
an “infection” context, and 2) the dynamic nature and phenotypic switch of dcsaB.
We showed an orthogonal example of this in a Western blot of protective antigen.

We found that many of the transcriptional changes associated with a CO2bicarbonate environment (upregulation of pXO1 and other virulence-associated
genes) (McKenzie et al., 2014; Passalacqua et al., 2009a) also appear to occur in
FBS growth, suggesting that FBS carries chemical queues that B. anthracis
responds to. Indeed FBS does contain bicarbonate, but there are likely other
components in the media as well that serve as queues for B. anthracis
transcriptional modulation. Eag expression is reported to increase with CO2bicarbonate exposure, and we note similar expression changes in FBS-cultured
Sterne and Sterne dcsaB. To our knowledge, our study is the first to examine via
RNA-seq the transcriptional changes of B. anthracis in serum versus rich-growth
media, though a previous report did study the transcriptional profile of B. anthracis
in bovine blood by microarray (Carlson et al., 2015). We link FBS growth, like that
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of CO2-bicarbonate enriched environments, to upregulation of genes important in
virulence, and give a global view of gene expression changes associated with BHI
and FBS growth for B. anthracis Sterne. We believe these two growth environments
may be good proxies for “infection” and “non-infection” environments, giving
researchers a useful resource to study gene regulation associated with growth
within and outside animal hosts. In addition, our RNA-seq data show the stark
differences in transcription arising from csaB mutation, again highlighting the
pleiotropic effects of this gene. CsaB-mediated pyruvylation of the SCWP enables
anchoring of Sap, EA1, and other Bacillus S-layer associated proteins with
demonstrated roles in virulence (Wang et al., 2013), cell-wall maintenance (Ahn et
al., 2006; Anderson et al., 2011), and nutrient acquisition (Tarlovsky et al., 2010). In
addition, CsaB may be acting in an, as of yet, uncharacterized manner on the
transcriptional level, similar to Sap and EA1 (Mignot et al., 2002). We believe csaB
mutation likely leads to a cascade of downstream effects, driving the large-scale
differential expression observed.

2.15 What accounts for dcsaB’s Sterne-like phenotype in FBS?

While our RNA-seq generated global transcriptional data, we cannot yet highlight
specific mechanisms behind the FBS-induced phenotypic switch for Sterne dcsaB.
Mesnage et al. reported the presence of csaB-independent pyruvylation pathways in
B. anthracis, detecting a pyruvylated fraction of SCWP in a B. anthracis csaB
knockout (Mesnage et al., 2000). It is unclear if SCWP pyruvylation is occurring in
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Sterne dcsaB in FBS growth environments, which would allow anchoring of SLHdomain proteins. Interestingly, expression of csaA-csaB is downregulated roughly 7fold in the csaB mutant grown in FBS compared to BHI. In Sterne, the operon does
not show differential expression between FBS and BHI culture, and comparison of
Sterne and dcsaB in FBS does not reveal differential expression of the genes, while
in BHI, dcsaB has increased csaA-csaB expression. This indicates that dcsaB
expression of the csaAB operon is increased in BHI culture. It is unclear why the
operon is more highly expressed in the mutant than in wild-type in BHI. It is
possible that CsaB protein might also act to control the expression of the csaAB
operon, in a similar manner to that of Sap and EA1, and that the truncated CsaB
product cannot exert such activity, offering a potential mechanism behind csaAB
upregulation. Alternatively, for the mutant in serum environments, CsaB protein
may play a diminished role.

We examined Sterne and Sterne dcsaB sensitivity to fBACA1 in FBS, finding that
Sterne—but not dcsaB—cultures were lysed by the phage (data not shown).
fBACA1 resistance is not reversed by FBS growth, and we believe it is likely the
fBACA1 receptor is not anchored to the cell wall in BHI or FBS cultures. This
result also suggests that an alternate pyruvylation pathway is likely not “picking up
the slack” for inactive CsaB. If pyruvylation is not occurring on the SCWP in FBS,
how does dcsaB grow in short chains with clear division septa? Mesnage et al. also
showed that CsaB-pyruvylated SCWP is not absolutely necessary for all autolysin
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activity, and Anderson et al. reported that in B. anthracis DcsaB, the addition of
recombinant BslO to cultures reduced average chain length of the knockout strain,
despite no apparent SLH-domain anchoring (Anderson et al., 2011; Mesnage et al.,
2000). So, it is possible that BslO or other peptidoglycan hydrolases could allow cell
wall division in the absence of CsaB activity. Our RNA-seq data shows that BslO
expression is higher in BHI than FBS, making it unlikely that increased BslO
concentration is directly contributing to the observed FBS phenotype. We cannot
rule out however that BslO or other peptidoglycan-modifying enzymes may possess
the ability to bind dcsaB SCWP in FBS and not in BHI by an unknown mechanism.

Interestingly, the genes encoding PatA1/B1 and PatA2/B2 (involved in
peptidoglycan and SCWP O-acetylation (Lunderberg et al., 2013)) also show
downregulation in dcsaB FBS growth as compared to BHI culture, suggesting a
possible reduction of peptidoglycan and SCWP O-acetylation in FBS cultured cells.
For Sterne, there is no DE for patA1/B1 or patA2/B2 between BHI and FBS
cultures, similar to the pattern seen for csaB. How this is directly related to csaB
mutation remains to be clarified. While a lack of O-acetylation has been linked to
limiting azide-induced autolysis in B. anthracis (Laaberki et al., 2011), the presence
of O-acetylation may contribute to the blocking of autolysin activity via steric
hindrance (Blackburn and Clarke, 2002). Therefore one possibility is that for dcsaB
grown in FBS, decreased O-acetylation may lead to increased autolysin activity and
peptidoglycan processing, allowing cell septation/separation even in the absence of
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CsaB-mediated SCWP pyruvylation. Given the number of genes involved in
peptidoglycan synthesis and remodeling, identifying specific gene products involved
in generating the dcsaB, FBS-associated morphologies may prove to be a difficult
and exhaustive task. However, focusing on those genes significantly upregulated or
downregulated in CO2/bicarbonate or FBS environments (Passalacqua et al., 2009a;
2009b; Rollins et al., 2008) may cull the list and offer potential candidate genes.

One possible candidate enzyme that may account for the serum-associated
morphology is EA1. In serum and bicarbonate environments, eag is expressed
higher than sap, and cells produce the eag-encoded enzyme EA1. In BHI culture,
the reverse is true, with Sap production dominating. This regulation by B. anthracis
is previously reported in the literature (Mignot et al., 2002; 2004; Missiakas and
Schneewind, 2017) and observed in our RNA-seq data set. Both Sap and EA1
proteins are capable of murein hydrolase activity (Ahn et al., 2006), and it is
possible that EA1 possesses the ability to septate cell walls in a manner similar to
BslO, while Sap may not have this activity. Experiments adding recombinant EA1
and Sap could examine both enzymes’ ability to cut cell walls in the absence of
CsaB-mediated SCWP pyruvylation and may indicate whether the expression of eag
relative to sap plays any role in the dcsaB serum phenotype.

If EA1 does not appear to alter the cell wall of dcsaB, an additional approach to
uncover factors important to dcsaB serum-associated morphology would be to add
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the supernatant from a dcsaB FBS culture to dcsaB cells grown in BHI. In the
absence of SCWP pyruvylation, autolysins and other associated peptidoglycansculpting proteins are likely secreted into surrounding media and FBS culture
supernatant could contain a variety of murein hydrolases that may have activity
against dcsaB cells. Addition of filtered supernatant to dcsaB cells in grown in BHI
could result in their decreased chain length and the loss of the csaB knockoutassociated morphologies. However, peptidoglycan and other SCWP modifications
present in BHI but not FBS culture may block their activity. If added FBS
supernatant does however shorten chain length and promote cell septation, then
these FBS-upregulated enzymes would be implicated in the phenotypic switch. An
additional experiment comparing added supernatant versus “heat-killed”
supernatant could show if the factors responsible are proteins susceptible to heat
degradation. Previous experiments comparing growth of dcsaB in FBS versus “heatkilled” FBS revealed that serum factors causing dcsaB’s phenotypic switch are not
heat labile, however the factors produced by the bacteria in response to serum may
be subject to such degradation. Mass spectrometry and/or fractionation could
elucidate specific factors.

Perhaps the most direct method to uncover factors critical to the dcsaB phenotypic
switch is through transposon mutagenesis or a similar gene inactivation approach.
Here, functional knockouts could be generated in dcsaB; screening libraries of dcsaB
variants on FBS-agar for clones lacking rough-edges or “Medusa heads” with convex
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colony morphology (i.e., the dcsaB-associated phenotype) could identify genes
important to the dcsaB serum switch. Alternatively, single colonies could be grown
in FBS liquid culture, with candidate clones as those failing to display the expected
culture turbidity. Either method could highlight gene products important to dcsaB’s
serum-associated morphological changes, however it is possible that multiple genes
are involved in this event, which could prevent identification of candidate clones, or
clones with intermediate phenotypes may appear as well. Regardless of these
potential shortcomings, this approach may help elucidate how Sterne dcsaB harbors
phenotypes atypical of csaB mutation when grown in FBS culture and should be
pursued. Identification of genes crucial to the phenotypic switch would also confirm
that the dcsaB morphologies associated with FBS culture are caused by B. anthracis
sensing its environment and adjusting accordingly via transcriptional modulation,
and not through direct serum activity.

2.16 How does phage-resistance affect B. anthracis?
The ability of Sterne dcsaB to alter its phenotypes dependent upon growth
environment suggests that csaB mutation may not have a negative fitness cost, at
least under our conditions. In our case, csaB mutation was selected for by exposure
to fBACA1, and serves a mechanism for the organism to acquire phage resistance.
Mutation in csaB was also found to impart resistance to AP50c phage, with multiple
distinct phage-resistant variants all showing different mutations within the csaB
gene. Why csaB is selected for by both fBACA1 and AP50c is likely because of its
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role in anchoring numerous S-layer and S-layer associated proteins which may
serve as cell-receptors for the phage. Indeed for AP50c, Sap is believed to be the
phage’s receptor (Bishop-Lilly et al., 2012; Plaut et al., 2014). fBACA1’s receptor
has not yet been uncovered, but is most likely an S-layer or BSL protein, potentially
even Sap. It is not clear however why csaB and not sap is selected for mutation as
knockouts of sap are viable (Plaut et al., 2014). It is also noteworthy that in the
csaB mutants uncovered in (Bishop-Lilly et al., 2012) as well as our dcsaB strain,
mutation in csaB always occurred with other secondary SNPs in seemingly
unrelated genomic loci. It is unclear why this is the case, but csaB appears to be a
hotspot for mutation in B. anthracis, comparative to other potential genes which
could also confer phage-resistance. Regardless, for B. anthracis we find that a CsaBdeficient, phage-resistant variant is selected for by exposure to fBACA1, but
interestingly and in contrast to what is typically seen with other pathogens
(Capparelli et al., 2010; Filippov et al., 2011), phage-resistance is not associated
with decreased virulence and fitness in our experiments.

Why might this be the case for B. anthracis? From our RNA-seq data, csaB
mutation does not appear to affect the expression of pXO1-encoded genes important
to virulence in FBS culture. In BHI culture however, the same genes were
significantly downregulated in the mutant. In other species, phage-resistance is
often associated with decreased expression of important virulence factors (León and
Bastías, 2015). While this is true for dcsaB in BHI, B. anthracis appears to encode
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mechanisms to minimize the virulence-reducing effects of phage-resistance when in
an “infection environment”. If the expression profile of dcsaB in BHI held firm
within the animal host, it is likely the variant would show decreased virulence as
compared to wild-type Sterne. Why B. anthracis appears to get around this phage
resistance-associated issue may have to do with the fact that it has multiple
lifestyles and is successful in both soil/earthworm environments as well as
mammalian hosts. That the pathogen encodes mechanisms to control expression of
its virulence factors in each environment may allow the success of phage-resistant
variants. Other bacterial pathogens such as S. aureus or S. pyogenes have more
limited lifestyles, typically existing solely as colonizers or invasive species of
humans. Therefore the effects of phage-resistance may be more impactful on their
virulence potential. It is also possible that the factors affected by csaB mutation in
B. anthracis (S-layer proteins) happen to not play large a role in virulence. If such
proteins were critical to virulence, then clearly phage-resistance would decrease
bacterial pathogenicity. It is unclear if this lack of virulence decrease in our phageresistant B. anthracis variant is pure coincidence or was selected for in some
manner.

While not related to phage-resistance, it is also interesting to note the general role
of phages and virulence in B. anthracis compared to pathogens such as S. aureus
and S. pyogenes. Phages are not obviously associated with the pathogenicity of B.
anthracis, and are not major carriers of virulence determinants, whereas the phages
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of S. aureus and S. pyogenes are well known to encode important virulence genes
(Bae et al., 2006; Beres and Musser, 2007). For B. anthracis, plasmids seem to take
up the virulence role, with pXO1 and pXO2 encoding toxins and capsule,
respectively, making the bacteria a dangerous pathogen. For S. aureus and S.
pyogenes, plasmids often encode antibiotic resistance genes, but are not the main
determinants of virulence potential. In comparing B. anthracis to other Grampositive pathogens, there appear to be important differences in the roles of phage
for the species. Further research may illustrate explanatory mechanisms behind
these differences.

Given that our experiments did not show a fitness decrease for dcsaB, we were
curious if reversion would occur in the absence of phage or without environmental
selection. We examined dcsaB for reversion of the csaB mutation via deepsequencing and in culture-based experiments, but did not detect any reversion to
wild-type. We did successfully revert our csaB mutant to form the viable Sterne
strain comp-csaB (still containing the tRNA-methyltransferase mutation),
suggesting reversion to wild-type should be possible as well as the selection of csaB
mutants without secondary genomic alterations. If csaB mutation was associated
with negative fitness, then reversion to wild-type would be expected, however it is
possible that we are not growing the variant in the appropriate environment for
such selection. We also found that temporal lysogeny of Sterne with fBACA1 was
possible, but the lysogen grew poorly and would often generate colonies with dcsaB-
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like phenotypes after multiple passages. In Sterne, fBACA1 appears to be carried
unstably and selects for a CsaB-deficient, phage-resistant population. For CA, our
deep-sequencing data suggests a comparable event occurs, though only in a portion
of the population. More stable carriage of fBACA1 in CA could explain why only
some of the population is CsaB-deficient: the rest may be lysogenized.

For CA, a subpopulation of CsaB-deficient variants may be advantageous, or at the
very least, not associated with a decrease in overall fitness. Sterne dcsaB has
increased hemolytic activity, altered cellular and colony morphologies, as well as
different biofilm formation capacity as compared to Sterne. Such phenotypes could
alter behaviors such as vegetative survival outside the host, while not impeding the
population’s virulence potential. Surprisingly, this may be similar to some of the
effects of phage carriage in B. anthracis (Schuch and Fischetti, 2009), however the
virulence potential of these reported lysogens has not been studied. CsaB mutation
however, also likely confers on CA resistance to other phages that also rely upon a
SLH-domain containing receptor for infection (e.g. AP50). This could protect a CA
population from complete lysis if encountering a novel phage. (Lysogeny will also
however typically provide superinfection immunity to compatible phages). It is
possible that CA may be “using” fBACA1, or at least benefiting from its somewhat
unstable carriage to drive the expansion of a CsaB-deficient subpopulation, giving
the bacteria a new tool for survival. Thus, both lysogeny and lysis may play
significant roles in the B. anthracis lifecycle. The research presented in this
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Chapter examines this lesser studied aspect of phage conversion—selection by
lysis—which may serve to enable B. anthracis to maintain a subpopulation with
different phenotypes “at the ready” for certain environmental conditions. Given the
insights from this work, a new, hypothetical model for the B. anthracis lifecycle
including selection by lysis is shown in Figure 2-17. The magnitude and importance
of this aspect of phage conversion for B. anthracis in the wild however, remains to
be clarified through future research.

95

Figure 2-17. A new, potential model of the B. anthracis lifecycle. After
anthrax disease and host death (1), vegetative B. anthracis cells enter the soil
environment where phage encounter (2) can drive lysogeny or potentially, selection
by lysis for phage-resistant variants. Both lysogenized cells and resistant variants
harbor different characteristics from non-lysogenized or wild-type cells, including
altered biofilm formation, vegetative cell-surface changes, and transcriptional
modulation (3). Lysogeny can also promote earthworm colonization, and lysogenized
cells occasionally shed phages into the environment by limited lytic induction. For
CA, further research is needed to understand the prevalence of phage-resistance in
its native environment. If a significant proportion of wild, uncultured B. anthracis
cells harbor resistance-causing mutations, then selection by lysis will appear to play
an important role in the natural B. anthracis lifecycle, and an updated model is
warranted. Alternatively, there may exist environmental phage-stabilizing factors
that prevent phage-shedding and expansion of phage-resistant subpopulations.
Both phage-resistant and lysogenized cells can sporulate (4), however phageencoded sigma factors can promote or block this event. In CsaB-deficient phageresistant cells, no effect on sporulation was observed. Spores taken up by an animal
host (5) can germinate, cause anthrax (1), and restart the B. anthracis lifecycle.
Figure adapted and modified with permission from (Schuch and Fischetti, 2009).
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SUMMARY

In this Chapter, we characterized a Sterne variant, dcsaB, that is resistant to
infection by fBACA1, a bacteriophage isolated from B. cereus Biovar anthracis CA.
Phage-resistance was the result of selection for a frameshift mutation in csaB, a
SCWP pyruvyl-transferase, with the mutation and resistance reversible by genomic
manipulation. We show that dcsaB harbors distinct phenotypes similar to CA and a
growth media-induced switch, where dcsaB displays Sterne-like phenotypes in FBS
or an animal host, and in addition, the variant does not show an altered virulence
potential. We examined the global transcriptional profiles of Sterne and Sterne
dcsaB in BHI and FBS by RNA-seq, highlighting the gene expression changes
associated with both FBS growth and csaB mutation. Lastly, we showed the
prevalence of csaB variants within a CA population, suggesting that phageresistance and selection by lysis may be occurring in the wild, and along with
lysogeny, is a potential factor shaping pathogenic B. anthracis populations.
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MATERIALS AND METHODS

2.18 Bacterial strains and growth conditions
All strains used in this study are listed in Table 2-8. Bacillus strains were grown at
30°C in brain-heart infusion broth (BHI) with shaking at 150 RPM and aeration
except as otherwise noted. E. coli was grown at 37°C, 200 RPM in Luria-Bertani
(LB) liquid media or on LB-agar plates with ampicillin selection or without selection
as required. S. aureus RN4220 and S. pyogenes SF370 were grown at 200 RPM in
BHI media. Antibiotics were used at the following concentrations: ampicillin, 100
µg/mL; kanamycin, 50 µg/mL.

Induction of phage from B. cereus Biovar anthracis CA was performed as follows: an
overnight culture grown in BHI was back-diluted 1:100 in fresh BHI containing 5
µg/mL mitomycin C and grown overnight. Cells were pelleted and the clarified
supernatant filtered with 0.22 µm filters to remove debris. To prepare high-titer
phage stocks, induced phage supernatants were amplified using B. anthracis Sterne
cultures. Overnight cultures of Sterne were back-diluted 1:100 in BHI and grown at
200 RPM, to an OD600 = 0.1 - 0.2. An equivalent volume of phage supernatant was
added to the bacterial culture and grown at 150 RPM until visible lysis occurred,
typically 3-4 hrs. Cultures were then spun down at 4000 RPM and filtered with 0.22
µm filters to remove bacterial debris. This procedure was repeated as necessary to
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generate large volume phage stocks. All serum growth media used in this study was
heat-inactivated fetal bovine serum (Sigma) unless otherwise noted.

To determine the minimum serum dilution required to observe B. anthracis Sterne
dcsaB phenotypes associated with serum (FBS) growth, BHI:FBS (v/v) mixtures
were prepared ranging from 100:0 to 0:100. Bacteria from an overnight culture were
vortexed to homogeneity, back-diluted 1:100, grown 36 hours at 30°C in BHI, FBS
or BHI:FBS mixtures, and observed. For experiments using heat-treated FBS, the
media was prepared by placing 30 mL FBS in a Falcon tube in a room temperature
water bath, and slowly increasing the bath temperature to 85°C to prevent serum
aggregation. The FBS was heated at 85°C for 60 mins. For all experiments,
negative, non-inoculated controls were included. Bacteria used in heat-treated
serum experiments were established from overnight BHI cultures, back-diluted
1:100 into media and grown at both 30°C and 37°C.

Table 2-8. Strains, plasmids, and primers used in this study.
Strains

Description

Notes

E. coli TOP10

Cloning host

Invitrogen

E. coli SCS100

dam-/dcm- cloning host

NEB

B. anthracis Sterne

Sterne strain Pasteur 7702, pXO1+, pXO2-

B. anthracis ∆Sterne

∆Sterne strain pXO1-, pXO2-

B. anthracis dcsaB

Sterne strain Pasteur 7702 with 2 single nucleotide
insertions, inactivating csaB insertion, insertion in
tRNA-methyltransferase

B. anthracis comp-csaB

Sterne strain Pasteur 7702 with 1 single nucleotide
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insertion, in tRNA-methyltransferase
B. cereus Biovar

Transition B. cereus strain containing pXO1 and

(Klee et al.,

anthracis CA

pXO2-like plasmids pBCXO1, pBCXO2

2006.)

S. aureus RN4220

Lab strain

Hemolysis
positive

S. pyogenes SF370

Lab strain

DNase
positive

B. cereus T

Lab strain

Motility
positive,
Penicillin
resistant

Plasmids
pASD2

pDD1001

E. coli - B. anthracis shuttle vector for generating

(Day et al.,

genetic knockouts and complements

2007)

pASD2 with wild-type csaB sequence insert for

this work

generating Sterne comp-csaB

Primers

Sequence

csaB_deep_seq_F

CCAACATTCCTTATATATTAATGTTAGG

for deepsequencing
experiments

csaB_deep_seq_R

CGCATTAAAGTTGAACTGGATATC

for deepsequencing
experiments

csaB_comp_F

csaB_comp_R

pASD2_F

TCGATCGGTACCAAATGTTGGAGGAGATTAAGAG

for comp-csaB

TGCGGTTAG

construction

TCGATCGGTACCTTAAGATCCCATTCCTCTTTTTT

for comp-csaB

TGAACTC

construction

CAATCAATCACCGGATCCCC

for Sanger
sequencing

pASD2_R

TAACCCTCACTAAAGGGAACAAA

for Sanger
sequencing

csaB_check_seq_2

GGTGTCACAAGTAATTGAGC

for Sanger
sequencing
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B_anthracis_16S_rRNA_

TGAAAACTGAACGAAACAAAC

for PCR of B.
anthracis

F

gDNA
B_anthracis_16S_rRNA_

CTCTCAAAACTGAACAAAACGAAA

R

for PCR of B.
anthracis
gDNA

phiBACA1_F

AAAATGAACACTTTGAAAGGTCGAATTGA

for screening
of fBACA1

phiBACA1_R

CTTCTGTATTAGTAGCAAAGCGATCCACTG

for screening
of fBACA1

tRNA_methyltransferase

TACGGAGAACTACGACGTTGCAATTATTG

sequencing

_check_F
tRNA_methyltransferase

for Sanger

CGACGATTCGACATGGAATATCGAC

_check_R

for Sanger
sequencing

2.19 Exposure and lysogeny of B. anthracis Sterne with fBACA1
Exposure and lysogeny of B. anthracis Sterne with fBACA1 was achieved following
a modified protocol (Schuch and Fischetti, 2009). Briefly, 10 mL cultures of B.
anthracis Sterne were grown overnight in BHI and back-diluted 1:100 in 10 mL
fresh BHI and grown to OD600 = 0.6. 1 mL of phage stock was added to 4 mL
bacterial culture and incubated with shaking for 30 min. Bacteria-phage mixtures
were spun down (4000 RPM, 4°C, 20 min), washed 1X in cold phosphate-buffered
saline (PBS), resuspended in 5 mL BHI, serially diluted and plated on BHI agar.
Plates were grown overnight at 30°C, and the resulting individual colonies were
patched onto new BHI plates, and grown overnight. Potential lysogens were
screened when applicable via colony PCR using the fBACA1-specific primers
phiBACA1_F and phiBACA1_R (Table 2-8).
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2.20 Phenotypic analysis of B. anthracis strains
Colonies were imaged using the Cell Biosciences AlphaImager HP instrument with
AlphaImager HP software or an iPhone 6 camera. For microscopy studies, strains
from overnight cultures were washed 1X with PBS and examined using the Nikon
Eclipse E400 Phase Contrast Microscope and images captured with QCapture Pro
5.1 software. Magnification and exposures were adjusted manually as necessary.
Strains were stained using acridine orange or 4’,6-diamidino-2-phenylindole (DAPI)
following standard protocols. To visualize B. anthracis extracted from animal
tissues, manually homogenized tissue samples were incubated with GFP-PlyGBD, a
B. anthracis-specific protein fusion containing the binding domain of the phage
lysin PlyG and GFP for visualization (Raz et al., 2017; Schuch and Fischetti, 2009).
Samples and GFP-PlyGBD were incubated for 10 minutes at room temperature,
washed 1X in PBS, and visualized using standard protocols.

To test for DNase and hemolytic activity, strains were grown overnight and spotted
onto BD Difco DNase Test Agar with Methyl Green for DNase testing, or BBL
Columbia Agar with 5% Sheep Blood for hemolytic activity tests. Plates were grown
at 24°C, 30°C, or 37°C overnight. For DNase testing, Streptococcus pyogenes SF370
was used as a positive control, and strains producing clear halos in the agar were
recorded as DNase positive. For hemolysis studies, Staphylococcus aureus RN4220
was used as a positive control, and strains producing clearing zones were recorded
as hemolysis positive.
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Penicillin resistance was tested following a protocol outlined in the WHO Manual
for Laboratory Diagnosis of Anthrax (World Health Organization, 2003). B. cereus T
was used as a positive control for penicillin resistance, and B. anthracis Sterne as a
negative control. BD BBL Sensi-Disc Susceptibility Test Discs: Penicillin (10U)
were used for assays. For motility assays, 10 µL of overnight cultures were spotted
on 0.3% BHI soft-agar and allowed to grow at 37°C overnight. Motility was
measured by outward growth from the initial bacterial spot. B. cereus T was used as
a positive control and B. anthracis Sterne a negative control for motility. For
sporulation studies, strains were grown overnight at 30°C on BHI plates from
freezer stocks, and the following day, single colonies selected and struck out on LD
sporulation agar plates sealed with parafilm and grown at 30°C for 7 days. After 7
days growth, plates were scraped into 0.5 mL BHI, the wet pellets weighed and
vortexed to homogeneity, and 0.25 mL aliquots removed, heated at 65°C for 30
mins, placed on ice for 5 mins, diluted and plated for enumeration of spores on BHI
plates. Viable colonies were counted the following day after overnight growth at
30°C. Non-heat-treated aliquots were plated and enumerated for viable vegetative
CFU counts on BHI plates. Sporulation significance testing was performed using
the Student’s t-test with GraphPad Prism software. Phage susceptibility was tested
by co-spotting 10 µL mid-logarithmic phase cultures with 5 µL high-titer phage
stock (or 1X PBS) on Columbia agar plates and growing at 37°C or 30°C overnight.
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For biofilm formation and analysis, a protocol adapted from (Schuch and Fischetti,
2009) was used. Overnight 5 mL cultures grown in BHI at 30°C with or without
0.2% glucose were washed 2X in PBS, resuspended in PBS and diluted 1:1000 into
10 mL BHI with or without 0.2% glucose. Cultures were grown at 24°C, 30°C, or
37°C. Biofilm formation capacity was measured visually weekly for 10 weeks and
assigned values of: no growth, weak, medium, or strong growth.

2.21 Next-generation sequencing of phage DNA, PCR and Southern blot
screening for fBACA1
To prepare phage genomic DNA for NGS, high-titer phage supernatants were
polyethylene glycol (PEG)-precipitated with 10% PEG 8K and 1 M NaCl added to
200 mL phage supernatant and shaken overnight (4°C, 80 RPM). The precipitated
solution was pelleted at 8000 RPM, 4°C for 1 hr, and the pellet resuspended in PBS.
Phage genomic DNA was extracted and purified using the Norgen Biotek Corp.
Phage DNA Isolation Kit following manufacture’s protocol. A phage DNA library
was generated using the Illumina Nextera XT kit, quantitated with the Agilent
Technologies High Sensitivity DNA kit and paired-end sequenced on an Illumina
MiSeq using the Illumina MiSeq Reagent Kit v2 (500 cycle). FASTQ files were
saved and downstream bioinformatic analysis done using CLC Genomics
Workbench software. Reads were de novo assembled using default parameters. The
resulting contigs were annotated using RAST (Rapid Annotation using Subsystem
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Technology) (Aziz et al., 2008) and PHASTER (PHAge Search Tool Enhanced
Release) (Arndt et al., 2016) online tools.

PCR screening of Sterne and Sterne::fBACA1 gDNA (prepared as described in
Section 2.22) was performed using phiBACA1_F and phiBACA1_R primers and the
KAPA2G Robust Hotstart DNA Polymerase following manufacture’s protocol.
Purified fBACA1 DNA or fBACA1 stock was used as a positive control. Southern
blotting was carried out using the same DNA samples. Briefly, gDNA was run out
on a 0.7% TAE agarose gel, transferred onto Hybond-N+ membrane (GE) using a
standard capillary action protocol, and UV fixed the following day. fBACA1 DNA
was used as a positive control. Detection was carried out using the Amersham ECL
Direct Labeling and Detection System. Probe was generated from a gel-purified
fBACA1-specific PCR product created using phiBACA1_F and phiBACA1_R
primers, fBACA1 DNA, and the KAPA2G Robust Hotstart DNA Polymerase.

2.22 Genomic DNA preparation and sequencing of B. anthracis strains
Genomic DNA for sequencing was prepared from an overnight culture using the
QIAGEN Genomic-Tip 100/G kit. PlyG (Schuch et al., 2002) and lysozyme were
added to Buffer B1 and allowed to incubate with resuspended bacteria at 37°C for
30 minutes before addition of proteinase K and further incubation at 37°C as per
manufacturer’s directions. Genomic DNA was dissolved in QIAGEN elution buffer
(Buffer EB). DNA concentration was measured using Qubit Fluormetric
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Quantitation and diluted to 0.2 ng/µL. DNA libraries for sequencing were prepared
using the Illumina Nextera XT DNA Library Preparation and Index Kit following
manufacturer’s directions. Libraries were quality and size checked with the Agilent
2100 Bioanalyzer with a High Sensitivity DNA chip, manually normalized and
pooled together with a 5% PhiX control spike-in. Libraries were paired-end
sequenced using an Illumina MiSeq with the MiSeq Reagent Kit v3 (150 cycle).
FASTQ files were saved for each sample and downstream bioinformatic analysis
was performed using Geneious software. Reads were aligned to the B. anthracis
chromosome (NZ_CP009541.1) and pXO1 (NZ_CP009540.1) and examined for
regions of variation and/or SNPs. Unaligned reads were de novo assembled.

2.23 Molecular cloning and complementation of B. anthracis dcsaB
The csaB gene and 500 bp upstream and downstream of the gene was amplified
using B. anthracis Sterne gDNA as template with primers csaB_comp_F and
csaB_comp_R and Q5 Polymerase (NEB). The PCR product was gel-purified, cut
with Kpn1-HF restriction endonuclease (NEB) and further purified with QIAquick
PCR Purification Kit. Plasmid pASD2 (Schuch and Fischetti, 2009) was miniprepped from an overnight culture with QIAprep Spin Miniprep Kit, cut with Kpn1HF, dephosphorylated with Antarctic Phosphatase (NEB) and ligated with the csaB
DNA fragment using T4 DNA Ligase (NEB) to form pDRD1001. 2 µL of ligation
mixture was used to transform One Shot TOP10 Chemically Competent E. coli
(Thermo Fisher) according to manufacturer’s directions. Colonies were screened via
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PCR using primers pASD2_F and pASD2_R, and PCR products Sanger sequenced
with GENEWIZ (South Plainfield, NJ). A single colony harboring the desired csaB
sequence was grown overnight, miniprepped, and pDRD1001 shuttled into the dam/dcm- Competent E. coli SCS100 (NEB) following manufacturer’s transformation
protocol. Miniprepped pDRD1001 from SCS100 cells was electroporated into 400 µL
electrocompetent Sterne dcsaB prepared as described in (Koehler et al., 1994) using
a Bio-Rad Gene Pulser and a 0.4 cm electrode gap Gene Pulser Cuvette with the
following conditions: 2.5 kV, 400 W, 25 µF.

B. anthracis Sterne dcsaB harboring pDRD1001 was then subjected to the following
growth protocol to promote plasmid integration followed by excision and curing to
generate a csaB revertant strain. A single colony from BHI-kanamycin agar was
grown for 5 hours in 10 mL BHI-kan at 30°C, then grown for an additional 5 hours
at 39.5°C (non-permissive temperature for plasmid replication), before plating at
10-1 - 10-4 dilutions on BHI-kan agar and overnight growth at 39.5°C. Single
colonies the following day were struck on BHI-kanamycin agar and grown overnight
at 38°C. Colonies were screened via PCR using primers pASD2_F and
csaB_check_seq_2 for plasmid integration. A single colony with integrated
pDRD1001 was then grown in 10 mL BHI at 30°C the following day for 8 hours,
back-diluted 1:100 and grown in 10 mL BHI at 39.5°C overnight. Following
overnight growth, the culture was plated on BHI agar at 10-3 - 10-6 dilutions and
grown at 39.5°C. Resulting single colonies were restruck on BHI and grown at
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39.5°C, then replica plated on BHI-kan agar plates and grown at the nonpermissive temperature to screen for plasmid loss. Colonies that grew on BHI but
not BHI-kan plates were restruck on BHI agar, grown at 30°C, and the csaB gene
region amplified via PCR and DNA sequenced via Sanger sequencing (GENEWIZ)
to check for the wild-type csaB DNA sequence, using primers csaB_check_seq_2 and
csaB_deep_seq_R. The resulting revertant strain was termed B. anthracis Sterne
comp-csaB.

2.24 In vivo virulence mouse models
The Rockefeller University institutional animal care and use committee approved
all in vivo protocols. Overnight cultures of B. anthracis Sterne and Sterne dcsaB
grown at 37°C, 200 RPM in BHI, were back-diluted 1:100 into pre-warmed BHI and
grown 2.25 hrs at 37°C, 200 RPM. Cultures were spun down at 4000 RPM, 4°C for
10 min and washed in ice-cold 1X PBS and resuspended in PBS and diluted to the
following concentrations for chain length normalization: for B. anthracis Sterne, 1.0
x 107 CFUs/mL; for Sterne dcsaB 1.5 - 2.0 x 106 CFUs/mL. To calculate the
normalization factor, Sterne and Sterne dcsaB were prepared as described and
images taken of individual chains on a phase-contrast microscope. Chain lengths for
each strain were measured for over 100 individual chains using ImageJ and the
average chain length determined. For mouse experiments, 4-6 week old C57BL/6
female mice from Charles River Laboratories were injected intraperitoneally with
0.5 mL bacterial suspensions. Survival was observed and recorded for 10 days
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following injection after which all animals were sacrificed. Survival and virulence
comparisons were calculated using the Gehan-Breslow-Wilcoxon Test and curves
generated using GraphPad Prism software. For experiments examining infected
tissues, a protocol was followed as described above, except animals with established
infection were sacrificed 48 hours after injection, with organs removed and
manually ground to homogeneity in 1X PBS. The cellular suspension was incubated
with GFP-PlyGBD and bacterial cells imaged as described previously by microscopy.

2.25 RNA-seq of B. anthracis Sterne and Sterne dcsaB in BHI and FBS
cultures
For RNA-seq studies, all growth conditions were 37°C, 150 RPM. Sterne and Sterne
dcsaB were established from overnight cultures in BHI, then passaged 1:1000 into
BHI or FBS and grown overnight. The following morning, cultures were backdiluted 1:100 into the same pre-warmed media, grown to late-log phase (an OD600
approximately 2/3 of the maximal logarithmic growth OD600), and 1 mL culture
removed for preparation of RNA. Sterne dcsaB grown in BHI was removed at
comparable time point as it was not amenable to OD600 readings. Four groups of
samples were generated: Sterne-BHI; Sterne-FBS; Sterne-dcsaB-BHI; SternedcsaB-FBS. Samples were washed 2X in PBS, cells lysed using PlyG and suspended
in 600 µL TRI Reagent (Zymo Research). Samples were frozen at -80°C, until RNA
was purified. RNA was prepared using the Zymo Research Direct-zol RNA MiniPrep Plus Kit, following manufacturer’s directions including an in-column DNase
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digestion. Additional DNase digestion was performed with DNase I, Amplification
grade (Thermo Fisher) as needed until RNA samples showed no DNA
contamination measured by 40-cycle PCR with B. anthracis-specific 16S rRNA
primers. RNA samples were quality checked after DNase digestion using an Agilent
RNA Nano Kit on an Agilent 2100 Bioanalyzer. RNA samples were then rRNA
depleted using the Illumina Ribo-Zero rRNA Removal Kit for Gram-positive
Bacteria. All samples were in prepared and sequenced in duplicate, except for
Sterne dcsaB, which was in triplicate.

rRNA depleted samples were submitted to The Rockefeller University Genomics
Resource Center for library construction and sequencing. Libraries were
constructed using the Illumina TruSeq stranded mRNA LT kit starting at the RNA
fragmentation step to prepare libraries. Libraries were prepared with unique
barcodes and pooled at equal molar ratios. The pool was denatured and sequenced
on an Illumina NextSeq 500 Sequencer, generating 75 bp single reads, following the
manufacturer’s protocol. Reads for each sample were generated as FASTQ files and
downstream analysis done offline.

Reads generated for each sample were first aligned to the Sterne Genome
(Accessions: NZ_CP009541, NZ_CP009540) using Bowtie2 (Langmead and Salzberg,
2012) and BAM files sorted, indexed, and converted to SAM files using samtools (Li
et al., 2009). Files were processed using RStudio and Bioconductor. Count and
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differential expression (DE) data was processed using a protocol adapted from (Love
et al., 2016). Read counts were generated using GenomicAlignments package
(Lawrence et al., 2013) to create a SummarizedExperiment (Morgan et al.) and
DESeq2 (Love et al., 2014) was used to generate graphical visualizations and
differential expression analysis. The following four DE comparisons were generated:
1) Sterne-BHI against Sterne-dcsaB-BHI; 2) Sterne-BHI against Sterne-FBS; 3)
Sterne-FBS against Sterne-dcsaB-FBS; 4) Sterne-dcsaB-BHI against Sterne-dcsaBFBS. DE was called using a minimum fold-change cut-off of 2, and an adjusted pvalue of < 0.01. DE comparison tables were saved as CSV files.

2.26 Western Blot of protective antigen from B. anthracis culture
supernatants
Supernatants for Western blot were prepared as follows: Sterne, Sterne dcsaB, or
Sterne comp-csaB strains were grown as described for RNA-seq sample preparation,
but upon reaching late-log phase, cultures were spun down, resuspended in fresh
pre-warmed media and allowed to continue growth for 1 hr. After 1 hr growth,
cultures were spun down and the supernatant sterile filtered through 0.22 µm
filters. DSterne supernatant was used as a negative control for protective antigen.
Supernatants were normalized for OD600 values/cell number and were run on
Thermo Fisher NuPAGE 4-12% Bis-Tris Protein Gels, with MOPS running buffer at
200 V for 1 hr. FBS supernatants, and BHI supernatants compared to FBS
supernatants were diluted 1:100 in PBS to allow for distinct FBS protein bands on

112

the gel. For blots containing only BHI samples, BHI supernatants were
concentrated 5x using Vivaspin 500 3 kDa MWCO filters (GE). Gels were stained
with the Colloidal Blue Staining Kit (Thermo Fisher) as per manufacturer’s
directions. Protein gels for Western blots were transferred onto Immobilon-P PVDF
membrane (Millipore) following standard protocols, blocked and probed with
Anthrax protective antigen antibody (Invitrogen Cat. # PA1-41695) as primary and
Peroxidase AffiniPure Donkey anti-rabbit IgG (Jackson Cat. # 711-035-152) as
secondary. Blots containing FBS and BHI supernatants were developed using
SuperSignal West Femto Maximum Sensitivity Substrate (Thermo Fisher). Blots
containing only BHI supernatant samples were developed using SuperSignal West
Pico Chemiluminescent Substrate (Thermo Fisher). Developed film was
photographed using an iPhone 6 camera.

2.27 Determination of B. anthracis Sterne spontaneous resistance rate to
fBACA1

To determine the spontaneous resistance rate of Sterne to fBACA1, an overnight
culture of Sterne was back-diluted 1:100 in 5 mL BHI and grown at 30°C, 150 RPM
to an OD600 = 0.1 – 0.2. The culture was then split and infected with MOI = 10 of
fBACA1 or mock-infected with an equal volume BHI. Cultures were then grown for
an additional 30 mins, before plating both untreated and treated cultures for CFU
counts. Resistance rate was determined by comparison of treated to untreated CFU
counts. Experiments were performed in triplicate.
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2.28 Determination of B. anthracis Sterne dcsaB genomic reversion
To observe potential reversion of dcsaB, an overnight culture of Sterne dcsaB was
back-diluted 1:100 and grown in 5 mL BHI or FBS at 37°C, 150 RPM. Following
overnight growth, each culture was examined under a microscope for Sterne-like
morphologies and phenotypes. 10 µL of each culture was then passaged into the
same media (BHI or FBS) and allowed to grow overnight in the same conditions. In
addition, 10 µL of each culture was also used to inoculate 10 mL of BHI, grown at
30°C overnight. 30°C BHI cultures (inoculated from 37°C BHI or FBS cultures)
were examined the following day for turbidity and visualized for Sterne-like
morphologies and phenotypes. This protocol was repeated for seven consecutive
passages.

2.29 PCR amplicon preparation and deep-sequencing of csaB
Genomic DNA for use as template in PCR reactions amplifying the csaB gene region
were prepared as follows: colonies from a BHI plate grown overnight at 30°C were
scraped and resuspended into 25 µL 0.5 M NaOH, before adding 25 µL of 1 M Tris
pH 7.0 and 450 µL nuclease-free water. PCR reactions used the Q5 High-Fidelity
DNA Polymerase (NEB), csaB_deep_seq_F and csaB_deep_seq_R primers, and 0.5
µL of previously prepared template DNA in a 50 µL reaction. PCR amplicons were
gel-purified using the QIAquick Gel Extraction Kit, quantified with Qubit, and
diluted to 0.2 ng/µL in QIAGEN EB. DNA libraries and sequencing was carried out
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as described previously in Section 2.22, with the exception that library quantitation
was performed using the Agilent High Sensitivity D1000 ScreenTape Assay on an
Agilent TapeStation. FASTQ files were saved for each sample, and bioinformatic
analysis done using Geneious software. Variants with strand biases > 98% or Phred
quality scores < 30 were filtered out from results.
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CHAPTER 3. EXTRA-CHROMOSOMAL DNA SEQUENCING REVEALS
EPISOMAL PROPHAGE CAPABLE OF IMPACTING VIRULENCE FACTOR
EXPRESSION IN STAPHYLOCOCCUS AUREUS

INTRODUCTION

3.1 Impacts of prophage on the biology and virulence of S. aureus

As discussed in Chapter 1, S. aureus is a major human pathogen which employs an
array of virulence factors to execute a highly successful infection program
(Thammavongsa et al., 2015; Thomer et al., 2016). Many of these determinants are
encoded by prophage elements (Novick and Matthews, 2005). In addition to the hlbconverting phages previously discussed, other phages of S. aureus carry virulence
factors important for pathogenesis. These include the pore-forming PantonValentine leukotoxin (PVL), and exfoliative toxin A (ETA), the causative agent of
staphylococcal scaled skin syndrome (SSSS) (Kaneko et al., 1998; Yamaguchi et al.,
2000). Important phage-encoded virulence factors of S. aureus are listed in Table
3.1.

The dependence of S. aureus on its resident prophage is clear, as phage-cured
strains show markedly reduced virulence (Bae et al., 2006). In addition, the
coordination of chromosomally-encoded regulators (e.g. Agr) with phage-encoded
virulence determinants suggests a long co-evolution and dependence on phage by
the bacterial host (Fischetti, 2006). As such, the importance of positive conversion
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for S. aureus’s virulence cannot be overstated, however, recent reports have
revealed that other processes such as phage excision/integration and atypical
genome localization play roles in the virulence potential of the organism in addition
to the “traditional roles” of positive and negative conversion (Goerke et al., 2004;
2006; Utter et al., 2014).

Table 3-1. Important phage-encoded virulence factors of S. aureus.
Virulence factor (gene)

Encoding Phage

Leukocidin (lukS, -F, -M)

fPVL, fPV83

Enterotoxin P (sep)

fN315

Enterotoxin A (entA, sea)

fMRSA252*, fMu50A*

Exfolative toxin A (eta)

fETA, fSTL

Toxic shock syndrome toxin (tst)

SaPI-1**

Staphylokinase (sak)

f13*

Chemotaxis inhibitory protein of S. aureus (chips)

f13*

Staphylococcal complement inhibitor (scin)

f13*

*f13 and other hlb-converting phages can encode sak, sea, scin, or chips
**SaPI-1 is a mobile pathogenicity island transduced by helper phage
Adapted from (Boyd and Brüssow, 2002) with permission.

For example, in S. aureus isolates from cystic fibrosis and bacteremic patients,
genomic alterations driven by hlb-converting phages were found to occur in the
transition from nasal colonization to invasive infection. Specifically, in infection
isolates, hlb-converting phages (Figure 3-1a) were found integrated at atypical
chromosomal locations, resulting in Hlb+/sak+ phenotypes (cells with an intact hlb
117

gene, but also positively converted by prophage encoding sak) (Figure 3-1b). Rarely,
in some strains, prophage appeared to undergo duplication and dual integration,
generating populations with a Hlb–/sak2 phenotype (cells with one prophage
integrated in hlb and a duplicated prophage integrated in another chromosomal
location, with both phages encoding sak) (Figure 3-1c) (Goerke et al., 2006). Such
phage mobilization occurred to a significantly lesser degree however in nasal
(colonization) isolates from healthy individuals, indicating selective pressure for
Hlb-producing strains in the transition to invasive infection, with atypical prophage
integration as a mechanism to allow for dual Hlb and SAK production. Previous
work in the Fischetti Laboratory uncovered a plasmidial prophage, fBU01, with the
phage DNA sequence highly homologous to known hlb-converting phages.
Importantly, fBU01 did not appear to integrate within the S. aureus chromosome
(Utter et al., 2014), suggesting that in addition to atypical chromosomal integration,
maintenance of prophage in the extra-chromosomal compartment can result in a
Hlb+/sak+ phenotype (Figure 3-1d) (Deutsch et al., 2016).
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Hlb-, sak+ (typical phage integration,
SAK production)
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Φ
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Hlb+, sak+ (atypical phage localization,
Hlb, SAK production)
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+sak

Φ
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+sak

Φ
Hlb-, sak2 (phage duplication, SAK production,
with typical and atypical integration)

hlb

D

Hlb+, sak+ (atypical extra-chromosomal
phage localization, Hlb, SAK production)

hlb
+sak

+

Φ

Figure 3-1. Illustration of phage localization in S. aureus cystic fibrosis
and bacteremic isolates. Atypical hlb-converting phage localization is described
in (Goerke et al., 2006). A) hlb-converting phage typically integrate in the
chromosome and disrupt hlb, but positively convert cells for sak, sea, scin, and/or
chips. Cells are Hlb–, sak+. B) Atypical phage localization (off-target chromosomal
integration) results in Hlb+, sak+ phenotypes. C) Phage duplication and dual
integration results in disrupted hlb, and 2 copies of sak. D) Alternatively, phage
localization in the extra-chromosomal compartment could also result in the Hlb+,
sak+ phenotype.
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3.2 The importance of phage-mobilization for bacterial pathogens
Excision/integration dynamics of lysogenic prophage also have important roles in
other bacterial pathogens. S. pyogenes SF370 contains the episomal, phage-like
chromosomal island, SpyCIM1, which integrates within the cell’s DNA mismatch
repair operon, disrupting transcription of the mutS-mutL genes and consequently
increasing the mutation rate of the cell approximately 200-fold (Hendrickson et al.,
2015; Scott et al., 2008). The phage-like element was found to be excised at low cell
densities, allowing fidelitous genome replication, but would integrate and increase
the cell’s mutation rate at higher cell densities (Scott et al., 2008)—conditions
where mutation might be beneficial (i.e. low nutrient availability) (Figure 3-2).
Here, excision/integration is a dynamic, switch-like process; in S. aureus however,
phage excision and re-integration (or extra-chromosomal localization) as previously
described creates stable isolates with prophage not believed to continuously pop in
and out of the chromosome. SpyCIM1’s temporal dynamics suggest that S. pyogenes
is using the phage-like element for its own benefit as a molecular switch at the
DNA-level.

Phage acting as such DNA-switches have been found in a number of distantly
related bacterial species, suggesting such a phage-role has existed over a long time
scale. Feiner et al. review SpyCIM1’s behavior and discuss a number of other
species (Listeria monocytogenes, Bacillus subtilis, and Escherichia coli) where
bacterial hosts have been found to employ similar beneficial strategies with their

120

lysogenic phages, allowing control of activities such as phagosomal escape (L.
monocytogenes) (Rabinovich et al., 2012), sporulation (B. subtilis) (Kunkel et al.,
1990; Takemaru et al., 1995), and biofilm formation (E. coli) (Wang et al., 2009). In
all three cases, phage excision allows the transcription of key chromosomallyencoded genes, altering bacterial behavior (Feiner et al., 2015).

Figure 3-2. Illustration of SpyCIM1 genome and integration dynamics.
SpyCIM1 is a phage-like chromosomal island of S. pyogenes. In the exponential
phase, SpyCIM1 excises from the chromosome and the mismatch-repair operon
(MMR) is fully transcribed. At higher-cell densities, the episome integrates between
mutS and mutL, disrupting transcription of the operon and increasing the cell’s
mutation rate. OD600 and % episomal SpyCIM1 analysis reveals excision is a
temporally controlled process, with the episome acting as a DNA-level switch.
Reprinted with permission from (Nguyen and McShan, 2014).
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Importantly, for SpyCIM1 and the phages described in (Feiner et al., 2015), excision
from the chromosome is not associated lytic induction; if it were, the impacts of
phage excision would be lost as phage induction leads to likely cell death. (Host
benefits from phage induction into the lytic cycle are described in Section 1.3.4
(also well-reviewed in (Nanda et al., 2015).) While excision here is associated with a
lysogenic state, in some cases it is irreversible, i.e., phages are cured or lost after
excision. In B. subtilis, for example, excision of the phage-element skin allows
reconstitution and transcription of a functional sk gene (sigk), promoting
sporulation. In this case, skin and the bacterial cell die, however a copy of the phage
genome remains in the new spore (Feiner et al., 2015; Kunkel et al., 1990;
Takemaru et al., 1995). Regardless of reversible or irreversible excision, Feiner et
al. describe phage capable of controlled excision/integration within the lysogenic
cycle as “active lysogens” and termed the process “active lysogeny” (Figure 3-3c).
Active lysogeny is distinguished from the more traditional effects of the lysogenic
cycle, as phage excision allows the expression or regulation of chromosomallyencoded factors, in contrast to positive conversion (Figure 3-3a), or even the
induction of a proportion of the population into the lytic cycle (Figure 3-3b).
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Figure 3-3. Forms of lysogeny and mechanisms for expression of virulence
or fitness factors. A) Lysogenic (positive) conversion involves the expression of
phage-encoded factors in the bacterial cell. For S. aureus, phages carry an array of
virulence factors (Table 3.1) and contribute to the pathogen’s virulence potential. B)
Induction of a subpopulation of cells into the lytic cycle can allow the increased
production of phage-encoded virulence factors. For S. aureus, enterotoxin A and
staphylokinase expression increases with induction (Sumby and Waldor, 2003). For
other species (e.g. E. coli) increased expression of toxins via induction allows for
more successful host invasion and infection by the remainder of the population. C)
Active lysogeny is a feature of temperate phage capable of controlled
excision/integration within the lysogenic cycle. Phage integration can disrupt
transcription of virulence or fitness factors, and excision (without lytic induction)
allows the reconstitution and expression of genes. Excision can be reversible or nonreversible, leading to prophage reintegration or loss, respectively. Reprinted with
permission from (Feiner et al., 2015).
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3.3 Uncovering extra-chromosomally localized prophage in S. aureus

Given the importance of prophages in S. aureus, and the potential impacts of active
lysogenic phage, research specifically targeted at uncovering extra-chromosomally
localized phage can lend important insights into the virulence potential of S. aureus
strains, either through the identification of novel phages, or the discovery of active
lysogenic phage. Previous work in the Fischetti Laboratory screened clinical isolates
of S. aureus for the presence of rare, cytoplasmically-localized prophage using an
extra-chromosomal DNA enrichment and next-generation sequencing (NGS)
approach. In this report (Utter et al., 2014), the plasmidial (non-integrating)
prophage fBU01 was identified and sequenced from the vancomycin-intermediate
S. aureus (VISA) NRS19, and found to encode multiple virulence determinants
including sea, sak, scin, and chips. In addition, an episomal prophage (found both
chromosomally-integrated and extra-chromosomal in a population) was also
uncovered in VISA NRS26 (Utter et al., 2014). Enrichment and screening of the
cytoplasmic compartment in this previous report revealed that extra-chromosomally
localized prophage were fairly widespread in S. aureus, and that such “hidden”
elements could alter the virulence potential of a strain.

The following sections of this Chapter describe an expansion of this work,
employing NGS to screen-by-sequencing 15 additional clinical isolates of S. aureus.
Unlike the prior study however, the strains selected for this study had previously
sequenced chromosomes, facilitating the classification of any extra-chromosomally
125

enriched prophage uncovered as either episomes or plasmids, and allowing the
identification of potential active lysogenic phage. In this screening, we find extrachromosomal prophage present in 5 of 15 strains, but surprisingly, these strains
contain only episomal and not plasmidial prophage. Experimental work
demonstrates that the enriched episomal prophages identified are circular DNA
elements, and qPCR experiments reveal that enrichment and detection of such
prophages by NGS would not occur if using conventional whole-genome DNA
preparations. In addition, we find that in the S. aureus strain MSSA476,
enrichment of its episomal phage (fSa4ms) is growth-phase dependent and that
fSa4ms does not appear to replicate after its excision, suggesting its existence as a
candidate “active lysogenic phage”. Follow-up experiments find that the excision of
fSa4ms can alter the promoter sequence and transcription of the stress-response
serine protease-encoding htrA2, with promoter alterations affecting heat-stress
survival in S. aureus COL. Here, the expanded and improved extra-chromosomal
enrichment and sequencing of S. aureus clinical strains is shown to allow the
detection of active lysogenic phage, giving greater insights into the genome
dynamics and mechanisms by which phage generate diversity and enhance the
virulence potential of the pathogen.
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RESULTS

3.4 Extra-chromosomal sequencing reveals the presence of episomal
prophage elements within S. aureus clinical isolates

For this study, we expanded our previously developed extra-chromosomal DNA
enrichment and sequencing approach to screen S. aureus clinical isolates for
prophage elements in the extra-chromosomal compartment of the cell (Utter et al.,
2014). We selected 15 clinical isolates sourced from different geographic regions,
containing a diverse array of antibiotic resistances and virulence factors. In
addition, these strains had fully sequenced chromosomes, facilitating the distinction
of any detected prophage as integrated, episomal, or plasmidial. We enriched and
prepared extra-chromosomal DNA (exDNA) as described in Materials and Methods,
and sequenced samples with Illumina NGS. Extra-chromosomal DNA samples were
analyzed by first mapping sequencing reads to their corresponding chromosomal
sequences, followed by de novo assembly of unmapped reads. Visual examination of
chromosomal read-mappings revealed areas of increased sequencing coverage,
especially over prophage regions (Figures 3-4a, 3-4b). Coverage analysis of readmappings highlighted regions of significantly increased read depth, indicating the
presence of episomal elements (and potentially active lysogenic prophage) that were
enriched in sequencing due to specifically targeting and isolating DNA elements
from the extra-chromosomal compartment of the cell (Figure 3-1c). Read-mappings
and coverage analysis are shown for strain MSSA476 as a representative example.
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Figure 3-4. Read-mapping and coverage analysis of MSSA476 extrachromosomal DNA sequencing. A) and B) Read-mappings of sequencing reads
from MSSA476 exDNA. MSSA476 contains two integrated prophages: fSa3ms and
fSa4ms. fSa4ms (B) has greater read coverage compared to fSa3ms (A) in exDNA
sequencing. Selected portions of the read-mappings surrounding prophage
integration regions for fSa3ms (A) and fSa4ms (B) are shown. Chromosomal
positions are labeled at top, and consensus regions are shown below for MSSA476
chromosome sequence and MSSA476 exDNA reads. Locations of fSa3ms (A) and
fSa4ms (B) integrated prophage genomes are shown. Extra-chromosomal reads are
shown below for each. C) Coverage analysis of MSSA476 extra-chromosomal readmapping. Portions of coverage analysis surrounding prophage regions shown for
clarity. Chromosomal positions labeled at top of image, and approximate positions
of fSa3ms and fSa4ms integrated genomes shown below. Histogram representation
of higher read-coverage regions reveals enrichment of fSa4ms prophage due to
exDNA isolation. Read-mapping across fSa3ms genome location does not contain
any regions of higher coverage, indicating no or very low prophage enrichment by
exDNA isolation.
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For each of the 15 strains, we documented whether prophage elements were
enriched in sequencing due to exDNA isolation and classified strains as: 1)
containing enriched prophage, 2) not containing enriched prophage, or 3) containing
unclear prophage enrichment, when partial but not complete prophage regions had
increased coverage detected (Table 3.2). Surprisingly, de novo assembly of
unmapped reads did not reveal any prophage elements, suggesting no plasmidial
prophage in the sequenced strains, and that all prophage uncovered in the extrachromosomal compartment by our approach were episomal elements. Importantly,
episomal prophage were identified in 1/3 (5 of 15) of the staphylococcal strains
analyzed. These included: fSa4ms in MSSA476 (Sa4-like integrase), a gehconverting prophage in NRS143 (Sa6-like integrase), one typically intergenic
prophage in BK2529 (Sa7-like integrase), as well as two strains each with three
episomal phages. One of these strains, HPV107, contained episomal prophages with
Sa2- and Sa3-like integrases, and in addition, one prophage with an unclear
integrase type, however its sequence was homologous to the integrase of a prophage
from S. aureus SA268 (Qu et al., 2014). The other strain, NRS22, contained
episomal prophages with Sa2-, Sa5-, and Sa7-like integrase sequences.
Interestingly, when integrated into the chromosome, the Sa2-like prophage of
HPV107 disrupts a 6-phospho-b-galactosidase encoding gene, which to our
knowledge is a novel integration site for a S. aureus prophage. The other phages we
uncovered as episomes have previously described chromosomal integration sites
(Bae et al., 2006; Goerke et al., 2006; 2009). Incidentally, known plasmids, such as
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pSAS1 in MSSA476, were fully de novo assembled using the unmapped reads, and
while they are not the focus of this current study, they do point to the sensitivity of
this exDNA isolation and sequencing method.

Table 3-2. Detection of episomal prophage in S. aureus strains from extrachromosomal DNA isolation and sequencing.
#
Strain

Resistance(s)

Prophage

Notes

Regions

Enriched prophage detected

MSSA476

MSSA

•

2

ΦSa4ms enriched, integrates immediately
upstream of htrA2

•
NRS22

VISA/MRSA

4

ΦSa3ms not enriched, hlb-converting

3 enriched prophages:
•

Sa2-lke integrase, intragenic in
RK87_02365 (hypothetical protein)

•

Sa5-like integrase, intragenic in
RK87_04825 (radical SAM)

•

Sa7-like integrase, intergenic between
rpmF and isdB

NRS143

MSSA

•

4

One enriched prophage: Sa6-like
integrase, geh-converting

HPV107

MRSA

4

3 enriched prophages:
•

Sa2-like integrase, intragenic in
RL05_04630

•

Sa3-like integrase, hlb-converting phage
(fHPV107.1)

•

Unclear integrase type, intergenic
between RL05_02285 (tRNA-Ser) and
RL05_01940 (enterotoxin)
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BK2529

MRSA

•

4

One enriched prophage: Sa7-like
integrase, intergenic between rpmF and
isdB)

Unclear enriched prophage

NRS153

MSSA

•

4

Unclear enrichment of Sa1-like integrase
prophage, intergenic between sufB and
transposon-encoded integrase
RK79_06750

NRS387

MRSA

•

1

Unclear enrichment of Sa3-like integrase
prophage, hlb-converting

NRS2

VISA/MRSA

•

2

Unclear enrichment of Sa7-like integrase
prophage, intergenic between rpmF and
isdB

No enriched prophage detected

BAA-42

MRSA

4

NRS156

MSSA

2

NRS127

MRSA

5

NRS158

MSSA

3

NRS271

MRSA

3

•

Enriched ICE within RK77_00405
(membrane protein)

E2125

MRSA

5

HDE288

MRSA

3

Relevant resistances (MSSA, MRSA, VISA, VRSA) and total number of
chromosomal prophage for each strain are listed.
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3.5 QPCR characterization of MSSA476 validates extra-chromosomal
sequencing data, but also reveals episomal prophage are detectable only in
extra-chromosomal DNA samples

Our screening-by-sequencing approach did not reveal any non-integrating
plasmidial prophage, however, a number of the clinical strains did contain episomal
prophage elements that were enriched by exDNA isolation. Thus, we were curious
what insights prophage enrichment, as uncovered by exDNA isolation and
sequencing, revealed about an individual strain. To better understand the nature of
enrichment, we chose to focus on the well-characterized S. aureus strain MSSA476
(Holden et al., 2004; Sumby and Waldor, 2003) and took a qPCR approach to
determine the excision rates and copy numbers of its prophages. MSSA476 contains
two prophages, fSa3ms and fSa4ms. fSa3ms is a hlb-converting prophage, while
fSa4ms integrates 30 bp upstream of the serine protease-encoding htrA2. In our
sequencing, fSa4ms was found enriched by exDNA isolation, while fSa3ms was not
(Figure 3-4). Therefore, MSSA476 is ideal to understand the characteristics of both
enriched and non-enriched phage in our screening.

We first wanted to validate our extra-chromosomal sequencing results by qPCR,
measuring prophage copy number in exDNA samples by targeting excised prophage
attachment sites (attP) normalized to DNA gyrase (gyrA). Sequencing data should
have a direct correlation to prophage copy number, predicting that fSa4ms copy
number would be greater than fSa3ms in exDNA samples. Indeed, we found the

133

copy number of excised fSa4ms (copies attP/copy gyrA) was significantly higher
than fSa3ms (P = 0.0004), supporting our exDNA sequencing data (Table 3-3,
Figure 3-5a). Following this validation, we next measured the excision rates of
fSa3ms and fSa4ms, since prophage enrichment in our exDNA samples suggested
that the excision rate of fSa4ms would be higher than fSa3ms. We calculated the
excision rates by targeting phage-less bacterial attachment sites (attB) normalized
to gyrA. As attB sites are present on chromosomal DNA, we prepared the genomic
DNA (gDNA) of MSSA476 using the same growth conditions as DNA prepared for
extra-chromosomal sequencing and performed qPCR on gDNA. Surprisingly, we
found the excision rate of fSa3ms (copies attB/copy gyrA) to be significantly higher
than fSa4ms (P = 0.0017), despite fSa4ms enrichment in our exDNA sequencing
and higher copy number by qPCR (Table 3-3, Figure 3-5b). This result was
confounding, but suggested that if we also examined the gDNA preparations for
prophage copy number by qPCR, fSa3ms copy number might be higher than
fSa4ms. Copy number qPCR of MSSA476 gDNA indeed revealed that the excised
prophage copy number of fSa3ms was significantly higher than fSa4ms (P =
0.0015) as suggested by fSa3ms’s higher excision rate, but in contrast to the copy
number results from qPCR of exDNA samples (Table 3-3, Figure 3-5c). The qPCR
and sequencing data obtained thus far for MSSA476 appeared conflicting; exDNA
samples showed enrichment of episomal fSa4ms compared to fSa3ms, however
fSa3ms had a higher excision rate and higher copy number than fSa4ms when
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gDNA was examined. We therefore performed additional experiments to uncover
the basis of these apparent conflicting results.

Table 3-3. Copy numbers and excision rates of MSSA476 prophages from
exDNA sequencing conditions.

Prophage

Prophage copy number

Excision Rate (copies attB/

(copies attP/copy gyrA)

copy gyrA)

exDNA

gDNA

fSa3ms

0.146 ± 0.010

0.086 ± 0.008

9.35 x 10-4 ± 9.75 x 10-5

fSa4ms

0.622 ± 0.042

0.023 ± 0.002

1.62 x 10-4 ± 3.37 x 10-5
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Figure 3-5. QPCR characterization of MSSA476 excised prophage copy
numbers and excision rates. A) Excised prophage copy number (copies attP/copy
gyrA) from MSSA476 extra-chromosomally enriched DNA (exDNA) samples.
Excised prophage copy number is significantly higher for fSa4ms than fSa3ms, in
accordance with sequencing data. B) Excision rates of fSa3ms and fSa4ms (copies
attB/copy gyrA). Excision rate of fSa3ms is significantly higher than fSa4ms. C)
Excised prophage copy number from MSSA476 whole-genome DNA (gDNA)
samples. Excised prophage copy number of fSa3ms is significantly higher than
fSa4ms.
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3.6 Extra-chromosomal DNA isolation enriches circular prophage elements

To uncover why fSa4ms was enriched by exDNA isolation but not in gDNA
preparations, we first compared fSa3ms and fSa4ms prophage genomes for %GC
content, which could alter DNA capture efficiency. However, %GC content does not
appear to play a role in enrichment differences as fSa3ms and fSa4ms contain
almost equivalent %GC content at 33.2% and 33.3%, respectively. Part of the extrachromosomal enrichment protocol involves alkaline-lysis followed by centrifugation.
We hypothesized that this step likely enriches for circular forms of prophage that
would remain soluble after alkaline-lysis and not pellet during centrifugation (i.e.,
would be captured in the exDNA preparation). Linear prophage concatemers
(contiguous copies of phage genome arising from prophage induced into the lytic
cycle in a subpopulation of cells) would likely pellet with chromosomal DNA and
other cellular debris and be removed from exDNA samples. The same linear
concatemers however, would not be excluded in whole-genome preparations,
potentially explaining the differences seen in qPCRs of gDNA and exDNA samples.

We designed and performed a selective depletion experiment of fSa4ms prophage in
exDNA samples to test this hypothesis. Specifically, we examined if fSa4ms could
be selectively removed from samples only by the combination of fSa4ms-specific
restriction endonucleases (linearizing circular prophage) followed by linear DNA
digestion, and not solely by the exonuclease treatment. fSa4ms depletion only by
sequential endo- and exonuclease treatment would indicate the prophage exists as a
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closed circular DNA element. A schematic of the digestion procedure is shown in
Figure 3-6.

Copy number: ΦSa4ms > ΦSa3ms

Copy number: ΦSa4ms > ΦSa3ms

Linear DNase
A

ΦSa3ms linear concatemer
Circular ΦSa3ms

1. PshAI, PspXI digest
2. Linear DNase
B

ΦSa4ms linear concatemer

ΦSa4ms removed,
only ΦSa3ms present

Circular ΦSa4ms

Figure 3-6. Schematic of endonuclease and/or exonuclease treatment of
MSSA476 exDNA. ExDNA of MSSA476 (left) consists of both fSa3ms and fSa4ms
genomes, in circular and linear (likely concatemer fragments) forms. Here, copy
number of fSa4ms is higher than fSa3ms. Linear DNase (exonuclease) only
treatment (A) removes linear concatemers of prophage DNA, leaving only closed
circular prophage genomes (right). With exonuclease treatment, fSa4ms copy
number should remain greater than fSa3ms. Sequential treatment (B) of MSSA476
exDNA with fSa4ms-specific endonucleases (PshAI, PspXI) linearizes fSa4ms
circular genomes (and cuts fSa4ms linear concatemers) and treatment with linear
DNase completely eliminates fSa4ms DNA. Following this treatment, only fSa3ms
DNA should remain.
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Thus, extra-chromosomal samples were treated as described in Materials and
Methods and end-point PCR measurement was performed targeting gapdh, the attP
sites of fSa3ms and fSa4ms, and the naturally occurring MSSA476 plasmid pSAS1.
An agarose gel containing all PCR reactions is shown in Figure 3-7. Gapdh (a
marker for linear DNA digestion) was depleted after linear DNase treatment but
remained in high abundance after treatment with the fSa4ms-specific restriction
endonucleases PspAH and PspXI. fSa3ms attP target was present in each condition
tested, indicating that it does exist in the circular form in extra-chromosomally
enriched DNA samples, however in low abundance. fSa4ms attP target is present
and in greater abundance than fSa3ms in untreated, restriction endonuclease-only
and linear DNase-only treated samples. Treatment with fSa4ms-specific
endonucleases followed by linear DNase treatment results in the complete loss of
fSa4ms target, verifying that fSa4ms is indeed abundant relative to fSa3ms in
extra-chromosomally enriched DNA samples, and that this enrichment is due to
circular forms of the prophage element. pSAS1, a circular plasmid in MSSA476, is
not affected by any sample treatment (Figure 3-7).
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Figure 3-7. Agarose gel of PCR reactions from fSa4ms selective-depletion
experiment. 1% agarose gel stained with SYBR Safe DNA Gel Stain containing
end-point PCR reactions from MSSA476 samples. MSSA476 exDNA was digested
with Plasmid-safe exonuclease, PspAH/PspXI restriction endonucleases, both
Plasmid-safe and restriction endonucleases, or left untreated with treatment
indicated by (+) and (-). Gapdh, fSa3ms attP, fSa4ms attP, and pSAS1 target were
amplified from treated and untreated samples. fSa4ms attP target is selectivelydepleted from combination exonuclease and endonuclease treatment but not from
solely exonuclease treatment, indicating its existence as a circular element in
exDNA samples. Higher levels of fSa4ms target compared to fSa3ms target
correlate with the phage enrichment detected by DNA sequencing. Negative
controls for each primer set are shown. 500 bp ladder band is indicated.
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We were now curious if a similar pattern was present in other strains, which also
contained episomal prophage enriched by exDNA isolation. To test this, we
performed an inter-strain comparison, examining by qPCR the excision rates and
excised prophage copy numbers of hlb-converting phages in three strains: BAA-42
(containing fBAA-42.1), MSSA476 (fSa3ms), and HPV107 (containing fHPV107.1).
Sequencing data revealed that only fHPV107.1 was significantly enriched by
exDNA isolation, and qPCR copy number examination of exDNA samples confirmed
this result. fHPV107.1 had higher copy number as compared to fBAA-42.1 (P =
0.0052) and fSa3ms (P = 0.0057) in exDNA samples (Table 3-4, Figure 3-8a (right)).
When we examined excision rates of the three phages, we found that in this
comparison, fHPV107.1 did indeed have the highest excision rate. The excision rate
of fHPV107.1 was significantly higher than fBAA-42.1 (P = 0.0009) and fSa3ms (P
= 0.002) (Table 3-4, Figure 3-8b). However as observed previously with MSSA476,
prophage copy number data from gDNA samples did not correlate with exDNA
data, verifying that the episomal prophage enrichment we uncover is only apparent
in exDNA samples. Significant copy number differences in gDNA samples were not
seen between fHPV107.1 and fBAA-42.1 (P = 0.3205), while fSa3ms had a lower
copy number than either fHPV107.1 or fBAA-42.1 (Table 3-4, Figure 3-8a (left)).
Similar to results for fSa4ms, qPCR of exDNA suggests that in a HPV107
population, fHPV107.1 exists as a circular, episomal DNA element likely in a
higher proportion of cells than that of fBAA-42.1 or fSa3ms in their respective
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populations. Induction of phage however, likely masks uncovering these events in
qPCRs of gDNA samples.

Table 3-4. Copy numbers and excision rates of selected hlb-converting
prophages.
Prophage

Prophage copy number

Excision rate

(copies attP/copy gyrA)

(copies attB/copy gyrA)

exDNA

gDNA

fBAA-42.1

0.138 ± 0.005

0.270 ± 0.016

1.65 x 10-4 ± 5.15 x 10-5

fSa3ms

0.146 ± 0.010

0.086 ± 0.008

9.35 x 10-4 ± 9.75 x 10-5

fHPV107.1

0.540 ± 0.073

0.291 ± 0.015

1.94 x 10-3 ± 9.94 x 10-5
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Figure 3-8. QPCR characterization of hlb-converting prophages. A) Excised
copy numbers of hlb-converting prophages fBAA-42.1, fSa3ms, and fHPV107.1.
Excised copy number experiments of prophage from gDNA (left) reveal no
significant difference between fBAA-42.1 and fHPV107.1, however fHPV107.1 has
significantly higher excised copy number than fBAA-42.1 or fSa3ms in exDNA
samples (right). B) Excision rates of hlb-converting prophages fBAA-42.1, fSa3ms
and fHPV107.1. fHPV107.1 has a significantly higher excision rate than fBAA-42.1
and fSa3ms.
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3.7 Extra-chromosomal localization of fSa4ms circular prophage is a
temporal and rare event

Since fSa4ms enrichment was due to episomal, circular copies of the prophage in
the MSSA476 population, we were curious if such an event was merely a precursor
to phage replication and the generation of linear concatemers or occurred without
subsequent replication, suggesting that fSa4ms might exist in an “active lysogenic”
cycle. To investigate this question, we repeated our qPCR approach, examining the
excision rates and excised phage copy numbers of fSa3ms and fSa4ms at different
time points of the growth cycle, to see if their values changed with different culture
densities. We sampled cultures at OD600 = 0.35, 0.7, 1.0 and overnight, and
prepared exDNA (to measure circular prophage copies) and gDNA (to examine
excision rates and potential increases in overall excised prophage copy number).
The excision rate of fSa3ms did not significantly change from OD600 = 0.35 to 1.0 (P
= 0.2403) while that of fSa4ms did significantly decrease during this time (P =
0.036) (Table 3-5, Figure 3-9a). The fSa3ms excision rate does however, increase
approximately two-fold from OD600 = 0.35 to overnight. Excised prophage copy
number, as measured by attP target for whole-genome preparations did not change
from OD600 = 0.35 to 1.0 for fSa3ms (P = 0.118) nor fSa4ms (P = 0.527) (Table 3-5,
Figure 3-9b). Levels of excised prophage copy number over the same range for
exDNA also did not change for fSa3ms (P = 0.0982) but did however significantly
decrease for fSa4ms (P < 0.0001) (Table 3-5, Figure 3-9c).
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Table 3-5. Copy numbers and excision rates of MSSA476 prophages at
selected optical densities.
Prophage OD600

fSa3ms

fSa4ms

Prophage copy number

Excision rate (copies

(copies attP/copy gyrA)

attB/copy gyrA)

exDNA

gDNA

0.35

0.380 ± 0.049

0.109 ± 0.010

4.64 x 10-4 ± 4.52 x 10-5

0.7

0.338 ± 0.064

0.095 ± 0.005

4.80 x 10-4 ± 1.10 x 10-5

1

0.265 ± 0.021

0.137 ± 0.013

5.05 x 10-4 ± 2.73 x 10-5

O/N

0.256 ± 0.014

0.123 ± 0.010

9.58 x 10-4 ± 2.14 x 10-5

0.35

2.220 ± 0.110

0.084 ± 0.006

1.51 x 10-4 ± 2.47 x 10-5

0.7

1.257 ± 0.229

0.065 ± 0.002

9.91 x 10-5 ± 3.13 x 10-6

1

0.427 ± 0.030

0.077 ± 0.008

8.44 x 10-5 ± 1.14 x 10-5

O/N

0.207 ± 0.019

0.070 ± 0.008

8.75 x 10-5 ± 8.15 x 10-6

O/N = overnight culture

148

Figure 3-9. QPCR characterization of MSSA476 prophage excision rates
and copy numbers from logarithmic and overnight cultures. A) Excision
rates of fSa3ms and fSa4ms samples at indicated optical densities. fSa3ms does
not show a significant difference in excision rates comparing OD600 = 0.35 and 1.0
samples, whereas a significant decrease is found for fSa4ms. B) Excised prophage
copy number from MSSA476 whole-genome DNA (gDNA) samples at indicated
optical densities. Neither fSa3ms nor fSa4ms have significantly different excised
prophage copy numbers comparing OD600 = 0.35 and 1.0 samples. C) Excised
prophage copy numbers from MSSA476 extra-chromosomally enriched DNA
(exDNA) samples at indicated optical densities. fSa3ms does not show a significant
difference in phage copy number from OD600 = 0.35 to 1.0, whereas fSa4ms copy
number significantly decreases in this interval.
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The data above indicated fSa4ms was likely an active lysogenic phage, with the
abundance of circular phage genomes not appearing to be a precursor to lytic cycle
replication. The prevalence of fSa4ms’s stable excision however was unclear (i.e.,
the percentage of cells with excised “active lysogenic” fSa4ms). We employed qPCR
using the naturally occurring circular plasmid pSAS1 to understand the level of
enrichment imparted by our exDNA preparation protocol. We found that pSAS1
existed on average at 1-2 copies per cell (copies pSAS1 target/copy gyrA) in gDNA
preparations of MSSA476 at OD600 = 0.35 and 0.7, but that the plasmid was
enriched 1500-fold to an average of 2322 copies pSAS1/copy gyrA in exDNA. That
fSa4ms copy number in our qPCR assay reaches, at a maximum, 2.22 copies
attP/copy gyrA (Table 3-5), suggests that the fSa4ms excision we uncover is a rare
event. The percentage of cells with stably excised fSa4ms, as well as its copy
number per cell, is presently unclear.

3.8 Promoter alteration by fSa4ms excision/integration affects htrA2
transcription and heat-stress survival in S. aureus

Since fSa4ms could act as an active lysogenic phage, a stable subpopulation of
MSSA476 cells may exist with an altered important chromosomal sequence, since
fSa4ms integrates 30 bp upstream of the stress response serine protease-encoding
gene htrA2. Sumby and Waldor previously noted the possibility of altered htrA2
transcription by fSa4ms excision/integration (Sumby and Waldor, 2003), and our
data suggested that indeed a subpopulation of MSSA476 cells would harbor htrA2
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under an altered promoter (Figure 3-10a). We developed a PhtrA2-gfp reporter
system to examine whether GFP fluorescence would be altered when the GFPencoding gene gfpmut2 was under the control of the fSa4ms-integrated (Pint) or
fSa4ms-excised (Pex) promoters. Experiments were performed in S. aureus RN6390
and COL htrA2 deletion knockouts, two well-characterized strains where htrA2 was
shown to impact COL but not RN6390 survival in heat-stress (Rigoulay et al.,
2005). Comparisons of GFP fluorescence at 37°C and 44°C showed that in both
strains, fluorescence was greater when gfpmut2 was promoted by Pex than by Pint,
indicating that Pex is a stronger promoter of htrA2 than Pint. GFP fluorescence was
greater in Pex constructs at both 37°C and 44°C at 3 and 6-hour time points (Figure
3-10b).

Due to its reported role in promoting heat-tolerance in COL, we examined if
promoter alteration could affect survival of htrA2-complemented S. aureus RN6390
and COL htrA2 knockouts. Complemented strains contained the full-length htrA2
gene under the control of the Pint or Pex promoter on the pCN35 plasmid or were
left uncomplemented with empty pCN35 and grown in a dilution series at 37°C or
44°C on agar plates. COL constructs at 37°C did not display any survival
differences among the three strains, however at 44°C, COL Pex displayed
approximately 2-log increased survival over COL Pint (Figure 3-10c, top).
Surprisingly, COL Pint survived 1-log worse than uncomplemented COL htrA2,
indicating that htrA2-mediated heat-stress survival may depend upon specific
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promoter sequences and not solely levels of transcription or promoter strength.
RN6390 constructs showed no survival differences at 37°C or 44°C, in accordance
with previous reports of HtrA2 activity in the strain (Rigoulay et al., 2005) (Figure
3-10c, bottom). Environmental conditions may select for cells with one promoter
versus another, and fSa4ms’s excision/integration dynamics and active lysogeny
could provide MSSA476 with a potential switching mechanism to create these
advantageous subpopulations.
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Figure 3-10. fSa4ms excision/integration alters the promoter and
transcription of htrA2. A) Diagram illustrating fSa4ms integrated and excised
states in MSSA476 and the unique DNA regions of the Pint and Pex promoters.
(Top) When fSa4ms is integrated in the chromosome, htrA2 is promoted by Pint.
(Bottom) fSa4ms excision joins the Pex region immediately upstream to htrA2, and
the gene is promoted by Pex. Pint unique DNA sequence is carried on circular
fSa4ms when the phage is excised. B) Ratio of GFP fluorescence from Pex- versus
Pint-promoted gfpmut2 constructs in COL and RN6390 htrA2 strains. Bars above
the dashed line indicate samples where GFP fluorescence is greater with Pexpromoted gfpmut2 than with Pint-promoted gfpmut2. C) Dilution series of COL and
RN6390 htrA2 knockout strains complemented with htrA2 promoted by Pint (int) or
Pex (ex). (-) indicates COL or RN6390 htrA2 knockout strains containing empty
pCN35 plasmid. COL (top) or RN6390 (bottom) constructs are spotted in a logdilution series and grown at 37°C or 44°C for 24 hrs. Dilution factor indicated on
left of plates; (ND) = not diluted. COL constructs display equal survival at 37°C, but
COL Pex displays 2-log survival above COL Pint. Unexpectedly, uncomplemented
COL htrA2 shows 1-log survival above COL Pint. COL Pint shows few colonies at
44°C in the undiluted culture spot. RN6390 displays no survival difference among
constructs at 37°C or 44°C.
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DISCUSSION

This study described in this Chapter explores the prevalence of extra-chromosomal
prophages in S. aureus as an extension of previous work uncovering the plasmidial
phage fBU01 in S. aureus NRS19 (Utter et al., 2014). We isolated and sequenced
the exDNA of 15 clinically-relevant S. aureus strains with known chromosomal
sequences, but unlike our previous study, we did not find any prophages existing as
solely plasmidial elements. We did uncover however, several episomal prophages
appearing to exist as active lysogenic phages. It therefore seems that the existence
of plasmidial prophage in S. aureus is uncommon and fBU01 may represent one of
these rare prophages. Episomal prophages, on the other hand, appear to be fairly
widespread and were identified in 33% of S. aureus strains (5 of 15) examined in
this study.

3.9 Strains and phages possess different mobilization capacities

We distinguished strains that carried episomal prophage from those with no
prophage detected in the extra-chromosomal compartment, but our study did not
reveal why some strains have such a phage-mobilization capacity while others do
not. Goerke et al. demonstrated a similar observation, finding that phages fs80b
and fs84b (hlb-converting phages) were integrated within the hlb gene in S. aureus
s64c, but were found to alternate between integrated and extra-chromosomal
carriage in strain 8325-4 (Goerke et al., 2006). Both s64c and 8325-4 are phage156

cured strains, suggesting that a host-factor (or factors) is likely determining phage
localization and mobilization capacity within the cell. In a separate manner, phage
induction capacity into the lytic cycle has also been observed to depend upon host
background, with fSa2mw induced by mitomycin C in strains MW2 and Newman,
but not 8325-4, RN6390 or ISP479c (Wirtz et al., 2009). We believe that the phages
we describe here are localized and harbored within the extra-chromosomal
compartment in a manner distinct from lytic excision and replication (Deutsch et
al., 2016; Utter et al., 2014), however it is possible similar host factors may govern
both events. The hlb-converting phages we characterized from strains BAA-42,
MSSA476 and HPV107 contained high sequence homology over their
integration/excision modules, however they displayed different levels of enrichment
in extra-chromosomal sequencing and qPCR characterization, with HPV107
carrying its hlb-converting phage extra-chromosomally in a greater proportion of
the population. Host differences similar to those affecting fs80b and fs84b
localization may account for the differences in hlb-converting phage localization
among our three strains, however such factors have yet to be uncovered.

Within individual strains, we also noted differences in phage localization. In
MSSA476, fSa4ms—but not fSa3ms—was enriched in sequencing, with the
localization of circular prophage confirmed by qPCR and selective-depletion
experiments. fSa3ms and fSa4ms share the same host background, indicating that
a phage factor is responsible for localization differences, but it is currently unclear
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which factor(s) may be responsible. Prophage excision requires recombination
mediated by integrase; stochastic higher expression of a phage’s integrase or
excision-related genes may be one mechanism by which phage localize into the
extra-chromosomal compartment. The process may also be controlled by as of yet
uncharacterized factors in a more regulated process. If excision occurs without
inducing conditions, then phages could be localized into the cytoplasm in a manner
consistent with the lysogenic cycle. Feiner et al. reviewed such phage activity in a
range of bacterial species, particularly those whose excision/integration dynamics
can act as a molecular switch for the cell, terming the process “active lysogeny”
(Feiner et al., 2015).

The mechanisms behind differences in mobilization capacity among strains and the
phages themselves are presently unclear, however an approach using a transposon
or gene-knockout screening, coupled with a reporter system, may be able to
elucidate such factors. Screening candidates for increased phage mobilization by
PCR is too exhaustive a task, but a reporter system in which a visual phenotype is
apparent with phage excision could facilitate such a screening. For example, a
reporter gene (gfpmut2, xylE) could be fused to hlb, geh or another relevant phage
integration site such that a phenotype is apparent when phages are excised, but
absent with phage integration. Increases in fluorescence or pigmentation of colonies
could indicate candidate genes that contribute to phage stabilization in the
chromosome. In parallel, a screening in which potential factors are overexpressed
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on a plasmid in the same reporter system could identify gene activity necessary for
the phage excision detected. Outside of screening, candidate genes could also be
identified between strains in which the same phage shows differential mobilization,
e.g. S. aureus s64c and 8325-4. Such differences between the strains may attributed
to changes in gene expression rather than sequence however, and could complicate
such an approach. Regardless, research focused on uncovering such factors will be
important in understanding the behavior of various strains versus others and
contribute to our understanding of the interplay between bacteria and phage. Their
presence would suggest a mechanism by which bacteria use phage to increase their
diversity and create new subpopulations, capable of altered gene expression,
virulence, and/or fitness.

3.10 Episomal prophage are detected only in extra-chromosomally
enriched DNA samples, and are circular DNA elements that appear to be
active lysogenic prophages

QPCR characterization of prophage excision rates and copy numbers revealed,
surprisingly, that episomal prophages are detected only in exDNA samples and that
their presence is masked in gDNA preparations. In MSSA476 for example, overall
excised prophage copy numbers as measured from qPCRs of gDNA is relatively low,
with fSa3ms and fSa4ms at 0.086 and 0.023 copies attP/copy gyrA, respectively.
This would correspond to very low increases in read-depth over the fSa3ms and
fSa4ms prophage chromosomal locations if MSSA476 gDNA was sequenced and
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read-mapped to a MSSA476 reference chromosome (likely 8.6 and 2.3% maximum
increases, respectively). Using gDNA, coverage analysis tools would likely not find
regions of significantly higher coverage spanning either prophage genome, so while
fSa3ms copy number was greater than fSa4ms in gDNA samples, neither prophage
would be found as enriched by this approach, and the episomal nature of fSa4ms
would be overlooked. fSa4ms excised prophage copy number in exDNA samples
however is much greater (0.622 copies attP/copy gyrA), and is sufficient for
significantly high read-depth across the prophage location in the chromosome. The
excised copy number of fSa3ms in exDNA samples, while elevated from that seen in
gDNA samples (0.146 versus 0.086 copies attP/copy gyrA, respectively), was not
high enough to have significantly higher read-depth or coverage over the fSa3ms
genome in read-mappings. Thus, our exDNA isolation and sequencing approach
allows the distinction of episomal elements, even when such elements would be
masked in qPCR and sequencing of DNA prepared by other methods.

We showed that our extra-chromosomal DNA isolation procedure enriches circular
DNA elements, allowing the identification of episomes and plasmids, and that
whole-genome approaches do not impart such selectivity in sample preparations.
Why fSa4ms copy number was lower than that of fSa3ms in gDNA despite the
presence of fSa4ms episomes, we believe, is likely due to the presence of linear, lytic
cycle prophage genome concatemers in the MSSA476 population. pSAS1 plasmid
enrichment by our protocol was approximately 1500-fold, suggesting that in qPCRs
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of gDNA, the percentage of total attP targets encoded by circular prophage is very
low. The copy number of linear prophage concatemers in gDNA samples therefore
likely masks the presence of circular phage elements, making it doubtful that the
DNA elements we uncover would be detected by sequencing or qPCR in the absence
of extra-chromosomal DNA enrichment. That the excised prophage copy number of
fSa3ms and fSa4ms is so low in exDNA samples despite ~1500-fold enrichment for
pSAS1 suggests that for MSSA476, both fSa3ms and fSa4ms excised prophage copy
number is primarily composed of linear elements, likely from a small subset of cells
whose phages are undergoing spontaneous lytic cycle replication. While both phages
in MSSA476 are capable of such lytic events, only fSa4ms showed enrichment for
circular prophage in its cytoplasm, suggesting fSa4ms’s circular prophage is not
participating in the lytic cycle, but is perhaps in a state akin to active lysogeny
(Feiner et al., 2015). We also note that samples for sequencing were prepared in
nutrient-rich conditions at mid-logarithmic phase, conditions unlikely to promote
DNA damage and associated prophage lytic induction (Nanda et al., 2015). A model
for how the MSSA476 population might exist in early logarithmic phase is
presented in Figure 3-11.
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ΦSa3ms linear concatemer
Circular ΦSa3ms
ΦSa4ms linear concatemer
Circular ΦSa4ms
Cell without induced phage
Cell with excised, active lysogenic phage
Cell with induced phage

Figure 3-11. Qualitative model of MSSA476 early logarithmic culture. At
early log phase, MSSA476 culture contains cells with prophage in both the lytic and
lysogenic cycles. The vast majority of cells are stably lysogenized (tan) with fSa3ms
(blue) and fSa4ms (orange). A subpopulation of cells contains excised prophage
elements that appear to be in an active lysogenic cycle (green). Of these cells, those
with fSa4ms excised outnumber those with fSa3ms excised. Cells with phage
induced into the lytic cycle are pictured in gray. Here, fSa3ms-induced cells
outnumber fSa4ms-induced cells. Subpopulations are shown at relative percentages
for illustrative purposes, rather than the quantitative levels suggested by qPCR and
other data.
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However, to further rule out the presence of circular prophage as a precursor to lytic
cycle replication, we examined MSSA476 samples by qPCR over a range of time
points. Surprisingly, the results revealed that excision of circular prophage into the
extra-chromosomal compartment is temporal, with the highest levels of circular
fSa4ms in early logarithmic growth but rapidly decreasing with increased celldensity. This decrease occurred without any concurrent increase in overall fSa4ms
copy number, showing that fSa4ms circular elements were not precursors to phagereplication and are likely not participating in the lytic cycle, but rather are in an
active lysogenic state. The data also indicates potential control of this event by the
bacterial cell, with some factors either promoting excision at early log growth, or
perhaps increased re-integration at later growth points. In addition, these data
show that phage enrichment would likely go undetected in MSSA476 if samples
were prepared at OD600 ³ 1.0. Therefore, it may be beneficial to purify extrachromosomal DNA at multiple time points in future studies, elucidating the entire
mobilization dynamics of a bacterial genome over its growth cycle.

The time-course qPCR data also showed that the excision rate of fSa4ms decreased
from early to later log phase, suggesting some circular fSa4ms may be reintegrating into the chromosome after excision. In addition, whether fSa4ms or
related circular prophage elements undergo any replication or remain as single copy
in this excised state is unclear. A previous study reported Hlb–/sak2 S. aureus
strains with multiple hlb-converting phages integrated in the chromosome (Goerke
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et al., 2006). Replication of excised lysogenic prophage could be the first step in
generating such strains. Our qPCR approach examined bacterial populations as a
whole, but cannot address these specific questions; further experiments on the
single-cell level are necessary to uncover such exact excision/integration (and
potentially replication) dynamics. One potential method to address this question is
through fluorescence microscopy with fluorophores attaching specifically to modified
phage genomes. Reporter systems have been previously developed to track P22
phage localization and replication in live cells (Cenens et al., 2015) and a similar
approach could be used in S. aureus to look at phage replication and determine if it
occurs in a lytic or lysogenic manner (i.e. the degree of replication and whether cells
survive after phage genome replication). A complicating factor here is that it
appears in MSSA476 and likely other strains of S. aureus, prophages can be in the
lysogenic cycle in integrated and excised states and it is unclear if such systems can
distinguish these cell types. Additional co-localizing labels specific to the bacterial
chromosome may be necessary to help determine if for lysogenic cells, phage are
integrated or excised. Nonetheless, such a system should be able to help uncover the
dynamics and some of the questions about the phage we uncover by extrachromosomal DNA isolation and sequencing.
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3.11 What is the biological significance of episomal phage?

The phages we describe as enriched in our sequencing appear to be active lysogenic
phage that have excised from the chromosome, and the distinction between phages
in the lytic versus lysogenic or active lysogenic cycle is important when considering
the roles of prophage as molecular switches or mechanisms to generate diversity in
bacterial populations. Excision by phage induction leads likely to cell death,
whereas excision of (active) lysogenic phage will generate stable diversity in the
population that can be passed on to daughter cells. While under our conditions the
percentage of excised phage is relatively low, other external environments could
select for and expand certain prophage-excised subpopulations. For example,
fSa4ms was shown to alter the htrA2 promoter, with the phage-excised (Pex)
promoter conferring increased heat-tolerance in COL. It is presently unclear if
HtrA2 confers this tolerance in MSSA476, however if the protein plays a similar role
as in COL, then qPCRs of phage excision rates and excised prophage copy number
in cultures grown at elevated temperatures may show increased proportions of cells
with excised (or lost) fSa4ms. Such growth could either select for survival of already
fSa4ms-excised cells, or could drive fSa4ms lysogenic excision by an unknown
mechanism. In either case, the overall percentage of cells with excised fSa4ms
prophage would increase.

In other strains, the external environment could also drive the expansion of
subpopulations with excised prophage. In HPV107 for example, a subpopulation
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containing excised hlb-converting prophage might expand in infection conditions
(i.e., serum culture or low-iron environments). Goerke et al. found that hlbconverting prophages moved to atypical chromosomal locations allowing Hlb
production in invasive disease isolates; localization of typically integrated lysogenic
prophage into the cytoplasm (without induction) could precede generation of such
unique S. aureus isolates (Goerke et al., 2006), or alternatively, prophage harbored
in the cytoplasm without reintegration could achieve the same phenotype. The
extra-chromosomal DNA enrichment and sequencing approach described here may
allow characterization of strains for such a mobilization capacity or potential. Other
phages such as those that negatively convert geh could excise under conditions
selecting for lipase activity as well.

A clear question that follows from the research described in this Chapter is the
biological role of phage mobilization. Two approaches may help drive at the answer
for this question. One approach would be to grow cultures in a variety of conditions
(e.g., BHI or serum culture, starvation or nutrient-rich conditions, or other relevant
culture environments) and compare the extra-chromosomal DNA profiles of each
sample. Comparison may show the favored excision of phage in one condition over
another and suggest biological roles and help formulate better hypotheses of how
specific phage may promote increased bacterial fitness. We did a “retroactive” extrachromosomal sequencing of S. pyogenes SF370 at mid-logarithmic phase, which
indeed showed the expected enrichment of episomal SpyCIM1, the phage-like
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element acting as a switch in the strain’s mismatch repair operon (Deutsch et al.,
2016). Follow-up experiments examining exDNA of S. pyogenes SF370 in nutrientrich versus nutrient-deficient conditions should show the enrichment of SpyCIM1 in
rich rather than nutrient-poor conditions and could serve as a test case for extrachromosomal DNA isolation and sequencing in a variety of environments. While the
biological role of SpyCIM1 is already partially known (Hendrickson et al., 2015;
Nguyen and McShan, 2014), without this information, extra-chromosomal DNA
isolation and sequencing alone could offer promising potential avenues of research,
i.e., exDNA sequencing of SF370 suggests SpyCIM1’s biological role without
knowledge of prior reports. While the same conclusions can be drawn from qPCRbased experiments, given the relative ease and low-cost of sequencing, profiling
bacterial extra-chromosomal compartments in this manner will allow for multiple
target identification and less bias in uncovering elements.

A more direct approach to uncover the biological role of such phage excision would
be to prevent it outright by creation of phage integrase knockouts. As previously
described, the movement of hlb-converting prophage in S. aureus to atypical
chromosomal loci has been shown to occur in isolates from cystic fibrosis and
bacteremic patients, with phage mobilization thought to be important for infection
(Goerke et al., 2006). An informative experiment could compare the virulence and
dissemination of S. aureus harboring hlb-converting phage that can freely
excise/integrate (WT), versus those that that are “locked into” the chromosome
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(Dint), or are phage-cured. Here, the comparison of wild-type, Dint, and phage-cured
strains should help elucidate both the role of the phage as a whole, as well as the
specific benefits of phage excision/integration. Given that phage mobilization plays
a key role in the transition from colonization to invasive infection, strains with
locked-in phage may show a decreased virulence potential. However, negative
conversion may allow for strains to better colonize in the first place, serving as a
mechanism for the organism to “get a foot in the door”, or in this case, the nose.
(Isolates harboring hlb-converting phage are overwhelmingly represented in the
nasal cavity, but have not been found essential for colonization (Verkaik et al.,
2011).) If this is the case, then phage-cured strains should show decreased initial
colonization and may be outcompeted by other strains or species. In addition, as the
virulence factors typically carried on hlb-converting phages were shown important
for infection (Bae et al., 2006), phage-cured strains may have weaker virulence
potential. Thus, the most virulent strain of S. aureus may be the one containing an
hlb-converting prophage capable of atypical localization, allowing colonization of the
nose via phage gene products, and successful infection by concurrent production of
Hlb and phage-encoded virulence factors. An illustration of the potential benefits of
harboring mobilizing phage is shown in Figure 3-12. Comparison of these three
strain types (WT, Dint, and Dfhlb-c) should illustrate some of the key biological
roles of active lysogenic phage in the S. aureus lifecycle.
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Phage-driven diversity
I. Hlb–, SAK+, SCIN+,
SEA+, CHIPS+

∆int (Hlb–, SAK+,
SCIN+, SEA+, CHIPS+)

II. Hlb+, SAK+, SCIN+,
SEA+, CHIPS+
Changes in colonization?

WT (Hlb–, SAK+,
SCIN+, SEA+, CHIPS+)

Virulence potential?

III. Hlb+, SAK+, SCIN+,
SEA+, CHIPS+

Other phenotypic alterations?

ΔΦhlb -c (Hlb+, SAK–,
SCIN–, SEA–, CHIPS–)
IV. Hlb+, SAK–, SCIN–,
SEA–, CHIPS–
Φhlb-c

hlb gene
Phage-encoded virulence factor
Hlb

Figure 3-12. Mobilizing phage can generate diverse subpopulations of S.
aureus. An illustration of a hypothetical experiment is shown above. Here, a S.
aureus strain is lysogenized with a hlb-converting phage that can freely excise from
and reintegrate into the chromosome (WT). Variants of the strain include an
integrase knockout where the phage is “locked” in the chromosome (Dint), and a
phage-cured derivative (Dfhlb-c). The WT strain can generate numerous
phenotypically- and genotypically-altered subpopulations (I-IV) via phage
mobilization. The external environment may select for the expansion of one or
multiple subpopulations. For Dint and Dfhlb-c, the lack of phage mobilization and
phage, respectively, prevents diversity in their populations. Dint can only exist as
population I, and Dfhlb-c as population IV. WT can reversibly switch between I, II
and III, and irreversibly lose its phage, creating population IV. Comparison among
the three strains for colonization, virulence, and other phenotypes (e.g. biofilm
formation capacity) could illustrate the importance of phage mobilization in S.
aureus, and phage as a potential switch allowing the bacteria to alter its phenotypes
for success in multiple environments.
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In a related but converse manner, one study found S. aureus colonization of mouse
ears was actually enhanced with Hlb production. In this report, the hlb-converting
phage of S. aureus MW2 (fSa3mw) was frequently lost upon murine ear
colonization, and a bacterially-controlled phage-switch to alter the organism’s
infection program was suggested by the Authors (Katayama et al., 2013). Here, in
contrast to typical observations in human isolates, fSa3mw was preferentially lost
in mouse ear colonization. It is unclear why the loss of fSa3mw is preferred for
mouse colonization while strains harboring hlb-converting phage are nearly always
found in human nares, but it is known that the virulence factors encoded by
fSa3mw are more human-specific (Katayama et al., 2013). Phage-loss in this case
may be selected for due to the murine host, whereas in humans, the importance of
such phage-encoded factors may select for strains harboring hlb-converting phage.
In addition, this study did not examine the propensity of such strains to cause
invasive infection; fSa3mw-cured strains may show weaker virulence potential and
be selected against in such an experiment or environment. Regardless, for S.
aureus, carrying lysogenic phage capable of excision without induction may allow
the bacteria to successfully balance the needs of colonization and infection, which
demand different sets of virulence factors.

The research detailed in this Chapter uncovered potential active lysogenic phage
that could modulate the expression of htrA2 (fSa4ms), and allow the full-length
transcription of hlb (fHPV107.1) by excision from the chromosome. In addition to
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these phage, this work also uncovered an intergenic prophage in HPV107 (unclear
integrase type, intergenic between tRNA-Ser and enterotoxin), and 2 intergenic
prophages in NRS22 and BK2529 (both with Sa7-like integrases, and intergenic
between rpmF (50S ribosomal protein L32) and isdB (iron-regulated surface
determinant)). The potential effects of their extra-chromosomal carriage on hosts
are unclear, and phage integration in these loci has been previously reported (Bae
et al., 2006; Goerke et al., 2006). Excluding fHPV107.1, the typically-intragenic
phages we found enriched in our screening included a geh-converting prophage in S.
aureus NRS143, a 6-phospho-b-galactosidase-integrating prophage in HPV107, and
2 prophages in NRS22 (one prophage integrated within a hypothetical proteinencoding gene, and one prophage disrupting a radical SAM-encoding gene). In
addition, we uncovered an enriched integrative and conjugative element (ICE)
typically located within a predicted membrane protein encoding locus in NRS271.
Lipase has been implicated in biofilm and abscess formation in S. aureus (Hu et al.,
2012; Jabra-Rizk et al., 2006; Kuroda et al., 2007), however some clinical strains
carry geh-converting phages without a clear mechanistic advantage. If some gehconverting phages are acting as switches to control the expression of lipase for the
bacteria’s benefit, then advantages to such prophage carriage would be apparent,
and future work should investigate this possibility. The effects of the other
intragenic phages are unclear, however their enrichment suggests that they could
act as switches to also control underlying gene expression. Disruption of genes by
the intragenic phages in NRS22 has been reported previously in other S. aureus
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strains (Bae et al., 2006), however to our knowledge, disruption of a 6-phospho-bgalactosidase encoding gene (HPV107) has not been previously reported and
represents a novel phage integration site in S. aureus. The role of the uncovered
ICE is also unclear, but its potential as a DNA-level switch is intriguing. Overall,
exDNA isolation and sequencing revealed the episomal nature of specific typicallyintegrated staphylococcal prophages. The reports of virulence program alteration by
mobilizing hlb-converting phages suggests that the DNA elements uncovered by our
extra-chromosomal DNA isolation and sequencing approach may act as diversity
promoting elements in S. aureus. The prevalence and number of prophage elements
uncovered in this screening suggests their widespread use and importance to the
pathogen. Follow-up experiments will have to elucidate their specific biological
roles.
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SUMMARY

This study screened the extra-chromosomal DNA of 15 clinical S. aureus isolates,
uncovering the prevalence of episomal prophage with potential roles in virulence
factor expression and regulation. QPCR characterization of one of these strains,
MSSA476, verified that one of its phage, fSa4ms, exhibits episomal behavior, and
may exist as an active lysogenic prophage. We show that episomal fSa4ms exists as
a circular DNA element off the chromosome, and that it does not appear to be a
precursor to lytic cycle replication. Importantly, the episomal prophage we uncover
are only detectable in extra-chromosomally enriched DNA samples, and their
presence would have been missed in sequencing or qPCRs of whole-genome DNA
samples. Lastly, this work finds that fSa4ms appears to act as a phage-molecular
switch, as its excision/integration alters the promoter sequence of htrA2, changing
its transcription levels and affecting heat-stress survival in S. aureus COL. fSa4ms
behavior suggests it is an active lysogenic prophage, and the other episomal
prophages identified may exhibit similar activity, given their integration sites.
Episomal lysogenic prophage, or active lysogenic phage, promote the generation of
stable, diverse subpopulations with impacts on bacterial infection; extrachromosomal DNA isolation and sequencing should allow the increased discovery of
such elements in S. aureus and other bacterial pathogens.
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MATERIALS AND METHODS

3.12 Bacterial strains and growth conditions
Strains and constructs used in this study are listed in Table 3-6. For preparation of
extra-chromosomal DNA, S. aureus strains were established from overnight
cultures grown in Bacto Brain Heart Infusion Broth (BHI), and back-diluted 1:100
into 50 mL BHI without shaking at 37°C unless otherwise noted. Strains were
grown to an OD600 of 0.6 - 0.8. Cultures were centrifuged at 4000 RPM for 10
minutes at 4°C and used immediately or frozen overnight at -20°C. For qPCR
studies, strains were back-diluted from overnight cultures and grown to specified
optical densities. For PhtrA2-GFP reporter studies, overnight cultures were backdiluted 1:100 in 15 mL BHI and grown at 200 RPM at 37°C to an OD600 = 0.2. E. coli
was grown at 37°C, 200 RPM in LB media with selection as necessary.
Concentrations for antibiotics used are as follows, for Escherichia coli: ampicillin,
100 µg/mL; for S. aureus: erythromycin, 5 µg/mL, spectinomycin, 50 µg/mL. For
heat shock studies, plates were grown at 44°C.
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Table 3-6. Bacterial strains and constructs used in this study.
Strains

Notes

Source

E. coli TOP10

Cloning host

Invitrogen

E. coli DC10B

Cloning host

Lab strain

E. coli

Strain containing pCN35

(Charpentier et al.,

DH5⍺::pCN35

plasmid

2004)

E. coli

Straining containing

(Charpentier et al.,

DH5⍺::pCN56

pCN56 plasmid

2004)

Restriction deficient

(Kreiswirth et al., 1983)

E. coli

S. aureus

RN4220

cloning host
RN6390

RN6390, htrA2::spc SpcR

(Rigoulay et al., 2005)

RN6390, htrA2::spc SpcR,

This work

htrA2
RN6390

ErmR

htrA2 DD01

harboring pCN35,

RN6390

RN6390, htrA2::spc SpcR,

htrA2 DD02

harboring pCN35 with full

This work

length htrA2 and 250 bp
int-promoter, ErmR
RN6390

RN6390, htrA2::spc SpcR,

htrA2 DD03

harboring pCN35 with full

This work

length htrA2 and 250 bp expromoter, ErmR
RN6390

RN6390, htrA2::spc SpcR,

htrA2 DD04

harboring pCN56,

RN6390

RN6390, htrA2::spc SpcR,

htrA2 DD05

harboring pCN56 with

This work

ErmR
This work

phtrA2-int insert, ErmR
RN6390

RN6390, htrA2::spc SpcR,

htrA2 DD06

harboring pCN56 with

This work

phtrA2-ex insert, ErmR
COL htrA2

COL, htrA2::spc SpcR

(Rigoulay et al., 2005)
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COL htrA2

COL, htrA2::spc SpcR,

DD11

harboring pCN35,

COL htrA2

COL, htrA2::spc SpcR,

DD12

harboring pCN35 with full

This work

ErmR
This work

length htrA2 and 250 bp
int-promoter, ErmR
COL htrA2

COL, htrA2::spc SpcR,

DD13

harboring pCN35 with full

This work

length htrA2 and 250 bp expromoter, ErmR
COL htrA2

COL, htrA2::spc SpcR,

DD14

harboring pCN56,

COL htrA2

COL, htrA2::spc SpcR,

DD15

harboring pCN56 with

This work

ErmR
This work

phtrA2-int insert, ErmR
COL htrA2

COL, htrA2::spc SpcR,

DD16

harboring pCN56 with

This work

phtrA2-ex insert, ErmR

Genome/Chromosomal
Accessions for read-mapping

BAA-42

MRSA

ATCC

JXZF00000000

MSSA476

MSSA; Hyper-virulent,

ATCC

JXZG00000000

NARSA

JXZU00000000

NARSA

JXZW00000000

community acquired
NRS156

MSSA; vaginal tampon
isolate

NRS271

MRSA; Linezolid-resistant,
wound isolate

NRS153

MRSA

NARSA

JXZY00000000

NRS127

MRSA; sputum source

NARSA

JXZZ00000000

NARSA

JYAD00000000

NARSA

JYAG00000000

from Tenn., oxacillin,
penicillin, ciprofloxacin
and erythromycin resistant
NRS387

MRSA; wound Washington
State

NRS22

VISA; MRSA; inpatient
ICU, bloodstream
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NRS143

MSSA

NARSA

JYAH00000000

NRS158

MSSA; HT 2000 0319;

NARSA

JYAN00000000

NARSA

JYAO00000000

VAF

JYAX00000000

VAF

JYAY00000000

VAF

JYAZ00000000

VAF

JYBA00000000

Strain was isolated from
skin infection in France
NRS2

MRSA; Mu3; ATCC
700698; Purulent sputum,
cardio thoracic surgery,
Japan; Oxacillin and Tet
resistant; VISA= MIC=4;
white colonies, robust
growth on BHI

E2125

MRSA; Denmark;
SCCmec1; 1964

HPV107

MRSA; Portugal;
SCCmec1a, 1992

HDE288

MRSA; Portugal;
SCCmecIVvar; MRSA;
1996

BK2529

MRSA; USA; SCCmecIV;
1996

ATCC = American Type Culture Collection
NARSA = Network on Antimicrobial Resistance in Staphylococcus Aureus
VAF = Vincent A. Fischetti

3.13 Whole-genome and extra-chromosomal DNA isolation and
manipulation
Whole genome DNA isolations (gDNA) were performed using the QIAGEN DNeasy
Blood and Tissue Kit, including an added manufacturer-detailed pretreatment step
for Gram-positive bacteria. Enzymatic lysis buffer was composed of lysostaphin (100
µg/mL) in 1X phosphate-buffered saline (PBS). Extra-chromosomal DNA isolation
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was carried out as previously described (Utter et al., 2014). Extra-chromosomal
DNA samples were visualized on 0.7% agarose 0.5X TAE gels stained with SYBR
Safe DNA Gel Stain. Electrophoresis was carried out at 50 V for 1 hr in 0.5X TAE,
and visualized with UV transillumination. Prior to DNA sequencing, extrachromosomal DNA samples were concentrated as needed using Microcon DNA Fast
Flow centrifugal filters, following manufacturer’s directions (EMD Millipore).

3.14 DNA sequencing of extra-chromosomal S. aureus samples
DNA sequencing of extra-chromosomal DNA samples was performed using the
Illumina MiSeq sequencer. Extra-chromosomal DNA was quality checked prior to
library construction and sequencing using the Thermo Fisher Scientific Qubit
Fluorometer High Sensitivity DNA kit to measure quantity of DNA and the Agilent
Technologies High Sensitivity DNA assay to measure size and quality of DNA.
DNA libraries were constructed as per manufacturer’s instructions from 1 ng DNA
per sample using the Illumina Nextera XT DNA Library Preparation kit. Each DNA
library was barcoded to allow for multiplexing during sequencing using the
Illumina Nextera XT Index kit. Libraries were quantitated and quality checked
using Agilent Technologies High Sensitivity DNA kit. Libraries were sequenced
using the Illumina MiSeq Reagent kit V2 (500 cycle). Prior to sequencing, libraries
were normalized and pooled together to make a pooled amplicon library at 2 nM
concentration. Sequencing generated FASTQ files to allow for off-instrument
analysis.
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3.15 Bioinformatic sequence analysis of extra-chromosomal DNA samples
Bioinformatic analysis was performed using CLC Genomics Workbench software
unless otherwise described. Extra-chromosomal reads were mapped to respective
chromosomal sequences (Table 3-6), and unmapped reads were saved as a separate
file and de novo assembled for plasmidial elements. Read-mappings were visually
examined for regions of increased read-depth corresponding to DNA element
enrichment in extra-chromosomal DNA samples. Read-mappings were then
subjected to coverage analysis to identify regions with significantly higher (P < 0.05)
coverage. Prophage and other mobile DNA element regions with high coverage were
noted for each sequenced sample.

3.16 QPCR analysis of S. aureus strains
For qPCR experiments, strains were grown as described for extra-chromosomal
DNA sequenced samples, or to other desired optical densities. Cultures were
divided, with one portion of the culture subjected to the QIAGEN DNeasy Blood and
Tissue Kit for gDNA isolation, and the rest undergoing extra-chromosomal DNA
isolation. gDNA samples were used to determine excision rates and phage or
plasmid copy number per cell of the bacterial population, while exDNA samples
were used only for phage and plasmid copy number measurements. Primer pairs
and probe sequences for each target are listed on Table 3-7. All primers and probes
were designed and purchased from Integrated DNA Technologies (Coralville, IA).
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Amplification was carried out using the TaqMan Gene Expression Master Mix
(Thermo Fisher) using the Life Technologies QuantStudio 12K-Flex Instrument
following manufacturer’s cycling protocol. Standard curves for each primer-probe
set were generated for each experimental run, with amplification efficiencies and
linear regression analyzed using QuantStudio Software. All primer-probe sets had
efficiencies 90-110% and R2 > 0.98. Excision rates, excised prophage copy numbers,
and plasmid copy numbers were calculated by normalizing target (attB, attP,
pSAS1, respectively) to gyrA. All targets were measured in biological triplicate and
technical duplicate. Graphical and statistical analysis was performed using Prism
GraphPad with significance testing done using two-tailed Student’s t-tests. Values
are reported as mean ± standard error.

3.17 Linear DNase and restriction endonuclease treatment of extrachromosomal DNA samples and end-point PCR of DNA targets
Prior to linear DNase and/or treatment with restriction endonucleases, extrachromosomal DNA samples were treated with PreCR Repair Mix (NEB) to repair
nicked DNA. PreCR-treated samples were then either 1) treated with PshAI and
PspXI (NEB) following manufacturer’s protocol, 2) treated with Plasmid-Safe-ATPDependent DNase (Epicentre), 3) treated with the fSa4ms-specific restriction
endonucleases PshAI and PspXI, then the Plasmid-Safe-ATP-Dependent DNase, or
4) left solely PreCR-treated. Plasmid-Safe treated samples were treated over the
course of 16 hours, where 2 µL ATP solution and 2 µL DNase were added at 2 and 4
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hour time points, with the reaction incubated at 37°C. Samples were heated to
inactivate enzyme prior to PCR. End-point PCR was carried out using targetspecific primers (Table 3-7) and the KAPA2G Robust Hotstart Polymerase (KAPA
Biosystems) with the following cycling protocol: 1) Initial denaturation 95°C, 3 min;
2) Denaturation 95°C, 15s; 3) Annealing 60°C, 15s; 4) Extension 72°C, 15s; 5)
Repeat steps 2-4 33 times. Samples were normalized for total DNA prior to loading
individual PCR reactions. PCR products were visualized using 1% agarose 0.5X
TAE gels stained with SYBR Safe DNA Gel Stain. Electrophoresis was carried out
at 100 V for 25 min in 0.5X TAE, and visualized with UV transillumination. Images
were captured using Alpha Imager HP software.

Table 3-7. Primers and probes used in this study.
Primers

Sequence

Notes

CGTGAAGGTGACGAAGTTGT

For per cell

qPCR/end-point
PCR primers

gyrA_F

normalization
gyrA_probe

TGTTTGCATGAGCTACATCAAGCCC

5' 6-FAM/ZEN/3'
IBFQ

gyrA_R

CCTTTACCACCACGATTTGA

For per cell
normalization

phihlb_attB_F

ACGTTTATATGTTATCGACCGT

for excision rates
of hlb-converting
prophage

phihlb_attB_probe

ACGCGCTGATTTAATCGGACAATCTTCT

5' 6-FAM/ZEN/3'
IBFQ
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phihlb_attB_R

TTGTCTGATGCACCATTATCA

for excision rates
of hlb-converting
prophage

phiSa4ms_attB_F

GACGCTTACGTCGGTACT

for phiSa4ms
excision rates

phiSa4ms_attB_probe

ACCAATATCCACTAATGTCCACTCCATTCA

5' 6-FAM/ZEN/3'
IBFQ

phiSa4ms_attB_R

TTGATGTGAAGCGGACAATC

for phiSa4ms
excision rates

hlb_attP_F

AAAGTCTCCAGTTTGGATACATAGA

for hlb-converting
prophage copy
number/ endpoint PCR
measurement

hlb_attP_probe

CAACAGTATTTATTGGGTTTGGAGTCC

5' 6-FAM/ZEN/3'
IBFQ

hlb_attP_R

GAAAGTATGTAATTTAGGGACCCATTAG

for hlb-converting
prophage copy
number/ endpoint PCR
measurement

phiSa4ms_attP_F

CCTTGCAACACATTCTGAACAC

for phiSa4ms
copy number/
end-point PCR
measurement

phiSa4ms_attP_probe

ACGGCCATTCTCAAACGTACACGA

5' 6-FAM/ZEN/3'
IBFQ

phiSa4ms_attP_R

TAAGAGCAAACACGAGTGGAAA

for phiSa4ms
copy number/
end-point PCR
measurement

pSAS1_F

CCTCGGAACCCTTAACAATCC

for pSAS1 copy
number

pSAS1_probe

ATGGTCGGCTTAATAGCTCACGCT

5' 6-FAM/ZEN/3'
IBFQ
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pSAS1_R

GCGTTGAGAAGAACCCTTAACTA

for pSAS1 copy
number

gapdh_PCR_F

GTCAACGAATATTGCAATTAATGGTATGG

for measuring
gapdh target via
end-point PCR

gapdh_PCR_R

CGCACCAGTAGAAGTAGGAATAATGC

for measuring
gapdh target via
end-point PCR

pSAS1_PCR_F

GAAGGTCGTCTATCTCTCAGATGTC

for measuring
pSAS1 target via
end-point PCR

pSAS1_PCR_R

AAGGATGGTCTCAAGAGGAATTAGCC

for measuring
pSAS1 target via
end-point PCR

Pint/ex and htrA2related primers

Pint_upstm

GCTTATGGATCCATAAATGATCAAACCACACCACCT

250bp upstream
of htrA2 gene,
phiSa4ms
integrated
primer, BamHI
restriction site,
for Pint
construction

Pex_upstm

GCTTATGGATCCAAAAATCGCATAAATAATTGATGTGAAG

250bp upstream
of htrA2 gene,
phiSa4ms excised
primer, BamHI
restriction site,
for Pex
construction

P_dwnstm

GCTTATGGTACCCTAAGGAATTACATGTTTTTTACCAATATC

30bp within 5’
end of htrA2 gene,
Kpn1 restriction
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site, for Pint/ex
construction

Pint_upstm_seq

ATAAATGATCAAACCACACCACCT

for Sanger
sequencing of
Pint

Pex_upstm_seq

AAAAATCGCATAAATAATTGATGTGAAG

for Sanger
sequencing of Pex

P_dwnstm_seq

CCTAAGGAATTACATGTTTTTTACCAATATC

for Sanger
sequencing of
Pint/Pex
constructs

full_htrA2_dwnstm

GCTTATGGTACCTTATTTTAGTTTAATATTAATTTCTTTC

3' end of htrA2,
for
complementation
of htrA2, Kpn1
restriction site

full_htrA2_seq1

GTACTGACTTTTAGGAATTACATGT

For Sanger
sequencing of
htrA2 constructs

full_htrA2_seq2

GTAATTACTGAATTAGATGGC

For Sanger
sequencing of
htrA2 constructs

full_htrA2_seq3

GTCTGAAACGGTGGGATATC

For Sanger
sequencing of
htrA2 constructs
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3.18 Construction and testing of PhtrA2-GFP reporter system and htrA2complemented knockouts
For construction of a PhtrA2-GFP reporter system, 250 bp upstream of the htrA2
gene and 30 bp of htrA2 were amplified from MSSA476 gDNA template using
Phusion High-Fidelity DNA Polymerase with two primer sets 1)
Pint_upstm/P_dwnstm or 2) Pex_upstm/P_dwnstm (Table 3-7) to amplify two
versions of the htrA2 promoter and 5’ gene region (Pint or Pex). PCR products were
gel purified, cut with restriction enzymes KpnI and BamHI (NEB), and further
purified. pCN56 vector (Charpentier et al., 2004) was mini-prepped, digested with
KpnI and BamHI, dephosphorylated with Antarctic Phosphatase (NEB), and gel
purified before ligation with T4 ligase (NEB) to the purified PCR products. 2 µL
ligation mixture was transformed into One Shot TOP10 Chemically Competent E.
coli (Thermo Fisher) and resulting colonies screened by PCR and Sanger sequenced
(GENEWIZ; South Plainfield, NJ) using primers Pint_upstm_seq/P_dwnstm_seq or
Pex_upstm_seq/P_dwnstm_seq for desired vector insert (Table 3-7). E. coli
harboring pCN56 with Pint or Pex inserts were grown and miniprepped, and the
vectors electroporated into electrocompetent S. aureus RN4220 using a Bio-Rad
Gene Pulser with the following settings: 2.5 kV, 25 µF, 100 W. Empty pCN56 vector
was also introduced into RN4220. Vectors from RN4220 colonies were transduced
using fNM4γ4 (Heler et al., 2015) into S. aureus RN6390 htrA2 and S. aureus COL
htrA2 (Rigoulay et al., 2005) following an established protocol (Olson, 2016). Colonies
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were screened via PCR and inserts Sanger sequenced to ensure the correct DNA
sequence.

To examine GFP fluorescence in each strain, overnight cultures of constructs were
back-diluted 1:100 in 15 mL BHI supplemented with 5 µg/mL erythromycin and 50
µg/mL spectinomycin and grown at 37°C, 200 RPM to an OD600 = 0.2. Cultures were
then grown at 37°C or 44°C with shaking. At 3 and 6 hr time points, 1 mL culture
was removed, an OD600 value measured, and 200 µL culture pipetted in a quartz 96well plate and RFUs measured on a Molecular Devices SpectraMax M5 instrument
(485 nm excitation, 515 nm emission). Fluorescence of pCN56 (empty vector)
cultures was subtracted as background, and OD600 normalized RFUs for each
sample were measured. Comparison of construct-GFP fluorescence was calculated
as a ratio of Pex/Pint. The experiment was performed in triplicate.

For construction of htrA2–complement vectors, the htrA2 gene and 250 bp upstream
of the gene were amplified using the primer set 1) Pint_upstm/full_htrA2_dwnstm
or 2) Pex_upstm/full_htrA2_dwnstm (Table 3-7) with Q5 DNA Polymerase (NEB) to
generate two DNA fragments containing the full length htrA2 sequence with
different 250 bp promoter sequences. PCR products were treated as described above
but ligated into pCN35 vector (Charpentier et al., 2004). The ligated vectors and
pCN35 empty vector were transformed into electrocompetent E. coli DC10B
prepared by standard techniques, shuttled into RN4220, transduced into S. aureus
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RN6390 htrA2 and S. aureus COL htrA2, then screened and sequenced as previously
described using primers full_htrA2_seq1, full_htrA2_seq2, full_htrA3_seq3,
full_htrA2_dwnstm, Pint_upstm_seq, and Pex_upstm_seq (Table 3-7).

To test viability and survival of complemented and mutant (empty vectorcontaining) S. aureus htrA2 strains, constructs were spotted in a log-dilution series
onto BHI-spectinomycin-erythromycin agar plates and incubated at 37°C and 44°C
for 24 hours following a protocol from (Rigoulay et al., 2005). Plates were examined
visually for survival and photographed the following day using a Cell Biosciences
AlphaImager HP instrument using AlphaImager HP software.
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CHAPTER 4. CONCLUSIONS AND OUTLOOK
Despite a wealth of research over the past 100 years, we are still constantly
surprised by the activities of the most abundant biological entity on earth:
bacteriophage. While larger themes of phage biology and phage-bacteria
interactions are clear, many of the details have yet to be filled in. Given the sheer
number of bacteriophage in the biosphere, and the magnitude of their interactions
with bacteria, there is clearly a long way to go.

Phages are the smallest “organism” on earth, and represent an evolutionary unit
with an extraordinarily rapid turnover time. While their genome size suggests they
are relatively simple, their dynamics allow nearly boundless opportunities for
evolution, and thus are far more complex that we can presently appreciate—
explaining our limited knowledge of them and their activities. The phage genome is
on average 1% the size of a bacterial chromosome (Hatfull, 2008), and such a
relatively small genome suggests that elucidating functional roles for phage genes
should be a straightforward task. However, 80% of bacteriophage genes show no
homology to known proteins; we simply do not know what the majority of phage
genes do, how they affect the phage, and likely, how they affect the host (Hatfull
and Hendrix, 2011).

From what we do know, phage have an enormous influence on the biosphere and
their hosts, and play major roles in virulence and bacterial survival (Brussow et al.,
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2004; Feiner et al., 2015; Gillis and Mahillon, 2014; Wilhelm and Suttle, 1999). The
details of this which we can currently describe are likely just the tip of the iceberg,
and as we learn more about the phage, we will no doubt uncover their invisible
hand in many biological processes. One area where phage are likely to be found in
increasingly important roles is bacterial genomic regulation. It is typically assumed
that in comparison to eukaryotes, bacteria are relatively simple and do not encode
the more advanced features of eukaryotic organisms. While true in some cases,
many analogues of eukaryotic systems have been uncovered in bacteria, i.e.
CRISPR systems (Marraffini, 2015). Bacteria are not thought to contain as many
regulatory mechanisms as eukaryotes for transcriptional regulation, however we
find examples where bacteria utilize phage to achieve the same end goal, either
through disrupting transcripts (SpyCIM1, hlb-converting phages (Feiner et al.,
2015)) or promoter-sequence alteration (fSa4ms). It is likely that more eukaryotic
system-analogues will be found in bacteria, and phage may turn out to be the tools
to accomplish some of these tasks.

Even for known prophages, determining why they are maintained by bacteria in
some cases has proven difficult. The geh-converting phages of S. aureus contain no
obvious virulence or fitness factors, but are stably maintained in the chromosome.
Prophage in this case may be kept around to prevent lipase expression or perhaps
the phage encodes a virulence factor not yet uncovered. It is also a possibility that
there is an effect beyond an obvious phenotype that we as researchers are currently
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not measuring. It is hard to imagine that the effects of removing a 40 kb DNA
element from a genome will be limited to simple on/off production of encoded
virulence factors. Indeed, curing of SpyCIM1, a 13.5 kb DNA element of S. pyogenes
SF370, was found to change global gene expression of the organism, affecting
seemingly non-related portions of the genome (Hendrickson et al., 2015).

In light of the many ways phage affect their hosts, a new term with a “big tent”
should be established to cover the all the mechanisms of phage influence, including
the more recently discovered phage-based switches, phage-driven gene expression
changes and other novel host-modifying activities. “Conversion” could serve as such
a term, with modifiers added (e.g., positive, negative, (active) lysogenic, lytic,
regulatory, etc.) to label specific classes by which phage affect the host (Figure 4). It
is likely that in almost every case of prophage carriage, there is always conversion,
we just don’t have the tools or aren’t looking for phenotypes in the right way.
Regardless of if we can observe conversion phenotypes, it is clear that phagebacteria interactions generate diversity within bacterial populations, either
contributing to altered genotypes and/or phenotypes. With the exception of
successful bacterial defense against phage infection, almost all other bacteria-phage
interactions are likely to alter the host and may generate distinct, biologically
significant subpopulations. (Even successful defense can alter bacterial genome
content, e.g., new phage spacer acquisition within a CRISPR array.) Whether or not
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such subpopulations have increased fitness and success depends upon the external
environment for selection.

Indeed the work presented in this Thesis for the Gram-positive pathogens B.
anthracis and S. aureus show that phage do serve to create diverse subpopulations
in each species. The research on B. anthracis illustrates a specific example of phage
biology and a bacteria-phage relationship that we need to better understand:
selection by lysis for phage-resistant bacterial populations. In S. aureus, a method
to more easily get at unexplored phage biology is developed, and proves to uncover
an example of a novel phage-switch: htrA2 promoter alteration driven by active
lysogenic phage excision/integration. These are two examples in a likely nearlimitless array of phage impacts on the host, and given the ubiquitous nature and
importance of both phage and bacteria, advances in biology necessitate further
study of their relationships.

In infectious disease for example, such research will allow us to 1) better
understand mechanisms by which phage drive bacterial adaptations in infection
environments (e.g., htrA2 regulation by phage excision/integration, superantigen
and DNase upregulation by S. pyogenes via phage lytic induction in the throat
(Broudy and Fischetti, 2003; Broudy et al., 2001; 2002)), and 2) better understand
the biology of bacteria’s natural enemy and aid in the development of new
therapeutics.
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Figure 4-1. Illustration of “conversion” and phage effects on bacterial
hosts. Conversion is a broad-acting term, encompassing all of the ways phage affect
their hosts. i) Positive conversion alters the phenotype of the host, where phageencoded factors often contribute to virulence or fitness potential (e.g., conversion of
S. aureus to SEA+, SAK+, SCIN+, CHIPS+, or promotion of vegetative survival in B.
anthracis by phage-encoded sigma factors). ii) Negative conversion by phage
integration can disrupt expression of host-encoded factors (hlb in S. aureus). iii)
Selection by lysis is the expansion of phage-resistant (R) or lysogenized (L) over sensitive (S) cells in a population. In B. anthracis, selection by lysis expands a CsaBdeficient subpopulation harboring a markedly altered phenotype which may impart
important survival advantages. iv) Conversion by induction refers to altruistic
subpopulations of cells where phages induce into the lytic cycle for the benefit of the
whole population. Phage induction can increase expression of phage-encoded factors
and help promote infection (e.g., stx phage) or alternatively, cellular debris (eDNA)
from phage-lysed cells can help increase biofilm formation (Nanda et al., 2015). v)
Regulatory changes mediated by phage-excision or “active lysogeny” can alter gene
expression in a number of species, including S. aureus (e.g., fSa4ms and htrA2
expression). vi) Phage sequences can serve as anchor points for genomic
rearrangements (S. pyogenes SSI-1); alternatively, phage excision and reintegration
can alter bacterial genomes. vii) Phage transduction is one of the most important
HGT mechanisms and can drive the dissemination of virulence and fitness
determinants. viii) Novel mechanisms by which phage alter their hosts are likely to
be discovered. In all cases i-viii, phage serve to increase the diversity of their hosts,
creating subpopulations which may alter bacterial fitness.
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For research focused on phage-based therapeutics, it is important to study phagebacteria interactions not just for antibacterial development, but also to understand
how resistant variants post-treatment may survive and cause further disease (i.e.,
how selection by lysis affects a bacterial population). For health and wellness in
general, phage likely play roles in microbiome-associated bacterial species, and
uncovering these interactions can potentially allow new strategies to improve
human health. In addition, the more we learn about phage, the more tools we have
at our disposal (e.g., CRISPR-based genome editing, endolysin and other phagebased therapies (Fischetti, 2005; Salmond and Fineran, 2015)).

Bordet suggested nearly a century ago that phage are the products of bacteria and
not a distinct entity. Today his finding is obviously viewed as inaccurate, but in
many ways, perhaps it is not far off from reality. Phage are selfish elements and the
predators of bacteria—but their survival and propagation absolutely depends on the
bacteria themselves, and clearly bacteria have in turn adapted their predators as
tools integral to their own survival and success. Regardless of which lens the phagebacteria/bacteria-phage relationship is viewed, it is clear we’ve only scratched the
surface of its intricacies. Uncovering more of the story requires one thing from
researchers: to look.
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APPENDIX 1. RAW SEQUENCES OF fBACA1 CONTIGS
Sequence file is available in FASTA format at:
https://www.dropbox.com/sh/b3alrq7k5y7q6pq/AABh2Usqstjt2MTzHXh2zJoSa?dl=0
Password:bacillusphage
fBACA1 Contig 1:

CTCCCTGGAGACCGCCGCCTAGCTTTCCATGCAAAAAATTCGTTTTATTTCATA
AAAGGGGGTTCAACTAAAGGAGGTGGTTCACATAGGACGAAAAGCGAAACCGA
TCCATTTGCAAATACTTGAAGGTAACAAAAATCGATTAACTAAACAGGAAATAG
AACAACGTGTGAAGGCTGAACAAAATATTCAACCGAAAGCGAATAGAATCAAA
GCTCCAACTTGGTTGAATGCTGTAGCTAAAAAGGAATTTAATCGTATTTCTAAA
GAATTAATGGAATTAGACCTTATTACAAATGTAGACATTAATGCTTTGGCGGCT
TATTGTGACGCCTACTCTGATTACGTTGAATGCACAAAGATTATCAGTGAAGAA
GGGTTAATGGTAGAGTATACGAATAAAGCAGCTGAAACCAATAAAGTCCCTCA
TCCCTTATTAACTAAAAAGAAACAATTGCATGAACAAATGAAGTCGTTGGCAAT
TGAATTTGGATTAACGCCGAGTTCTAGAGCATCTTTAGCAAAACCCAAGGGTGA
TGATAAACCAAAAACCAATGCTGAAAAGCGGTTTGGTGATAGGGTATGAGATT
AGAAGAAAGACTAATGCAATATGTTTATGACATTTCGGATGGTAACATATTGGC
TTGTAAGAAACATAAATGGGCTTGTGAGCGTTTTTTAAGAGATTTAGAACGTAC
ACAAGAGGATGAGTGTCCATTCTATTTTGATATTGAACAGTTATATGATTTTTA
TGAATGGTGCAAGCAGTTTAAACATTTTAAAGGTGTATTAGCAGGGCAATATAT
TGAGTTAACCGATTTTCAGTTATTTGTAGCAGCTAATATATTTTGTTTTCTTATC
AAAGCTACAAATAATAGACGTTTTCTACGTGCATTTATTGAACTTGCAAGAAAA
AATGCAAAATCGCAATTCTTGGCCCTTATTGCTTCTTATATAACCTTTTTATCTG
ATCAACAAGAAGAATGTTATATAGCTGGTTGGGATAGACAACAATCAAGCCTTG
TGTACAATGATATTTTAAAGCAACTAGGCGCATGTGATATGTTATCCAAAAAAT
ATAAGGATTCTTATGGGAAAATTACACATATAAAAAGTGGTTCAACAATAACAC
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CACTTTCTAAAGAAGCAAAAAAGACCGGTGATGGTACAAACCCATCGCTTGGT
ATTGTCGATGAATATCATGCTCACGATACTAGTGAAATTTATGATGTAATCGAT
TCTGGAATGGGTGCACGTGAGAATACATTGATGTTCATTATCACCACAGCAGG
ATTTAACATCAATGGACCTTGTTACAAGGAGTATAAATATTGTTCAAGGATATT
AGATCCAAACGATGCAGGTGTGGAGAATGATGAGTATTTTGTTGTTATTTGTGA
ACTTGATAAAGATGATGATATCAAGGATGAAACTAATTGGATAAAAGCCAATCC
AATCGTAGCAACTTATGAGGCTGGGATGAAGAAGCTACGTAGTGACTTGAAGG
TTGCTCTTGATAATCCTGAAAAAATGCGTTCTTTTCTAACGAAACGTATGAATA
TATGGGTTAACAGAAAAGAAAACGGTTATATGGATATGTCCAGATGGAATAAG
TGTGATGAAGTAATTGATCTATCTGAATTAAAAGGCATGGAATGCACAGTAGGT
GCTGATTTATCAGCGAAAATTGACTTGACTAGTGTAGATTTTGAATTCAAGAAA
GACGAGAAATACGTCGTGATTAGTCATAGTTTTATACCGGAAGACACTTTATTC
GAGAAAATGAAAACGGATAAGGTGCCATATGACATTTGGGCGCAGCAAGGTTG
GATTACTGTAACACCTGGTTCAGTAGTAGACTATAATTTCGTGAAAGAGTATAT
AAAAACGATGGAATCAGATAATGAGTTTAAAATAAAAGAAATATGTGCTGATCC
ATGGAACGCAACTCAATTCATGCAGGATATGGAAGCGGAAGGGTATGTCGTTG
TAGAAATCCGGCAAGGTATGGCTACTTTATCAGGCCCAACAAAAGACTTTCGG
GAGCAAGTGTATCAAAAGAAAATTATTCATAATAACAATCCAGTACTGAATTGG
GCAATTGGAAATGCTGTTACTAAGCAAGATGCTAACGAAAATATTATGTTGGAT
AAGTCAAAAGCAACAGAAAGAATTGATCCGATTGCGGCTGTAATTAACTCGCAT
GTTAGATGCATGCTCAATTCTGGTGAAATGGATTTGAATTCATATATTTTAAGT
CAAAATTTCTCATTCTAGGAGGAATTACATGCGGTTTTTAATGTTTTTTATCAGT
GTTTTAGATGATATTTTATTCGTTTCAGGGTTGTCCATTATTATAGGGACGACT
TTTTTTATTAACCCTATTTATGGATGGTATTTGTTGGGTATTATTCTCACAATGC
TGGGGGTGGTAATGATCAGAAGATAGAAAGGAGGTGAAATTTTTGATTTTTCG
GCAGCTATTTAAGAATCAGGATACAACAAACTTAAAAAATCCGACTCCTTGGTT
TAAAAGTTTATTTGGTTATCAAGCCGCAAGTGGTGAGAAGGTAACAGTTGAATC
ATCTTTAAGTGTTCCAACAGTTTACCGATGTATTAATATCCTTGCAAATAGTGTT
GCAATGCTTCCATTTCAAACATTTAAAGGGACAGCAAAGGGAAGGGAACGAGA
TAAGATGCATCAAGTGTCTTTTGTATTAGAAAGAAGACCAAACCCATTTCAAAG
196

TCCATTTAAATTCAAACATTTAATCGAAACACACCGTAATACATGGGGAAATGC
CTATATCAATATTCATTGGGGTGTGGATGGAAGACCGAAAGAATTGTGGGCAT
TAAATCCGGCTGTTACAACCCCAATCGTGGATCTGAAGACGAATAAATTATGGT
ATTTTACAAATTTACCAGATGGTACACCTATTAAAATATCTGATGATGACATTAT
TCATCTTACTACGTTGTCTACTGATGGATTGAAGGGAAAACCACCTATTCAGAT
TGCAAGGGAGTCTATAGGCAGCTCACAAGCGGCACAAAAATTTAAAGGTAAAT
TTTTTACAAATGGTGCAGCGCACAGTGGGCTATTAAAAACTCAACAAACATTGG
GTAAAGAGGCGAAAGAAATACTTCGTGACGCTTGGGAAGAAGCGAATACAGGA
TTAAATAACGCTCAAAGGATTGCCATTTTAGATGCTGGACTAGAATTTGAAAAG
GTTGGTATGCCTTTAAAAGATGCTCAATTTATTGAAGGTATGAAATTTGATAAA
GGTGAGATTGCAAATATTTTTAACATTCCTTTGCACATGATTAATGAGTTGGAT
CGTGCTACTTTCTCCAATATTGAGCAACAGGCGTTGGACTTTATTCAAAATACA
TTGAGTCCAATTCTTATACAGTATGAAGAAGAGTTTTCCTACAAAGCCTTTTCA
TTTAATGAGCAAAAACGTTATTATTTAAAGTTTAATCTGACAAGTTTATTGCGC
GCTGATTCTAAATCACGAGCAGAATTTTACAAAATCATGCTAGATGCCGGTGCT
TTCTCAATTAATAAAGTACTAGAACTAGAGGATATGGATGGAATTGGAGAATAT
GGTGATAAACATCGTGTTGATTTAAACCATGTATCCATTGAAATTGCGGATGAA
TACCAATTAGCAAAAGCTAGTGGAGGTTCGTCTCTGAAAGGAGGTGAGGACAA
TTAAAGACGTGTTTACTATTAAAAACCAAACAGATTCGTCAGCCGATCTATTCA
TTTATGGCGACATCATAAACAATTCCGGATGGAAATGGGATGATTCAGATGTTA
TGCCTGATGATGTAAAAAACATTTTAGGGCAATTGGATGATAAAAGTAACTTAA
ATATCTATGTAAATAGTGGTGGCGGCTCTGTATTTGCTGGTTTAGCCATTTATA
ACATGTTAAAGCGCAATAAGGCTCAAAAAACTGTTTATGTGGATGGTGTTGCAG
CTTCTATTGCTTCTGTAATTGCTTTGGCTGGTGATCGTGTTGTTGTCCCTTCTAA
TGCTTTCTTAATGATTCATAAACCTTGGACCTATGCAGCAGGAAATGCAATTGA
TTTCCGAAAAGCGGCAGAGGATCTTGATAACATTGAGTCAGGAATCATGAATG
TATACAAAGAGAACTTAAAAGAAGGCATTGAAATTGAAGAAATTCAACAATTAG
TAGATGCCGAGACCTGGTTAAGTGGTGAAGAAGCTGAAAAATACTTCAACATC
GAGGTTGTGGAAGCAAAAGATGTTGCAGCATGTATGAGTGATTACTTTGATAA
ATATCAAAAAACACCTAATAAGGTAGTAGCAAAAGCTCCTTCCATTCCAAAGAA
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GGATACTAATGAACAATTAAAAATTAAAAATGCACTAGACCTGTTAGAACTATA
GGTCTATTTTTGGTGCCAAAACAAGGAGGAAATACCGAATGGATAAACATGAA
CAAGAGTTACGTCAAAAAGTTGCTGATTTAAAAGCGAAAGCAGAAGAGTTTAAT
AATAGCGGTAAATATGAAGATGCTAAGGCGAAGATTGAGGAAGCAAAAAACGC
GAAAAATGAACTAGATAATTATCTAGCCATGAAGCAAATCCAAGTTCCCGATCC
TGTAAATTCACAAGCAGGAGTATTACCTCCAGCATCAGTAAAAAACGAAGACCC
ATCATATAAAGAAGTGTTTATGAAAGCTATCCGTGGTCAAAATTTAACTCATGA
AGAAGCAAGTGTTATGCAGGAATATAAAGCAGCATTATCTGAGAATGCAGGTA
AAGATGGCGGTTTTATTGTACCGGAAGATATTACTACAACTATTAATCAGTTAA
AACAAACGGTTGATAACTTAGAACAATATGTAAATGTACAACCTGTTTCAACAA
ACAAAGGAGCTCGTACATTAGAAAAACGTGCGGCATCTACACCTTTTGCACCAT
TATCTGAGTATGGTAAGCCAAATGCAATGCAAGAAATCGCTTCTCCTGAATTTG
ATCGTTTATCTTATGCTATTGAAGATTACGCAGGATTCTTACCAGTACCAAATG
ATCTATTAGATGATACAGATCAAGCTTTAGAAGAATATTTACGCCAATGGATCG
CGAAGAAATCTATTGCCACTCGTAACTACCTAATTTTACAAGAACTCAACAAAT
TGACAAAGGTTGATTTTAAGGATTATAAAGGCATTAAAACAGCATTAAATGTTA
CATTGGACCCAGCTTTTGCAGCCGGAGCTAATATTTTCACTAACCAAGATGGAT
TCAATTACTTAGATCAATTAGAAGATAAGGATGGTCGTCCGCTTCTTCAACCAG
ATCCAACAAATCCAACTCGTAAATTATTGTCAGGAAAGCCAGTTATTGTTTTAT
CCAATAAGACAATCGCTACAGATAAAGATGGGAAAGCACCTTTCATTGTTGGTA
ATTTAAAAGAAGCTATTATTCTTTGGGATAGAAAACAATTATCTATCGATATGA
CTACAGAGGGTGGAAACGCTTGGAGAACAAATACTTCTGAGTTCCGAGCGATT
GAGCGTGAGGATGTTACACCATGGGATACAGAAGCGGTTGTATATGGGCAAAT
TAATATCACACCGAAAGCTGGAGTTTAATAAAATAGGGGGTGTCCTTCTTGGTA
CTGAAATTAGAAGAAGCGAAAGAGTATCTTCGTGTGGATGGTGATGAGGAGGA
CACACTCATTTCCTCCTTGATAATAGCAGCTGAACAATATATTAAAAACTCAAC
AAGTAAAGATGTAAATTTGAATGACGAGCTTGCTAAATTAGCAGCTCGTATTTT
AATTGCTCATTGGTATGAAAATCGTGAGCCAGTTGGGAAAACTGGAAAACTATC
ATTTAGTTTGCAGTCAATATTAATTCAATTGCAATATTGTGTAGGTGATTCCAC
ATGAACCCAGGGAAATTAGATAAACGTCTTACATTCCAAGTAATAGACGAGGAT
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GCAAAGGGCCCAGATGGTGATCCAATAGAAGGATATAAAGATTCTTTTACTGTA
TGGGGCTCTTTTATTTTTTTAAAAGGAAGAAAATACTTTGAAGCAGCCGCAGCG
AATAGCGAAGTCCAAGGTGAAACAGAAATCAGATATCGTGCTGATGTGAATGC
CGATATGAAAATTAAGTATAAGAATACGATTTATGACATTGTTTCGGTTATTCC
AACTGAAAAACACACGTTGTCAATCATGTGGAAGCGTGGTGGAATGAATGGCT
GATGGTTTAGATTTATTAGGTTTTGATCGTTTAATCACTGAATTAGACCAGATG
GGACTACGTGGGGAAAAAATTGAAGATAGAGCTCTTGCAGCAGGTGGAGAACC
TATTCGAAAAGCTATTTCTGAAATAGCCCCAAGAAGTGATAACCCTAAAACAGC
AACAAAAAGTGAACCATGGCGTACAGGACAACATTTAGCTGATAATATCCGTGT
TACAAAGGCTAAAATGGAGGGCGGCATAAAAACTATCAAAATCGGTATAGATA
AAGCAGATCGTTCTCCATATTTTTACGGGAAGTTCGTGGAATGGGGGACATCTA
AAATGCCAGCCCAACCTTTTATAGAACCTGGATTTAATTCTTCGAAAGAAGCGG
CAATTCGTGCTATGACAGATATTTTGAAGAATGAAATGAGGCTGAATCTATGAT
AAATTTGCGCCCTGAAATTGTACAAGCTCTTGAAAATAATCAGGAGCTGGTTTC
TTTATTAGGTGGAAAACGCGTTTATTATCGTAAAGCCAAAAATGCTGAAGAGTT
TCCACGTATTACATTTTTTGAATTAGACAATAGGCCAGATGGATTCGCAGATAA
TAATGAAAGCGAAAGTGAAATAACATTCCAAATCGATATTTGGTCAAAAGGCAG
TACAACAGCAATCCACCAAAAAGTGAATGAGGTCATGAAAAGTATTGGTTTCTC
ACGTTATAAGGTTGCTGATTTATATGAAGAGGATACGAAAATCTTTCATTACGC
GATGCGATTCGCGAAAGGAGTGGAATTATAGATGGCTGGAGAAATTATTACAA
TTAGTTCGACTGTCGGTGTAGATAGTCTTGTTTATTCGAAATTATTGAAAGATG
ATACAACAGGCGTCAACTACGACACAGTAAAGAAATTGGAAGGTGCTGTAAAG
GTTAAAACATCTAAAAAAGTAGCTTCTGAAATTATGTGGAGCGATAACAAGAAA
TCGGAAATTGCTGAATCTGACGGTGAAGTTGAAGTTGAAATTGAAGTTAGGGG
ACTTTCACTATCCACGAAAGCAGATATTGAAGGATATCCAGAAGTTAAAGATGG
CGTATTAGATGAAAAACGTGTGGGAGAAAAACCATATTTAGCAATTGGATATCG
CTTTTTAAAAGCTAACGGTAAATATCGTTATGTTTGGTTACTTAAAGGAAAGCT
TTCGCAAGAGGAAGAAGAAGCCGAAACTAAGAAGGATAAACCAAACTTCCAAA
CAACTAAACTTAAAGGTTCATTCATTGAACGCGATTTCGATGATAGACCAAAAT
TTACAGCTGATGCAGATGAACCGACATTTACAAAAACGGTAGGAGATACTTGG
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TTTAGTAAGGTGTATGAAAAACCAGTAGGTAAGTAAGAGGGGGGGAGCAAAAG
CTCTCTCTTTCTTTATTAAATTTAGGAGGAATAAACTATGAAACTAACATTAAAA
ATCGATAAGGAAAATAAAACTTTTAATTTACCGGAGTTCATTCCAGCTCGTTTA
ATCCGTCAAGCACCTGAGCTTGCTGAAATCCCAAACAATCCTGGTCCAGAAGAT
ATGGATAAAATGGTTAAATTTGTGGTGAAAGTGTATGATGGTCAATTTACATTA
GACCAGTATTGGGATGGTGTTGATGCTCGTAAATTCTTATCGACAACTTCAGAT
GTAATTAATGCAATTATAAATGAAACTGTGGAAGCAGCTGGTGGTAATCCTGTA
TCTGGAGAAGAAAACCCAAACGCGTAGAGGGGGGAGGGCTAACGTTCAGTGA
GTTTATGGACGAGCTTTACCTCTCTTTATTACGTCAGGGATATAAACACCATCA
CATCGATAACGAAATGGATATTTGGCATTATTTAAGGTTAAATCAGAAACATCG
TGAACAAGGTAATTCAAATGGCGGGAGCCAAAATTCAAACGAGATTGAAGTAC
CAGCAGAAAATATTATCTAGCAAGGGGGTGAGACATTGGCGAATGAAATGAAT
AATTTAGTAGTTAGACTTTCGCTTGATAATGTTAATTTCCGTCAAGGTATTGCA
AATTCAGGCCGTGCAGTAAGGACATTACAGAATGAATTGAAATCTGTAAGTACA
GGTATGGGCGGTTTCGCTAGTGCTAGCCAACAAACACAAGCAAAAATGGATAC
TCTAAGCAGGCTCATTGACGCGCAAAAAGAGAAAGTTAAAGCGTTAAGGCAAG
CTTATGATCAAAATAAGGCTAAATTAGGTGAAAATGATGCAGCAACTCAAAGAT
ACGCTTCACAAGTTAATAAGGCTGTTGCAGATTTAAATAGATTTGAAAATGAAT
TAAAGCAAGTAAATAAGCAAGCTGAACAAAAGGGAATCGATAAGTTAAACAAT
TCTTTAAAGTCTCTACAAGCTGAATTCCAGTCTATTACATCCGGTATGGGCGGT
TTTTCTAATGCAACTGAACAAACACGCGCTAAAGTAGATGTTTTAACTAGAATG
GTAGATAAGCAAAAAGAGAAGATTAGAGAACTTCAACAAGCTTATAATCGTGCT
AAAACAGAAGAAGGCGAAGCAAGTCAGTCAGCACAACGATATGCTGAACAACT
TCATCGGGCAACAGCTGAACTTCATCAATTTGAAACTGGATTGCAACAGGCAAA
TCGTGAATTGGAACAGCAAGGCAATCGTCTATTGAACTTCGGTAATCGTATGGA
GACATTAGGTAATCATTTGCAAAATGCTGGAATGCAGATTGGCATGGTATTTGG
TGGTATGACTTATGCAATTGGTCGAGGATTGAAATCAGCTGTGGAAGAATCCAT
GAACTTTGAACAACAGATGGCTAATATAAAAGCAGTATCTGGTGCAACAGGAG
ATGAAATGAGAAAACTCTCTGAATTAGCTGTTAAATATGGGGAAGACACAAAAT
ATTCTTCTGTAGAAGCTGGAAAAGGAATTGAAGAACTAATAAAAGCTGGTGTTG
200

GTTTAACCGACATCATCAATGGTGGATTAGAAGGAGCTTTAAACTTAGCAGCCG
CAGGTGAATTGGAACTAGGAGAAGCAGCAGAAATTGCGTCAACCGCTTTAAAT
GCATTTAAAAGGGATGGTTTAAGTGTTACAGATGCCGCTAACTTACTTGCAGGA
GCCGCTAACGCTTCAGCCACTGATGTACATGAACTGAAATACGGTCTATCAGCT
TCTGCAGCTGTTGCAGCCGGAGCAGGTATGACATTTAGGGATACATCCACAGC
TTTAGCAGTATTTGCACAAAATGGTTTAAAAGGATCTGATGCAGGGACGTCCTT
AAAAACGATGCTTATGAGGTTGAACCCCTCTACTAAAGAAGCATATAACAAAAT
GAAAGATTTAGGTCTAATCACATACAACGCTCAAGCTGGATTTGATTTCTTAGT
ACAAAATGGGATTACACCAGCATCTAGAAGTGTGGGAGACATCGAAGTCGCAT
TAGAAAAATATGTAATGAAAACTGAAGGAGTTAAGAAATGGAATGATAAATGC
GAAACTACATTCCGTGAATTAGCAACTAGTTCAGCTTTCTTATCATCAAAATTC
TACGATCAACAAGGGAAAATCCAAAGTTTAGAAAATATATCTGGAATTCTTCAT
GAATCCATGAAAGGTTTAACAGACCAACAACGAAGTATGGCTTTAGAAACATTG
TTTGGTTCTGATGCAGTTCGTGGCGCAACAATTTTATTTAATGAAGGCGCGCAG
GGTGTGAATAAAATGTATGGTGAGATGTCTAAAGTAACTGCTTTAGAGACAGC
CAATACAAAAATGAACACTTTGAAAGGTCGAATTGAACAATTGAGTGGAGCATT
CGATACAATGAAAAAGACAATTGGTGATGCGCTTGCCCCTGTGGTTAGTGCTTT
TGTTGCTGGGCTACAGAAACTTGTGGATGGGTTCAATGCATTACCTGGTCCAGT
ACAAAAAGCGATTGCGATTACAGGTGGAATTGTTCTTGCTTTAACGGCTATTGC
AACAGTTATTGGCGTAGTTCTAGCAGCGGTTGGAATGGTGGTTTCGGGAATTG
GTTCTTTAGGAGTTGCACTCGCAGCAGTTGGTGGTGTTGCTGGAATCACAGCA
GGAGTAGTAGGATTTTTAGGCGGTGCAATAAGTTTATTATTGGGACCAGTAGG
ATTGATAGCGGCGGCGCTTATCGGAACTGGAGTCGTAGCGTATAAAGCGTATC
AGAAAGCAACTGAGGACAGTATCGCGTCAGTGGATCGCTTTGCTACTAATACA
GAAGGGAAAGTGAGTTCCTCCACAAAGAAAGTTCTTAGTGAGTATTTCAAATTA
TCGGATGGCATTAGACAAAAGTTAACTGAAATTAGACTAAATCATGAAGTAATT
ACAGAAGAACAATCGCAGAAATTAATTGGTCAATATGACAAATTAGCTAATACC
ATCATTGAAAAAACCAATGCAAGACAACAAAAAGAAATTGAAGGACTTAAAAA
GTTTTTTGCTGATTCATATGTTTTAACAGCTGAAGAAGAAGCAAAGCGAATAGA
ACAAATGAATCAGCACTATGAACAGGAAAAATTAAAAACGCAAGAAAAGGAAA
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ATAAAATTAAAGAAATCTTACAAACAGCAGCTAGAGAAAACAGAGAATTAACAA
CATCTGAGCGCATCTCTTTACAAGCATTACAAGATGAAATGGACAGAGTTGCAG
TTGAACATATGTCTAAAAATCAAATGGAGCAAAAGGTTATTCTTGAAAATATGC
GTGTGCAGGCTAGTGAAATTTCAGCTAGACAAGCAGCAGAAGTTGTTAAGAAT
AGTGCTGATACTAGAGACAAGGTTATAGCAGATGCAAAGAAAACTCGTGATGA
TAAAATTGCAGAAGCTATTCGTCAAAGAGACGAAAATAAAACCATTACAGCAGA
AGAAGCAAATGCAATTATAGCCGAAGCAAAACGTCAGTATGATAGCACTGTTTC
TACAGCAAGAGATAAACATCAAGAAATTGTAAGCGAAGCTAAGGCGCAAGCTG
GTGAACATGCTAATCAGGTAGATTGGGAGACTGGTCAAGTAAAATCTAAATTTG
AAGTTATGAAAGATGATGTTGTTAGAAAAATGAAAGAAATGGGTTCGGATGTTT
CTAATAAATATGACGAAATGAAAAATGCAGCCAGCAATAAAGTAGAAGAAATA
AAAAATACAGTTTCAAGAAAATTTGAAGAAAAGAAAAAAGCTGCTTTAGATAAA
ATGTCAGAAATAAAAAGTGGTATTGAAGATAAGTGGAATGCAGTTGAAAAGTT
CTTCAGTACAATCAATCTTTATTCCATAGGTAAGAGTATTCTAGAGGGACTTGG
AAGAGGTATCGATGATGCATCTGGTGGTTTATTTAGTAAAGCGGCCGGAATTG
CAAGCGAGATAAAAAAAACCATTTCAGGAGCTCTTGAAATAAACAGTCCATCGA
AAGTAATGATACCCGTTGGTAGTGCGGTTCCAGAAGGTGTTGGTGTTGGGATG
GATAAAGGGAAACGTTTTGTTGTGGATGCAGCAAAGAATGTAGTCGGAACTGT
TAAGAAGCAGATGGGTAATATGCCATCTGTATTTGATTTTGGATTCCAAACCTC
TCATTATAGTGTTCCAAATGATTTAGTGAGTGGTTTTACAGATTATACGCAGCC
TAATACTTCTCATAGTAGCTCATCTACTTCTAAAAAAATATTCCCGAATAGACA
AGCTGAAGAAAAAGAATTAAATCTCACATTGAATATGACTAATGTTTTAGACGG
GAAAGAATTAGCGGGTGGAACTTATATGTATACGACAGATTTTCAAGATCGTGA
TAAAAAACGTAAATCTCAATTTTAAAGGTGGTGGCAATGTGGGGAAACTAAGCT
TTACATTTAATAATGTTCGAAAAGATTATGTGCAAATGCTTGCAGGAAGAAAAC
GTCCAACATGGGCTCCAATTAAACGAAAACTCTTAAAAGTCCCCCATCGTCCAG
GGGCTTATTTTATTAATACAGAAACTGAGGAACGTCATATCGATGTTCCTATTT
TTATTAGTGCAAAAAAAGACATTGCTGATTTGCAAAAGTTAAAAGAAGACTTAG
CGAACTGGTTGTATACTGAAACGCCGGTTGAGTTAATATTTGATGATGAACTAG
ATCGAACGTACTTAGCTTTTATTGATGGAGCCTTAGATTTGGATGAGTTAGTTA
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ACAAAGGAAGAGGTATTATTAGCTTTCTTTGCCCAATGCCATACAAATTAGGCG
CTACTAAAACAAGTGAGTTCGTTCAAGGTTGGACTACAGAAACCACAGCGTATT
TTACAAATGAAGGTAGCGTTGAAACATCGCCGATAATCGAAATTGAGGTTAAAA
AGCCAAGTACCTTTTTAGATGTCTGGTTTGGTGAATATCCCAATGAACGTGATT
ATTTTCGCCTTGGTTATCCCCGAACTGTGGAGGAAACACCAGTGCAAGCGCGT
GAACGCGTGATGTGGGATGAAATGGGTTCGCCTATAGGTTGGACTCCTGTTAC
AGGTCAATTTGAGGACATGAAAGGGACAGGTAGTTTTAAATCAAGGGATGGTC
ATGCACTGTATTGTGAAAATTACGGACAAGATAAAGGGTTCTATGGTGCAATAG
CTAAGAAAAACATTCCAGGCGGACCATTACAAGATTTCGAAATAGAGGCATGG
ATGACTTTTCAGTCTAAAAGCATCGAAGAAATGGGGCGTTGTGAAGTTCTCTTA
CTGGATGACACAAGCAATCTGGTAGCTCGCATTAACATGAATGATTTATACGTC
ACTGCAGAAATCACAAAAGCGCATATGAAAATGGGGAATAGTGGAACGCCTAA
TAGCATTCGTAAATTGGTCGATACCAGCGGATTTTATTCAAATACATTCAACAA
ATTTCGGGGGCGCTTGCGTATCGCTAGAAGAGGGAAACAATGGTCTGTTTATG
TAGCTAAATTTAAAGATGGTACAGAGATAGACGGAGCATCACTAGTTGAACAAT
GGAACGATGTTGACAACAGTAATCCAATGACAAATCGGAAAATCGCACAAGTA
ATGATTGCAATGTGCAGATGGGACAATCACCCCGCAGTTGATATCATGCAAATT
GATGACTTGAAAATTTGGAAAGTGAATAAAGTTGATGAGAACGCAAGACCATA
TATCTATGATGTTGGCGACAAAATTATCATTGATACCGAAAAAAGCCTCGTCAC
AATCAATGGTAAGAATGCTATAAATTTTAAGGATATCTTCAGTAACTTTCCAAC
GGTCATACAAGGATATAACCGTATGGATATTTCTCCTCCTGACGTTAAGGCGAA
AGTATCGTTTAGAGAGAGATACCGATGAGGAAACCTAGTGGAACATTTCATATT
GTTGATTTTAAGAGCGATCAAATCATAGCGGCTATTCAACCACAAGATTATTGG
GGTGATAAGCGACATTGGGAAATTAAAAATAACATTGATATGCTTGATTTCACT
GTATTTGATGGAACAGAACAAGCAACTACATTAATGCAACAAAATTTAGTTTTA
AAGGAAGTAAGAGACGGTCGTATAGTTCCGTATGTCATCGATGATACGGAAAA
AAAATCCGATGGTCGTTCCATGACGGTGTATGCTTCAGGTGAATGGGTGTTGTT
GAAAAAGGCAGGAATTATCAAACCACAACGGATTGAGAGCAAGACAGTGAATG
AATTTATTGATATGGCGCTTGTAGGAACCAAATGGCAGCGTGGAATTACAGAAT
ATGCTGGTTTTCATACAATGACAATCGAAGAATTTATTGATCCACTCAAATTTC
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TAAAAGATATCGCCTCACTTTTTGGTTTGGAAATTGTTTATCGAGCAGAAGTTG
TTGGTTCTCGTATTGTTAGCCGTTATGTAGACATGGTGCAAAAAAGAGGTAGAG
ATACTGGGAAAGAGGTTACTTTAGGTAAAGATCTAAATGGAATTACTAGGAGA
GAAAACTCTCAAAATGTTTGTACAGCACTTGTGGGATTTGTAAGGGGAGAAAA
CGAAAAAATAATAACTGTAGAGAGTATTAATAATGGTCTCCCTTATATTGTCGA
TAGTTCAGCTTTTCAGCGTTGGAACGAAGACGGTCAACATAAATTTGGTTTTTA
CACGCCAGAAACTGAAGAACAAAATATGACACCTGAACGTTTAATGGCACTTAT
GAAGATTGAATTTAAAAAACGGATGAATTCTACTGTTCAATATGAAGTGGATGC
AATTGCACTTGATAAGATATTTGGATTGTCACACGAGGAAACTGTAGAAGGTGA
CATTATAAGGATTAAAGATACAGGGTTTACCCCTGAATTATATCTAATTGCTCG
TGCTATCGCTGGCGATGAATCATTTACAAATCCATCTGAAAATAAATATGTGTT
TGGTGATTATATAGAAGTAATCGATACGAGAGAAGAAATGCAAAAGTTATACAA
TAAGATTCGAAATTCCCTGTGGGATAAAGCAAGTAACGAGGCATTAAAGCTGC
TAGAAAAGCAATTAGAAGACACGTCTAGTGGTTTTAATGAAAGATTAATTGCTA
TGAAGACAAGTATTGAAAAAACGGACGAATCTATTATTTTAAATGCCCAAGCTG
TTAATCAAAAATTAGAAAAGCTAATAGCTGACTTGAAAGTTACTGCTCAACAAA
TAAGTGCAAAAGTCGGAAAAGGTGATATCGCTTCTGAGCTAAATATTAATCCAC
AAAGTGTACTTATAAAGTCAGAACTTATCGACCTAGTTGGTAAAGTAAAGGCAG
AATGGTTAATTGCGGGATTACTCGAAGGTATGACCATAAAAACTAGTAACTCTA
AAGAGCATATCCATATGCAGAATCAAGTGGTTAAGTTCGTTAATCAAGGTATCC
CTAAAATGATAATGGGGTTTGAGAATGAGTACAACAGTAGCACTTCAAATCCAT
ATATTACCTTAGGACAGGGGGATGGATCAGGACGAAATGTTGGTACCATTTAT
AAAGATGGTGGTGGACTTTACTTACGTTTTATAGATTTAAATGGTGCTGAAAAT
AATATTCGCTTAACAGCACAAGGGAATATAGGTGTTACAGCTCAAGATGGTATT
TGGGTAAATTCCAAAAGAACAAATTTTACATCTCTAATAGAAGTCCCAGCCATT
AGGTTTAATTCGTTAGGTACTACTCCAGGTTCGCAGCAGGGTAATTTTTGGATT
GGCAATGGATATAAAGGATTTGGAATATATTACTACGATAATTATTGGAAGTTT
GTACAAGGTTCATAATAAATAAATGAAGGAGAAATAAAATGAATAAATTTTTAG
GGGTTTTAACAGTAGTTGGGGAAGATGGAACGATAAAAGTACCATTAGACAAG
TTACAAACCGCAGGTATTAAGCCTAATTCAAAAGTGGAAATATTCAGCGACAAT
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TCTAACTTATTCATTAGAACCGCAGAGAAATTTTGTGATATTTGTGGCACTAAT
ACTAATACTACGAGTGTTGGTAATCAAGAAATTTGCAAAGACTGTTTAGATAAA
ATTACAAAAGCGTCACAAGAGAAACAACAGACGGTCTCAGAATAGAAAATTTA
ATTAGTTAAAACAGATGGAGCAGCAAACGCTGGTCTTTTTTATTTTGCATAAAG
GAGTGATTTTATGACATTCAAGACCTATGAAATTAACGTAGATTTAGTAAATGA
TACATCCACAACTAGTTCCAATCGCTTTTCGCAAAATGATAGAAACTCCGCTAA
ATTTGTATTAAATATAACAAATGAAGGACGGGAATTAGATTTAAGCCAAGCGAA
ATCGGTGCGGATGTCATTTAAGAAGCCAGATGGAACTCGTGTTTTCCAAAACG
ATTGCCAACCGATTAATGCAATGAAGGGTAAATATCAAATTGTATTAAAGACCC
AAACTCTGACTTCAGTTGGTAATGTTATCGCGCAGATCCACATTGAGGAAGAG
GACAGAATCCTTGATACACAAAAGTTCTTTTTTGTAGTAAATGATTCGTTGGCA
AGTGATGAAGCGATTGAGAGTACAAATGAATTCACAATTATTCAAAAAGCAATT
GAAGCAGGGAAGAAACTTGAAGGTGTAGATATCAACGGGATTATTGACGCTGG
CGTGAAAGCGGAGGGGGCCGTAAAGAAAACAGGGGATACGATGACGGGGCAC
CTTGATTTAGATGTGACTATTACAACAAAAAGCATTAGAAGCACCTCAAGTGGA
AATAGACAATCTGGAATATTTTTTGATCCAAACGGGGACTTAGGTGCCTATGAT
TGGGGGAATCCTGATGGCGGGACAGCTCTTTTTAGATACACTAGAGCTAGTAA
ATCATTCGATATAACCGCCCCCACTACTAATCTCGTAAGGAAGGCAGAGGTATT
TACAGATATAGCTAAACCTAATGGTGACGCAGCTATTTCGATACAAACAGGACA
AGACATGCTTGCAGAAGTAATAAAACTAGGGAGAGGTATCCGTACTATATACG
CTCCAGGTAGCGCGCTTAATAGCCCTTCAGATAAAGTGTTCCGTGGTATTGCAA
ACCTTCAAGGTACTTCTTATGGGTACATAATTGGAGTTAGTTCTGATAATAAAG
TTTGGTCTAATTTTATCAATGGTTCTACCTGGTCGGGTTGGGTTTGTGCTAATG
GGAATATAAAAGATGGACAAGCTACTCTTACTTTAACAGATAACGCCGCTCAGT
ATGGCACAACATATACGCCTATAGCTATTAGAAGAGGTAATACTGTAACTATTC
GAATGGCAATTACTCGAAACAGTAATGCAAGTGGAATTTTAACTACTTTACCAT
CCGATATGCGACCTAAAAATGGATGGATCTCTACGATTATTTCGACTGACGGAA
TGCCAAGTGATTTAACTATTAGAGTAAATGGTGAGGTTGAAGTTCTCACTAAAA
GTAAAACATTCTACATCACGCTTACTTACGTAGTAGATTAAAAGGAGGATATCA
CATGGCTAAATATTACGGTTATTGTTATGACGAAAACGGTAAATTCACTGAAAT
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GATTCCTTTAGAAGAAAAGGAAATTACTGAAAAACAAACTTTTTACCGAGAAGA
AATGAAAGAGATTGTTACAGAAGAGAAACTATGTAAGCTTCATCAATCGATTGT
GGAGGGAGCTTACAAGCCGTCTGAAGGTGAGGAAGAACCAATCAGTAAATACG
ATTGTCCTGATTGTGTAATGGCAAATGTAGAGTATGAAACTTTTAAAGTACCAT
ACGAGGAAGATGTTGTTATAGGTTATGAGCCTGACATCCCTGAAAACTGTACCT
TAGAGGTTTGTCCTGATGGAATTTATTATCCAATATTCAAGGATGGTAAATGGA
TAAAAACAGTTGAACCGAAGCCTGAAGAACCACAACCACAAGAACCATCTGAA
TTAGAAAAAGTAAAAAAGCAACAGGAATTAATGCAACAAGCAATGGATGAAAT
GATTATACAAAATCCAACCCCGGATGAATTAGTAGAGTTAAAGAAACGTTTGAT
ACTTATGCAATCAGCAATTGATGATCTCATTATTTCCGCTACTCCAGCAACACT
GGAAGGAGGTAGTAACTAATGGCTGAATATATGGCGCAACGAATTATTGATGA
AGCTTTTACCTATACGTTTATCATTATAAAAATGAAGGCGTACAAGGAGCGAAT
TGATAAATACCTAACTGATAATGGTAGAGCAGATTTAATTACAGATAACGTAGT
AGCGGCTTATTTAGTATAAAATACGGCTTTGAGTAAAAATTCAATTCATAGATC
AAGAGAGGCATATACATGCTTCTCTTTTTATTTTGAGGAGATGATCAGTGTGAA
ACGAATAGTAGACCAAGCAATTTATGAAAAGCATGTTAGCCATGAAAATAAAAA
CCTAGTCAAAGATTTTCTAATTGAAAAGAAAGCACAAGGGAAAGCGGCAAGCA
CTTTACAGCAATATCATTGGGACTTACGAATTATTTTGTTTCTAATACATCAACA
CTTCGAAAATAAAAATCTTATTGAATTAACACGAAAAGACATTCGCAATTTATC
TATTATTTTTCAAGAGCTGGGAATGTCTAATGCACGTGTGAATGGATTAATGAG
TGCATTAAGATCCGCATTAGAATTTTGTGCGGATGACGACGACTATGCTTATGA
ATTTAATGTAGGTTCACGAGTTCGAGGATTACCTAAAAATCCAGTTAGAGAAAT
TACTTTTATAACTGAAGAACAAATTGAGTGGTTAATCGATGAATTACTTAAACA
AGAGAAATATATGTTAGCAACTTATTTAGCGCTTTCTTACTACAGTGCAGCAAG
AAAGAATGAGGTTTATCAGGTTCAAAAGGAAGAGCTAACAGAGCGATATTATA
CAAATATCGTTCGAGGGAAACGCGGTAAAAAGTTTAGGTTATATTACAATCCCC
GAGTACAAGAATGTATTCGTTTATATATAAATCAACGAGGTAAGGATACTGTTC
CAGATTTGTTTGTAAGAGTTTATAAGAATGGTGAACGAAGAGTGTTAAATAAGA
GTGTATTCAACTACTGGTGCAAGATATTCGCTAAGATGCTGTATGAAAAAGAAG
GAAAGGAATATAAAATCAATCCTCATTGTTTCCGTCATAGCAGATTAGATAATT
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TGAAAGTACAAGGCGTACCATTAGAAAAGTTAAAATCGCTTGCAAATCATTCAG
ATATTTCAACAACACAATCCTATTTAAAAGATAGAAGTGAAGAGGATATTGCAG
ACATCTTTGAAATGGATCCAAGTTGTTTTGCAGCGTAAAAGGAGATGAGGAGA
TTGCCAGAACATGAAAATCATGATGATTTTACAAAAGTAATTATTGGATTAACG
AGGGTAGAAACAAAGATTGATGGTCTTGGTAATGTAAGGGAGCTTGCGATTGA
AGCGCAACAATCAGCGAAAAGTGCTCATTTACGCGTTGATCGATTGGATAGGC
TTGTATTTTGGATGGGAACAACAGTTATCGGTTCGCTTATCGCCGGTGCGATAG
CGTTACTTTTTAAATTTGCAGGAAAGTGATCGTATATACGGTCACTTTTTTTATT
GAAGGGAGGTGAAAATATGAAAAATTTTGATACGGCTTCAATTAGTCGATATGT
CGTATTAGTAATCGCTGTGATTAATAGTGTCTTAAATCTTGTGGGATACCAAAC
GATTGATGACAAAATCACGAACGATTTAGTCGCGGTAATTACAGGGGCATTCA
CTTTGTATGTAGCTTGGAAAAACAACTATTTAAGTAATAAAGGCTTACAGCAAA
AAGATGTATTAGAAAAAAATAACTTACACTAAGAGGAGATGTTGAATAATGGCT
AAATATAGTTTACATGGTGGTCACAATAATATTGTACAAGGTGCTAATTATGGT
GGCCGTAAAGAACATATTATGGATCGACTTGTTAAGGATGCAGTTGCAGCTAA
ACTTCGAGCATTAGGGCACACGGTATATGACGATACAGATGAAACGGGTTCTA
CACAAGCACAAAACTTATCAAATATTGTTCGTAACTGTAATTCTCATGATGTTG
ATTTAGTTATCTCATTCCATTTAAACGCTTATAATGGAACAGCTAATGGGGTAG
AGGTTTGTTATTATGACCAACAATCTTTAGCAGCAAAAGTGTCGGCTCAACTTG
CAAAAGATATCGGTTGGTCTAACCGTGGCGCTAAAGAGCGAAAAGAACTTTAC
GTATTGGCAAACACTAAAGCACCAGCAATCTTAATTGAACTTGGGTTCATTGAT
AATGATGCGGATATGGCCAAGTGGCATGTAGATAATATCGCAAACTCAATTGTA
TATGCTTTAACTGGACAAACTGTCGGTGGTAATGGGAACACAACAACTCCACC
GTCTAAACAAAATATCATTCAATCAGGAGCGTTTTCACCGTATGAAGCTCCTGA
TGCTATGGGCGCGCTAACGTCCTTAAAAATGACAGCTAAATTCATTTTACAATC
TGATGGATTAACATATTTTGTTTCTGACCCAACATCGGACGCTCAATTAAAAGC
AATGAAAGAATACCTTGACCGTAAAGGTTGGTGGTATGAAGTTAAATAATACAA
AAGAATAGTTTTATGAACAAAAAAAGCCGTCATTAGACGGCTTTTTTAATTTTT
CCATTCAACGAGAGTACGTTTATTACATCTACGACAGATAAACCCCTCAGCTTT
ATGTACAATAGGCTGTTTTTTGTTACAATTTGGGCATTTTACAAGTTGCTTACCT
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AAAGCGGAATATATAAAAAGTGCAGAAAAGAATGCTAAACCTAAACCTGGTAA
TATTCCAATTATGGTAAAGCATAGCACTACTGAAATTAATAAACCGAACGATCC
GATTAAAAAGTATATAACTCTTTTCAACTGATTAGCTGTAGAACTTTTCTTTTCT
TCTAATTCAATAATGAATGTTTCTCCATCAGCTGTTTTTCGTAGCTCCATAAAAC
CTCCCCCTTATATTAAGTAAATCATACCAATTAATTGTATATTTTAAAAGTGTGA
TTTTATTCAATATCCACCCATATATCCTCAACCCGCATATTGAGTGCCTGGGCT
ATACGCATTGCAACTCGTAGTGTTGGTTCGCTCTTCCCCCGTACTATCATACTT
AATGTTTGATCTGTTATGCCAGCTCGTTTTGCTAATGCAGATTGTTTAATCATTT
TATCAGCTAAAATTACTTTCAATTTGCACTGCATAAAATCCCTCCTTTTAAAATA
CTCAATCATATTTTTGAAAAAACTTTTGATTTTTTTATTGTTGGACAAACAAGTT
TTTAGTAGTGAAGTCATATACCTATATCAAAGTAACTACAAAGGTAAGGAAACA
GGCGTTATTACCATGAAAAGGAGACGGTCTACAAAGGTAGCTGAAATTGTAGA
TGTTTCAAAATTAACAAAGTAATTACCAATGTATATATCAAGGTTCGATTACCA
TGGTTTTGAGTCCTGCAACATAATGAGAATGGGATTTTAAATTTTGTTTATAAG
GGAGCGAGGAAGATGGGAAGCGGAGGAGCTACGAGATTAGAAAATGGATATG
AGGTTATTGGAAACAAAATAAAGTTCTTTTTAAATCAAGATCCAACAAAAGGGT
GGAACCAAATTCCGAAACCTAAATTTAGAAACATTCAAGAAATAAATGAGTGGT
GTGGAAGTTCTGCTAATGAGATAGTTTGTCAATGGGATGCACTAAATCAAAATG
CAATGAGTACATCGGAAACCACAGATTTTTTATATAGGTGGATGAGTTGGTATG
TAACCAAACCTTTAGATAGCACAGCAGTCGAAATAAGGAAATTGCCGGATGAG
TTAGCGATATTCATTACGAATGTTCCATTCGATGCAATTGATTTATTGAAGCGT
ACTTCTCAGATGGTTTTAGAGTGCGTGTGTTTGATGTTTAAAATGTTCATGTGA
AGGAGTGGTCTTATGTTTAAACGAAAAGAAATCATACCATTTCGTGACTTTATG
GATGGATCATTTAAGAAGCAAAAGCAAACAAAGATACTAAGCGTTGAACCAAT
AAGTCCAATAGCATTTTTTCATATGGCTCAACCGCTTGTACACACATATGTAGC
GCTAGGGATATTAGGGGGACTTACAATTGGAGCCGTGTTATTGGAAAGATACT
TAGTTCAAAATGATCATATTACAGCGGGTAAAATGGTATCCGATGGGTTGTATC
ATGGACTCCGGATAGGTAGTATTGGCTTCATTGTATATGTGTTCATTCGTATCG
TAAGGATGTTTTAAAGGGGAGTGTATGAACTTGATGAAGGAATGGTTTCATAAA
AGAGCTGTCAAGAATCTGTTAATTGAGGTATTCAAAAAAAGTGGTATCTATTAT
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GAACATCAAACAAGGGGCGGTAAATTACCCGTTTTCCCTAAAATCCATAATGTT
TTAGAAACAAAAGATTCTATTCGATATACATTTACTTTACCGAATGGAGTAGAT
CCACAAACGATTGAAAAGAAATGGTTTTGCTTTCAGCAAATCTTAGGAAAGGAA
CTGGCGATCGAAGGGGATATCAAGCGCTTTGTACTTCACTCGTTCAAACATAAT
AAAAGTTTACAAGCATACTCGTATAACTATTCAGATTGGTTACCACATCTAAAA
GGACATAGCATCCCTGTAGTGGTAGGAAAGGACCAATTTGGGAAATGGATTGT
ATATGATATGACGGATTCCAATAGCCCACACCTATTAATAGCAGGAGAAACCG
GATCAGGAAAAAGTAGTATGGTTCGAGTTATATTGTCTACATGGATTCAATATT
TGCCACCAGAATCATTGCAGCTGTATTTAGGTGATCTGAAGAACTCAGAATTTC
ATTTTTTAAGAAGAGTGCAGCATGTAAAGAAAGTGTGCATGGAAGAAGCAGAA
ATGGAGTTAATGTTAAATCAGTTGTGGATGGAAATTATTAAAAGACGTAAGTGC
ATGGAGAAATATGAAGTGGACCATGTTAACGAATACAACAAAGTAACCAGAGA
AGAAAAATTACCTTATATTGTAATTTGTATTGATGAAGTGGCTATGTTGGAAGA
TGAAACCGATAGTATGAAGATTGTTAGAAAAATATCAGCTGTTGGACGATCGCT
AGGCGTGTTTTTACTGTTATCGATGCAACGTCCGGATGCAACAGTTATAGATGG
TAAATTGAAAGTGAATATGACAGTTCGAATGGGTTTCCAGTGTGATTCATCACT
AAACGCAGGGATTATTGGTACACCCGGATCAGAACTGTTAGAACAATCAGGAC
AAATGATTTTCAAATTAAAAGGATTAAAGAAAGTGCAAGCTCCAGAGCTAAAGT
TAGAAAAAGCAAAAAAAATAGTGGCTCCTTTCAGAATGAAAAAAGAAATAGAA
GTAAGTACTGAAGTGAAAGAGGAGCCTTTATTTGGGGTGTTAGATGATGAGGA
ATAGAGATATGGCTATTTTGAAGGATTTGACTAAATTTCGTTGTATGTCACGGG
ACGACATTATGGAATTACACTTCGGCCATTTGAAAAATCCAATCACATCATGCA
ATACAGTATTAAAAAGATTACGTAGAGATGGACATATAGAAGTGAATACTACAT
TTCAGCCATATGTATATTTTCCGCAACCAAGTACAATTAGGAAAACAAGTCAAA
AAATACCACACTTTTTAGGCATAGTAGACGCGTATAAACAGTTAATTCCACATG
AGAAACCTAAGATTTTTAAAGTAGAACCTAAGTATGGAAAAGAATATATGGAAC
CTGACATATTTACGATTTGGCGAAAAGCTCCATTTTTTATTGAAGTACAAAAAT
CAATATACAGTAAAGCCGTAATGCAAGAAAAAATTAAAAGATATGAAGTGTATT
TTTGTAGTATGAAATGGCAAGAAGAATCATGGCAACCATCCAATAAAAAAATAT
TCCCCGCCATTTTAATTCTTACTGATAGAAAGTATGATGTCTCCAGCACAAATT
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TCCGTATTTTTCAAGCGAATTCAATTAAAGATTTCCTCAATCAAATAACACCTAA
ACAACCTAAAAAAGATATTTCTATTCAAGTTGGATCAAGAAAAAATTAATTTAA
AAGGAGCGATTTATTATGAGTGAAGCAACAAAAGAGTTAAATGAAATTTTTTGT
AAGTATGATGTGAGTGCTGAAGAAATAATCGAAATGATGTCACAATGGTTAGA
AAGAAAAGTTTGTGATAATCATGAAGAAACTTTAGAGGAATATGGAGAAAACG
ACTTTATACGTTTAGATAACCTTCATGCTGATATAAATAAATTAGATTGGAAGT
ATAATTTCCCGTATTAAAAATAAATCACAAAAAAAATAATGGGCATATATATAA
GAAGAGAGTGTCACTCAAAATGACCACTCTCTTTTGACCACACAGACCACATTG
ACCACAACTGGTACCACATTTATTATTTACTTTATGTCCATTTTGTCTAAAATAG
AAAATATAGCTAGACAAGAAGGTACGTTTTAACACATAATGGACACAATGCTTC
TTTAGAGGTGTAAAGAAAAAACTTACACTATAAAAGCATTATATCACTTATACC
GCAGGGTTTAACCTTCTTGTTTTTCTTCACCGACCACTTTTTGACCACTTCGAC
CACTTTTTAGTACATTTCCAAGCATTTCAGTTACTTCAATTTGACGTTCTTCATA
AACATCAGTATAAATATTTAAAGTTGTAGAAACATTTGTATGACCAAGTAATTT
CGAAACAACCTTTGCATTTGCACCAGAATCGATTAAAATAGTTGTAAACGTTCT
TCGGATATCGTGGAATCTAATATACGGTACGTCAATTGCTTCGCACAAAGCTTT
CATTTGATAGCGTATCGTATATGGATGCACGATTTTTTTATTTCTTGTACAAATT
AATAGGTCGAAAGAATTTTCCTTCTTGTGATTTTGATATTTTAACAATTCTCCCA
TTAATTCTTCTGTCATTGGGATTATACGATTAGATGCTTCGGTTTTTGTCTCACC
TAATTCATACTTACCATCCACAAGTGTTAACGTCCTTTGAACATGGATAGTCTT
GTTTTCGAAATTAATATCATTCCACTTTAGAGCCAATACTTCTCCGATACGCAT
GCCTGTATGCAATGCTAAAACAAATGTAATATAGTAACTTCCTTGTATTTTTGC
ATACTCCATAAATTTCATTGCTTCTTCAATTGTCCAACTAGCTTGCGCTTTCTTT
TTAACTTTTGGTCGTTTTGCTTTCTTAGCTGGATTAGAGTTAATCATTTCTAGCT
CTACACCTTTATCAAGTATTTGTTTTAACATAACATCAACAGATGAAATGTATTT
CGTAGTTAGACCCTCTTTAAGTAGTTTCTGGTGAAAATTATGAACAGTTAGGGG
TTTTATATCTGATAACCTCTTCTCGCCAAATTCAGGCATAACACGAGAGCGTAG
AATGCGTTTGTATTGATACAATGTTGATGGTCTACATGATGATTCTTTTTCTTGC
ATCCAGATTTCTACGAGCTGAGAAAAGCGAATATCACTATTCTCATAATCCCCA
TTTGCTAAATCATTTGTTACCCTAGCCACTTCTTCTTGAGCAGCTTTCTTTGTTT
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TAAAACCACCTTTAGTGATTTGTTTCCGTTTACCTGTGAGAGGGTCTTTGCCGA
TATCCATAGTAAAAGACCACCTCTCACCACGTTTACGAAAGTATGCCATGATTT
TTCACCTCGTCATAGTCGTTTTCTAGATACAAGCTGTGATATGTGGTAGTGGTA
TAAGAAATGATAGCATGTAAGCCTAATTTCTGTAAAAGGAAATTTACAGATATA
AAAGAAGTGAGCTACAATATTTGTATATTAAATAAAGGAGGGGAAAATATGTG
GGAATTTACAAAGGACCCTGGTGGTCACAGAGGAACCGATCCTGGTGTAGGGT
GGCATAACGATCCAGGCGGTGGTGGCTGGAAATACAATGAAGATCCAGGAACA
GGATGGAAACCAATTTATGGTCCGGGGACAGGTGTATAAAAAGGGGGAGAGTG
AGATTATGAAAATCTACATAAAAGACCCAGGAGGCTCAAAGGTAATTTCTGATC
CAGGAGGAGCAGGTGGAAGTCCGTTAGTACTTGATCCAGGTAATGGGGGCACA
GGATTAAAAATAGAACCAGGTGGACATAGAATGAACGAGCCAGGTGGTGGAGG
TTTAAAAAATAATACTGATCCAGGAGGATGGTAATTATGTTATTACACTCTAAA
GAATCACAGGAACCTGGTACAGGATGGAATTTATACGATCCGGGTACAGGAAT
GGGTATTTTCGATCCAGGTGGCGGAATGGGTATGTATGATCCTGGGGCAGGTG
GAGGATACATAAAAGATCCAGGCACAGGAATATAAAAAAGAGAGCTATATGCT
CTCTTTTTTATCGGTAAAAATTTGTTAATTTTTACCGTTGCGATTGGAAATCATT
TCTTCTAAAATCAAATCATAACAACTCGTTATGATTTTTAAGAAACTTTGCATAC
AAAACGAGTTGCTTGCAGAATTGCTCTCGATGAGACTCATCCAGGCCTGCGAA
AACCGTTTGAATCTCATTGAGAGTATTTGCTATATTCTTCTCGTTTAGTGTAGTT
GTTCTTCCCATTAAAGCATCAACCGATACACCTAGATATGATGCAATGCGATCC
AATGTGTCGAGATCAGGCTGATTATAGTTGATTTCTAAATTACCAACCTGGCTA
CGACTTAATTGTACTTTTTCACCGAACTCTGATTGAGTCAGGGAACGACTTGCT
CTAAACTTTTTTAAATTTTCTCCAAATGTATTCATAATTTCAGTATAAATACATG
AGAATTTTTAGACTATACATGTCATGAAATTTGTCTATATAATATTAATTATCAC
GTAAATTGACAATGAATTTGAAAACGTATAGAACAAATGTTCTTTTGGTGGTAA
AATATTCTTAATGAAAAAATTGATTTTTTGAAAAAAACTTTCTCAACATGATTTG
ACCATAATCGGAACGAACATTCTAAATCTTATGATAAACTGAAATTAATAAAAA
AAGGAATGAAAAAAAGACCCACGGTGTTATAGATGTGAGGCCACACATCTATA
ACATTTCACCCTAGCCTAGATAGGGAAAAGTTTCCATGAGTCAGTACATAGTAT
ATCATACTTCGTAAGCATAAAGAGAATTATGGTTCGTTTTCCTATTGAGAAATA
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AGGGATGTGTTTTGGGTTCTGATTTAGGAGGAATTTTATAATGAAGAGCTTTAT
CAAGAACTTACAAGAACATATCAATTATGTTAAGTTGGACGTTGGCACATTAGC
TAAAAAAGCAGAAATTGATAGAACTAATCTTAATAGGGTATTAAATGGGAAAAT
TAAAGAAATGAAGTTAGATTCATTTTTATTAATGGCTCCTGATCTGTATCCGAA
CTGGGCAGAACGTAGAAAGAAAATTAGAGAGTTTATATTAGTTTGCGAGAGTG
ATTTAAACATAAAAAAGGGGCTGTCTTATTGTCAAACAGTCGGTGAGTATCAAT
TAATGAGAAAGTTAATAAAGAAACATATTAGCAGTGATAAGAAAGGGAAAATA
AACAAATATTTACATTTGTATGATTTATACAATCAAAGGAATCTCAGTAAGTTG
GAAGGAGAAGGATTACAACGAAAACTAAATGAATTACCTTTCTCTAAAAATGTT
GACTATCAAATAATAGTAGACATGCTGCATGGATTCTCTCTATATGACAGTAGT
AATTTCATGGCTATGGTCCCGTATTCTAAAAAAATTGATCTAAACTTACCTCTA
GTAGAAAATGCATTTATAAAAAAACATTTGGATTTGCAACACGATGATCGAAAA
GCTCATATTAATTTGTTTAGCAATAAATTAAAAGAATGCAGAGACATTTGTAAT
AGTATTATAAAATCGGCTCCGGAAGATTCAGTTATAAAGGCCAAAGCATTAAGT
TGCTTAGGGGAGTCTTTTATATTTGAAAACCCTTTGCAGGCGGAAATGTACTTT
TTGGAAAGTTTAAAGTTAATAAAAAAATTAGGTATTACTGATTATAGTAAATTG
TATCGTGCAGTACATGGCACATTAGCCTTTTTACGAATTGAATATGGAATAAAC
TTAGATGAAATAGATTGGAATTTTGTAGGTGAAGCAGAAAAAGCATTCTTTGAT
GCTAAATTTGGGTCTGGGGATAAAGCTAAAGTTTATTTTGAAGACTTAAAAAGA
CAAGGAAAAACTTTGTCTGCATTTAAATTATATTATTTATTTTTTGTAGATGGAA
ATGATATAATGGTTCTTAAAGATGCGTTAGAAAAATTTGCGAATAATGGAAATG
TATTCTATTCAAATTTAATTACACGTGTATTAATTAAAGAGGGAGTGAAGTAGG
TTGAAAAAAATTATTATTACAATGGTATGTGTCTTAGGATTACTAGGAGTATTT
GAACAAAATAAAGATACTTCACAAGTGCATTCGATTAAGGCAGAAACAACATAT
TTCATGGTTGATCCAGGAACTCATTAAAAAAATAAAAGTTATTTTTTCAAGACG
CTACTAAAAAGTAGCGTCTTGAGTGCTTTTTAGGGGATATGCATTTTTGAAATG
CGTAACAAAAATGCACAGTTTGTTAAAAGAATCACATAGTTATTGGGATGGAGG
AGTTCGTATTGTTAATAAGTGGCGAAGATAAAATAAAATCCATGATTAAATATT
TATTGGGGGATAAAGTCTCAGAAAATGATACTCTTCATGCTTTAGAAGAAATAC
ATAAACAAGGATTCATTACTGATAATGAATTAAGTGAAGTCATACAGCTAATGG
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AACCAAAAAAAGGACTAGCCTCATGCTAATCCTTTTTTCTTGTTTTAACATTCTT
TGGATAGCTACTTCTAAAAGTGCTTTGACACTTTCGATCTCGTCAGGAGACAGT
TTTCTTCCATCCCAATGTAATTCGTCACTTTCAAATATTTCTTTTATATTATTGC
TGATTTTAATGGTGCTATCACTTTTCCCTAACAAAAAGTCAGTGGGTACATTGA
AGAAATCAGCTAATTTTTCAATGTTCTCACGAGAAGGGATTTTCGTCCCTTTTT
CATATTTAGAAACAGTTTGCTTGCTAACACCAATGTTTTCGCCTATTTTTTCTTG
AGTTAGCTTCTTTTCTTTTCTTAACTCAAATATTCTCTCCCCTATGATATTCATC
TATAACATCCTTTCCCGCTACTTGTAAAAAAGTATCTAGTTTAAATGTATCAATC
AGTAGCTCTATTGGCAACGCAAAAATAAAAAATAAATTTTTAAAAATAAAATGT
TGCCTTGAGGGCTACTTTTGGTTATACTAAGTTTAGAAGTTGAAGGTGGTGACT
TAAAATGCTAAATACACAAAGAATTAAATCTTTACGACAAGAGAATGGACACTC
TTTAGACTATGTTTCAAAAGCTTTAGGTCTAAAATTTAAACGTTCATATCATAAT
GTTGAAAAAGGCGAATCAGGTTTATCAGTAGAGAAACTAAAAAAACTTTCAGA
GCTTTACGGTGTACCAATTAGTGATTTAATAAAGTGAGTGAGTTTTTTTTTACA
ATTAAAGTCGCCCTGAAGACTACAAGTTAAGGGCGACACTACATGATAGTGTAT
CCATATTTATATTTCTAAAAAATGATTGGAGTGAAAAGAATGTATCAAATAAAG
CAACTACCATTCTCGATGAAAGCGGAGGATGTACAAGAATTCTTAAATATTTCT
CGTTCATCTGCATATGCACTTATGAAGAGAAAAGATTTTCCCACAATCGTAATC
GGAAAAAGCAAACGTGTTAAAGCGGAAGATTTTCTTAAATGGGTGGAAGCACA
AAAGGTGGGAGCAAATGCTAGTTAAAATTAAATTTCGGATTTTCGATAAAATTA
CCGTTTGATAAATAAGGGGGTGATTTAGTGGAAGATTTAACAGCATTAGCTATA
TTCGGATTTTCAACCACAGGTGGTTTATGGCTGCTTTATATCACTTATGAGCCG
ATAAGAAAATGGGCTTGGAGTGATGTAGAACAAAATAAAAAGACCCATGGCAG
TGGGTCCATTAGAAAAAACAAATTTTTATAAGTATACCACGGAAAGTAGGGAAA
TGGTACATGGATTTAATCGAATATCAAGTGCTATTACCTAATAAGTTTTGGAAT
TTAGCAAAAAGCCAAGATGAATTAAAAAGAATGATTGAACAGTATCTCAGTATC
GGTTATCCGCATTATGAAATTCAACAAATTATTAAAAGTGGACAAGCGCATATA
GCAATTTGCACGAGGAGGTAAGGGCTATGTCTGAAGTAAAAGTGAAATGGATA
AAACTCTCAACAACGATGTTTGAGGATGAAAAAATACGCCTAATTGAGAGCATG
CCTGAAGCTGATACATTATTAATCATATGGATTAAGTTATTAGCTCAAGCTGGT
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AAAACAAATGCAAGTGGTTATATTTTTTTAAACGAGAATATCCCATATACGGAA
GATATGCTAGCGACGCTATTTAATCGACCTCTAAATACAGTTCGGATGGCACTA
GGTGTATTTAAAAATTTCGGAATGATTGATATTGACGATAACCATTACATCAAC
GTCGTTAATTGGGGAAATCATCAGAATCTAGACCGTTTAGAAAAGATAAAGGA
AGACACTAGAAAACGCGTAGCGGCACACCGAGAAAGAAAAAAACAACAAACAC
TTAGTTGTAACGTTACAGGTAACGATGACGTAACGGACATAGATAAAGATTTAG
ATAAAGATATAGATAAAGAAATAAAAAAGAATTATAGTCCTGAAAAACCTCAGG
ACATCGTTCAATCTATTCCATATCAAGAAATTGTTGATTATCTCAATATGAAAG
CAAAAACCAATTACAAATATACATCTAAAAAAACACAAGATCTAATTAGGACAA
GATGGAAAGAGGGTTTCAGATTAAATCATTTTCAACAGGTAATTGATATCAAGG
TTTCACAATGGATCGATAATACGGAAATGAGTGGCTATTTGAGACCTATCACTT
TATTTGGAACTAAATTCGAAAGTTATTTAAATGAAAAACCTGTACGACGAAAAG
GAGTCTATAAAGGAGGTTCAACTAATGCAAGCGATCAAAAAGATAGTAGCTTC
ATCAACAAATACGACTTCAAGAAACGTTAATCAAAGATATGTATTGTCGCCTAA
TAGATGTACGAATGTATTTTTAGTAGGAAAAGAAAATTTTAAGGATGTTTGCAG
TAAACGCATGTTGATAGATACAGAAACATGCGAGGAATTTTGTCCGCAATGCA
GATCGGTAGAAAAGGAAGATCAGAAATTAGCTATAGAGACACTATCTATAAAA
AAGAAAAATGAAATCATTCATTTATATGATTCATTTGCTGATAACAGTTTAATAA
ATGACAAACTCAAAAAAGCTACATTTGAAAATTATGTACCTACCAAAAGGGACT
TAGCTGATGCAAAAGAAACAATAATGAATTTTGTTGCTTCATTCAATAAAGAAG
AACCAACAAGCATGATAATAACGGGTGATTATGGAGTAGGAAAAAGTCATTTG
TGTGTGGCAGCCACTAAAGGACTTATGAAAAAGGGTCACAGTGCAATGTTTATT
CAAATGAATAAGCTATTTACCAAAATCAAATCAACTTGGAATAAAAATAGCGAA
ATGACAGAGGACAAGCTTATGTCCCTTATAGCAAAAGTTGATGTCTTGATTATC
GATGACTTTGGAGCGGAATTCACAGAGAAAGATAAAGAAGGCGTCACTTGGAA
ACAAACGAAAACAAATGAAATTGTAGATAGCCGTATAGGTAAAAGTACATTATT
TACTACTAATTTTACGGTCGATGAATTAGCAGGAATGTATGGAGAACGTGATTT
CAGTCGGATGATGGAAAACGCTGAAATGTTAGAAATGTATGGGGATAATTATA
GATTACGTAATTTCAAAAAGGAGGAATAAGTATGTGTGTATTATGCCGTAATAC
AGGAATTATTCGTAAAGAAACTTATCCAGGTGTGATTGAAACGAGCGGTTGTAA
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TTGTGAAGTAGCAAAGAAACAGCAAGCAGAAAATGATAAGCGTTGGCAAGCAT
GGTTAATAAAATTCGAATCAATGAAACAAGAGTTACAGCGTAATAAACAACAAA
AAGTTAGTTAACAAGGGGGAGAAAGCTATGAAAAATACAGGTGTTGCAAGAAA
AGTGGACGAGCTAGGGCGTGTGGTAATTCCAGTTGAGCTACGCAGAACTTTGG
GGAGTGCTGAAGGAACGGCACTGGGATTTCATGTTGAGGGTGAAAATATTGTT
TTAAGAAAACAAGAAAAGTCATGCTTTGTAACAGGTGAAGTTTCTGAATCAAAC
ATGGAATTATTGGGCGGTCGAATGTTTTTGAGTAAGACGGGAGCAAGTGAGTT
ACTTGATGCTCTTGAAAAGAGTGTGAAGGTACATGCCTAAGCAACTAAATATTT
TCGATGTAGAGCCAGCAATTTGTGAGTTCGATGTAATGAAAGCCAATATTAAGA
AAGGAACTGGACGCAATACATACGCTGATGTACGCGTCCAAGTTCCAAATAAT
GCAAAGTGTACGGATGAGTTGCCACGCACAACTAAACAAGATGATCGCTATGA
CATCTTTGAACAATATGTAATAGCAATTTGGAGATTCCAACGTGCTGTAGATAA
GCTTTTTAGTTGGGATACAGCGGAAGAGTTATGTAAGGCAGCAAGGGATAAGA
AAGAAATTATCACGATAAGGATTTATTTAGGGAGTGGCTTTAAACCTGATGTTG
TCGAGTACATGCGGTAGTAAAGGGGAGTGGGACATATGAAAAAAATAGAAATT
GATGTTAGCAGCAACAAGCTGTTAATAGTGAAGGACGGAAATGTAACAGCAGT
AAATCCACCAATGAGTGGATTTGGTGAACAAGTCGCGGTTTGGATAAACGGTA
AAGTTGATCGTGTGGATACTAAGTTTACTGAAAAGATAAAATAATTTTTTGGAA
AGTAGGTTCGCTTATGAGTGTAGCAAGAAATCATGAAGCGATGAAAGAATCAC
GTTTAAAAATATACATCGCTTTAGAAGAAGCTAACTTCATTTGGGATGAAAGAG
ATGTAATTCGTTTTCGTGAAATGTGGAGTCAAGGTATGAGTTTGCCAGAAATGG
CAGAATCACTAAGGAGACACCATGCTGAGGTTGCGCTCCTTGTAATAGATCAG
GCTGATAAGTATTTAATTGAAAATCGTCCGATAGGATTAGGCATTTTCTAAATA
GGAAGTGGGAAAAAGAAATGGCAAAAGAAAGTCAACGTAAATTAAAACAGATG
TATGAAAATTTAGAACGGTATGGAATGGCGTTAAATGGTGCTGTATATGGTCG
GGATACGTTTGGTGGTGTTAGACAAAAGAAATCGAAAGATTATCGTGGCAAAC
AAAGAAGTGCGGATATGAAGGCGAGACAAAATTAACAGGGGTTAGCATGGACA
AGAAACAAATCTACATCGATGTATTACTACATAAAGGGATTTACAAGGAAAAAG
ATACAGGACGGCAGCTTTATGAAATGGATGAAATAGAGTTATGGAAACTATTAA
AGGGAGATGAAAAGAATGGAAGTAATAGAAAACAGTGTTTATGAAATCACTAA
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ATTATTAGCTGGATCTAAAGGTGGTAAGTAATGAAAAAAGAAACCGTGGTGCA
GGTGCAAAGTGAACTTGAGGTAGTAAAGAGTGAGATTCGTAAGATGGAATATC
ACCTGATTGGATTGAATAACGAAAAGCGTAAGACAAATATGGCTTTGGAAGAG
CTGAAGAATCGGAAAGAGAAGTTGAAAAGTTACTTATAAGGAGCGGGTTGAAT
ATGGAACTAACTAAATTATTCGTAGTACAAGCTGGGTTAAAAAAGCACATTGGG
TACAAAGGGAAAGATAAATTCAGCAAGATGATGTTAGCGATGTTAGTTGAATTT
ATGGAGTGTGCGAATGATTGGCGTGGTTTTAAATATTGGAGCGAGAACCCTAA
GGCAAAAGAAACGTTGTTAGAGGAATATGTGGATGGATTTCACTTTGTATTAGA
AACAGGACTGGATTTAAAAGAACACACTATAATCATGACGCTTCCAAATGAAGT
TGAATTACCAGAAGAAATTCATGACATGTCGGAACAACGTATCATAAAACAATA
CAAGATATTGACAGGTAAAGTGCTTGAGTTAGAAATTGAGGTTCATAACGGTAT
AGATTATATGGATGGATCATATGGAGACTTTATTTATCGATATTTACTGTTAGG
TAAATTATTAGGATTCACTGAAGAACAAATTGAAAAGGCGTATATGGATAAGAA
TGCGGTGAACCATCAGCGTCAGGAAAACGGATATTAAGACCGAATTTGAATTTT
GTTAAGAAATGAGGGTGATTGAAATAAGTTGGTGGGCAATAGCGATCGGTTTA
TATCTATTGATTGGAGTTGCATTACTTATATGGATAATCGCAACGGATAGTTGG
GGTTCGTTATTCTTATATCCTGTTTTTGCGGTAGTCATTGTTTTGGGATGGCTT
CCATTAATGATAAGAAGCATTGTACAAGAGATATCTAAAGCGATTCATAAGTGG
AAAAGAAAGCAGAAAACTGAATAGAAGTATTATTTCAGGGAGGGAGAATAAAT
GATTTATGAAGTTACAGATTATTGCAGTCAGTGTGATAGAAAAATAGAGAATTG
CGATTGCTGTTGTAATAAGTGTGATGAGTGGTTGCACGATTGTAAATGTAAAGA
TAAATAAGCAAAAAAGGGGAATGAAAGATATGAAATGGATGTACAACCTTGAT
AGCAATAATGAGATTTGGACAAGCGATAAATTTGAAATGAAAGAAGAAGCTATT
CAAGCAGCTTTAAAAGATTGGACAGATAAAATGGTAGCGGATAGAGCGGCAGT
CGATAATGAATTCCAAATTGGACAATTCAAACAGTATTCTCCATGGATCAATGC
AGATGTATTGTTGGATGAATTGTATGAACGAGCAACCGATGAATGTGGAGAGG
TTGCGGAATATTGGCTTTCAGGTGTGCCGATGGACGAAGGGGAAAAGCTTCAA
GAACAAATTAATAAGGTAGTTACAGAATGGCTAAAAGGAATAAATGAGCATCCT
AGCTTTGGTTCAATTGAAAATATTGAAACGATAGATGCTAGCAAAATTGAATAT
AAAGAAAACTAAACAAAAGCGTTATTT
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fBACA1 Contig 2:

AACAAAAGCGTTATTTTGCAGAAAAGTGAGGGAGTAGAATGGCTAAAACAGAA
AAGTTTAGTGTCGTCCTTGAGTTACCAAGGGATATAGAAGTAGGTTCAACTGTA
AAGCAAAAAGGAAAAGTGTTAACTATCACCAGTATTAGAAAGATTGAGTGTATA
TCAAGCAGATTAATTTTAGTTAGTGGAAATGCTACAGTCCAGAAATGAGGTGAA
AGCAACATGAAGCGTATTGGGATAAATGAAAAGTGCATTGGGTGTGGTGCGGA
TGTCAACGATCCAGAATGCGAATGTGAATGGAGAACATGCTCGTGTTGTGGTT
ATCCAGACTGTTTCGTTTATGAAGAAGGTCGCTATTATCATTGTAAAAACTGTG
ATCATTCAACTGATCCAGGACATTATACGTAATCAAAAAACTAAACAAAATAGT
TATTTTAATCGAAAAGTGAGGGAACAAAATGGCTAAAACAGAAAAATTCAGTGT
AGTTCTTGAGTTGCCAAGGGATATAGAAGTAGGTTCAACTGTAAGGCAAAAAG
GAAAGATATTAACTATTACGAGTATTAGAAAAATCGAGTGTATATCAAGCAGGT
TAATTTTAGTTAGCGGGAATGCTACAGTTCAGAAATGAGGTAAGGGCGACATG
AAGCGTATTGGTATAAATGATAAGTGTATTGGCTGTGGTGCGGAGGTTGATGA
TCCAGAGTGCGAGTGCGAATGGAGAACATGCTCGTGTTGTGGTTATCCAGATT
GTTTCGTTTATGAAGAAGGTCGCTATTACCATTGTAAAAATTGCGACCATTCAA
CTGATCCAGGACATTATATGTAAGTAAAAAAATAAGGGGATGGAAATCATGAG
AGAACGTGAAAATTGGGATGTATTGTGTGAAGAATGCGATAAAGTAATCATCAT
TGGTGTAAAAACGGAATCCGGGGATCATTATTGTGAAGCATGTTATGACAAGTT
AGCGTACGGAAACAAAGATAAGTAATTTAATAAAATCGTTATTTTATTAGAAAG
TGAGGAAGATAGCCATGAAAACATATGAAGAGTTGGTTGAAAAGTGTAAGGAA
CTGGTTGAAAAAGGATGGACTCCAGAATCAGTGCGTGAATGTTTCGAAGCATA
TTCTGAATTCGGCATTGATGCTATTCAATCCGCAATGAATGAAGCGCTACTTAA
TAATGGGTGTTCAGATAATGTATTAGATTATCGGCCGAATCTAGAAAATTTAAA
AGCGTTGGGATTGGAAGAGGATTATGTTTTCCAAGCTTTAGCTTATATGGGGAA
TGCTTCTCAATTTATGAGTTGGGCAAATACGGTACTGGCACTCGTGGACGATGT
TCCAGAACAGTTAAAACAAGATATCAAAAAAGTACATTCTGGTATTTATGAAAT
GCAAGAAAAATTAAGAGAATATAAGAAAGAGGATGATGAGTAATGGAAGAAAT
CTTAGTGCAGGGAAACATAACTGAAGATTTAAAAAGATTAGGTGTTAAGGCAA
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ATAGAACATATGGTGATGAAACTACTTCGTACCAAGTATATGAAGTTTCGGAGG
AAGATTTTCGAAAGTTAAGTGATGATGCGGAGAATATGGATACAGATGATAGT
CATTGGAAAAATGGCGGATGGCGCTGGGATACAGGAAGTAATCAACCGATACC
TACCGACAAAGCTGAAGTCAACAACCAAGAATTAGTATGCTGGGTAGAAACAA
TAAACGATGACGAAGAAACATATCGAAATGATTGGTATGTGGATCTACTAGAAT
ACCTCGATGTTGGAGTTGGCTGCACAGCTTTCCGTAATGTGTGTGCCGTAACG
AAGGACTTGGCGAAATACAACAATATGTCAATGGCCGAGTTATTCAAAAAGTAT
CAAGGGTAATTCAAATAAAAACTTTATTTAATAGAAAAGGAGAATGAATATGGG
AACATTAGTTGTTAATTGTGGAGAATATGAATTTACTAGATTTGAAAGTGCTGT
CCGAACTTTGGAACAAGAATATGGTTATGAAGGCGAAGCTTGGGAAATGGTTG
TGGCAAGTGGTGATTTAGAGATATTAAGTGACTTCTTAAATTCTGATGGTTTGA
ATGCAGAAATCGAATAAAAATTTCATTTTGTCGAAAAGGGGAATGGATATGACC
GTAGTAAGCAGATCACATAGAGCATTAAAAAGAAAATACAGACCAATAAGAAA
AGAGTTTAAGAAAGATATTTTAGAAGCGACAAAGAATAATCGCGCTTTTGCAAT
GATGATTATTGAGACATATACAGCAAGTCAACATAGAACGCACATTATGAAAGT
TTGGGAGCTACTAGGAATTCATCATAGAGAAGCTTATAAAGATTATTGCGATAA
ATTGATGGGTAAGCATTTAACGGGACGTGATGAAATAATGAGGTCGATATATTT
TGCGGATAAAGTATTATACGACAAGTACCATCGCAAGTTACCAGAATGCTATGC
AATGGGTGATGCACTAGGTATTGCTTATAAGGTATTAAAACAATAAAAGAGCAG
CTAGCAAAAGCTAACTGCTCGGGTAATGGAATATGGTTCGAAATGGGTTGTCT
ACAGTATTGACGGAATATTGAGTTTTATTCAGGGGAGGAAGAGAATGAGTAAA
GTAATTGAAGGACAAGAAGTTTATGTAAGCACAAGTGGTGGATGGGTAGGTAA
GTCAGAACCTAATTTAAGAAAATACATCGTTGTCAGAGCTAATAAAACAAGTTT
TTACGCTAATCCTGAAGGGGTAGAAGATAAATCACCATATAGATTCAACCAAAA
GGATTTATCGCATAACACTGGATGGGGATATCATTATCAAGCTTATCGGACCGA
AAAGGAATATTGGGACATGATTGAGAGAGGTAAAGAAAAAGCTCAATTAAGAA
AAGAATTAAAGGATACGGTTGATAAGATGTCACTTATAGAATTACGGAAGTTAA
AAGAAGTACTGTTTGTAACAAAATAATCCTTTAATAGAAAGTGAGGTGAATACA
TGGATAAGATATATGCATTTCAGATTGCCACAACAGCGGGCTTGTTAGCCATGA
TTGTACTCAATATTATAACCGGTCAAGAAGTAAGATCATCCTCAATAGTTGTAG
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CAGCAGTTTGTTGCGTAGGAATGTTAAAGTTTAATCCGTTGTTTAGAGAAATGA
TTGATAAATATAGAAAGCGAGGTTAAGAGAATGAAACCTTTGAAGAAAAGAAA
GGTAAGAAAAGCTATTGCTCGCCGTGCTAAGGCAGTTGAGAAACATCAAGTTG
ATAAAGCTTGGAGAAACATTTTTGTACGAAATGGCTATTTAAAATAAATGAAAA
CCGAATACAGTCCGGCTAGAAAACTAGAGGACACCAATTCATTAAAACGGCGA
TTAAGGCTGTTTTAGGAATAGGTGTCCTTTTTATTTTGAAAAGGGAGATGGGGA
AATGAAGGTGTTAAAAGATCAATTACGTGAATGGAAAAAGCAATCTAATCAAAT
GAAAAAGAAACCTAAGAAGAAACGAAAAGAGAAGTTAAGCACACGTGACATTG
AAGGTTTAATGGGAATTCATGGGCCGCGTTATGAACGTAGACGTGGAGCATTA
AGACAAAAGTAATTTAAAAATAAAAAGGAGTGGTCTTACATGACTAAACAATTA
TCTTTCTTACCAAAAATTGATAGAACAGCGACACAGGAGGAATTAGAAGGTGT
GTTGGAAAGTGTACGTATACATAGACAATTTGGGATGATGCGTAAAGAAATGA
AAGTCACTCCTTCTTATGAAATACGTGAGCACGGTCCTACACATACAGTTGGTA
AGCCGTTAGAAGATGTTGCTATAGCAAATATTCAGCAAAGCAAACGAGAAGAG
TGGCTTGAAAGAATGTCAGTACGTATTGATCAGTTTTTAAATCGATTAGGAAAC
GGACGTGCTGGAAGCATCCAAAGAGATATTATTTATAAACGTTATTTAGAAGAA
GAGGACGTATGTGATTACATGGTTTATAACGAAATAGGAATGTCAGAGCGTAC
TTATCGACGTTGGAAGTCTAAAGCATTTTACAAACTTGCTTTTGCGCTTGGATT
AGAAGTTTACGAGACAGAAGAAACGGGAGGTAATGAATAATGAATTTCGTTCA
ACCGATACGTGATCCAGAACAAATACAGCAGCTAAAAGATTATTTTAAGGAGAA
GAGCTTACGTAATTACATTCTTTTCATTATGGGAATCAATACAGGCCTTAGAAT
CTCGGATATTTTGAAATTAAAGGTAGGAGACGTCAGAGGCAGTCATATATCTAT
GAGGGAAAAGAAGACAGGGAAGCAGAAACGCATACAAATTACTGCAGCACTGA
AAAGAGAACTTAAATGGTTCATTGAAGAAAGAGAAGATAATGAGTACCTATTGC
AAAGTAGACAAGGGAGGAATCGTCCTATTGGGCGCAGCATGGCCTATAAGATA
TTAAGTGGTGCAGCGGAAGAGTTCGGATTAGATGAAATAGGTACACATACATT
GAGAAAGACATACGGGTATCATATGTACATGCAAACGAAAAACATAGCATTACT
CATGGAGATATTCAATCACTCGTCAGAGAAGGTCACATTACGTTATATAGGGGT
AAACCAAGATGCAATGGATAAAGCAATGACTAGGTTTAAAATCTAATCATTGCT
TTTTTCTTTTTAAACACATACAGTTACTCATAAATTTCGTACTGTGTAACTCAAA
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AGGAAAAGTATTATAAAGTTAATGATACCAAGGGATTTGGCGAAGGGGTCAGT
TACACACAATATAAGATATGGGTAAGTCATTGATATAAAATACATATGAGTGAA
GAATAAAAATAAGTGGCAGAGTCATGACCGCTTTTTGGCAGGAAATGTGCCGG
TTGTTTTGGGATTTACGTGATATATTTGTATTGTGAGAAGTGGCGGAAAACACA
ACTCACTATGTTGATTCTAAAATTCTAAACGGCTTCATAATGACGGCGCATAAA
ATCCGAAACCAGCAGATGGTACTGATTGAATGTTACCGTTAATAAGGAGAGCTT
TTGCTCTTCTTTGAGCTAACAACATCCTAGGTAGACAGAATTAGGAGAACCTGA
TAAGTTTTCCGATGGTGTCTGTCGTGGTTGTTAGTTCAAAGAAGATTAAAACTT
CACATACCATAATTAAAAAGTAAATAAGAAAATGATGAAAAAAGCATCCATTCG
GGTGCTTTTTATTTTGAAGGAGGATGAAGGATGGAATTAACATTTGAGGGATTA
GAACAGTGTTTTAATGAAGCTAAAGATGTAGAGGCTAATTATGTAGCCGTACAG
ATCGAAATGGAAGAATTCCCTAGTGATGAGTTGATTATTAATGACAAACACAAT
ATCTCTTTAAAACTAGAGTACTATAAGAAAACTTATAACGAAGACTTAGAACAC
AGATATGCTCCAGGTATTCGTATTGTAGGTTATGCATACGGACATACGTTATCT
GGTATTCAACGTGAGTTAAAGTTACTCAATGATTAAGGAGGATGAATGATGAGT
GAACAGAAGAGCGCATTGTCAGTAAAGGTAGAAGTTGATACAAAAGAAGCGAA
TGAAAACATTAAAGAATTAACTGCTGCAGTTAATGAATGCGCGGAAGCATTTGA
TAATTTAGAAAAGGTTATAAGTAATTTTACAGGTCAGCATAGGAAGGTTAGATT
CTTTAATGATTGTGGCGAATTGATTGTTTCAAAGAAGGAGTGAGGATAGATGCA
AGTCTATTGTTCTAGCTGTAATAAAGATTACCATATGCAACCAAAAGTAGCACA
GCTTCCTAATCGTATTGAGAAGTGTTACTTCACTTGTCCTCATTGTGGCCATGA
ACATGTTGCGGCATATGTGAACGATAAGATTCGTAAACATCAAGCTGACATTGC
AAAGTGTCATGATCGTATTAACAAGAGGAACCTAGACATCGAGAATGAAATGA
AACGGTTGAGGAAGAGGATGGAGGGAAGTAAATGATGATGATATTAGGATATC
TTATTATTGGTTTACTTTATAGTTCCATTACAATGTATCCAGTTGCGAGAGACG
TTGGACAACGAAAGAAACATGACGGTGTATATATAGTAAGTACATTTATTATTT
CTATTGCATTTGCCATTTGTCTCGCTCCTTTCTGGATTATTCTTCTTGGGTTTAA
TATAGCTAAGTGGTTTTATAAATGGAAGAATAGAAACCAAATGAAGTGTGAATG
TTTTAATTGTGGTTATGAATCAACGATAGATATAGTAACAGGTGCTGGTAAACG
TTGCTCACAATGTAATGGTATAACAATACCTAAAGCGTCAGGTGGTACACATGC
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CAAGTAAACCATTCAAGCCATGTAAGTCGTTAGGTTGCAACGAACTAACAAGG
GATAAGTATTGCACTAAACATTTAGAAAAGGAAAACGAAACCGTAAAATATTAT
GACAAACATATCCGAAACAAAAGCTCACGTTCATTCTACAACTCAAGATTGTGG
AAGGATATGCGTGAGTTTATTTATCGTAGAGATCATGGTCTATGTGTTCAATGT
AGAAGCAATGACATCATTAAGATAGGTGATGTAGTCGATCACATCATACCCATT
CGAGTGGATTGGTCTAAACGATTAGAACCATCTAATTTACAAACGCTCTGTCAT
GCTTGCCATAATAAGAAAACAAAAGAAGACGAGAAGAAAAACAGAAAATAATT
CGAAAGAAAAAAATCATAAACAACCCCCCACCATGAAAAAGCAAAGGACGACT
CCCTGGAG
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APPENDIX 2. PRELIMINARY DATA AND SUGGESTED FUTURE
EXPERIMENTS

A2.1 Determination of fetal bovine serum (FBS) component(s) responsible
for dcsaB’s phenotypic switch

To determine the FBS component(s) involved in dcsaB’s phenotypic switch, we
fractionated FBS into >10 kD and <10 kD fractions. Briefly, FBS was filtered in
10,000 MWCO Amicon Ultra-15 Centrifugal Filter Units (EMD Millipore). Flowthrough was collected and sterile filtered through 0.22 µm filters and labelled “FBS
flow-through”. The >10 kD fraction was washed 3X in 1X PBS and resuspended to
10% of its original volume (i.e., 1.5 mL from 15 mL starting material) and labelled
“FBS proteins”. BHI broth was also subjected to this fractionation procedure and
split into <10 kD “BHI flow-through” and >10 kD “BHI proteins” fractions.

Sterne dcsaB from an overnight culture grown in BHI at 30°C, 150 RPM was backdiluted 1:100 and grown in the same conditions, however in four different
combinations of each fraction component: 1) reconstituted BHI (BHI flow-through +
BHI proteins); 2) BHI-FBS (BHI proteins + FBS flow-through); 3) FBS-BHI (FBS
proteins + BHI flow-through); and 4) reconstituted FBS (FBS proteins + FBS flowthrough). The 4 cultures were formulated as 90:10 mixtures, with 90% culture
volume as flow-through and 10% culture volume as 10X concentrated >10 kD
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fractions. Cultures were grown for 24-36 hours, the time until reconstituted FBS
cultures were dispersed and resembled those grown in unfractionated FBS.

Examination of cultures revealed that the two different fractions of FBS appear to
play different roles in the dcsaB phenotypic switch (Figure A2-1). Reconstituted
BHI and reconstituted FBS were used as controls for the dcsaB phenotype and to
ensure that the fractionation procedure did not alter serum activity. dcsaB grown in
reconstituted BHI resembled that of dcsaB grown in unfractionated BHI. The
culture was connected as one bacterial mass that fell to the bottom of culture tubes,
with the rest of the supernatant clear (Figures A2-1, A2-2a). Reconstituted FBS
cultures were dispersed with dcsaB in shorter chains and possessing a Sterne-like
phenotype (Figures A2-1, A2-2b).

BHI-FBS (BHI proteins, FBS flow-through) cultures were of an intermediate
phenotype between that of BHI and FBS alone. In BHI-FBS, the bacterial clump
associated with dcsaB was less compact and its rope-like structures appeared
unraveled, however dcsaB chains were still of longer length and cells did not
disperse into the surrounding media (i.e., the culture was not turbid) nor did they
show any apparent division septa (Figures A2-1, A2-3a). FBS-BHI (FBS proteins,
BHI flow-through) cultures had a distinct phenotype where a compact bacterial
pellet was present at the bottom of culture tubes, however, cultures were also turbid
with dispersed cells harboring clear division septa (Figures A2-1, A2-3b-d).
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Reconstituted BHI

BHI-FBS

FBS-BHI

Reconstituted FBS

Figure A2-1. dcsaB displays different phenotypes in fractionated FBS.
Sterne dcsaB was grown in combinations of BHI and FBS previously split into >10
kD and <10 kD fractions. Left) dcsaB grown in reconstituted BHI (BHI >10 kD and
BHI <10 kD fractions) displays a bacterial clump at the bottom of the culture tube
with non-turbid growth. Middle-left) Growth in BHI-FBS (BHI >10 kD and FBS <10
kD fractions) results in a more loosely-bound bacterial clump, however still
connected as one mass. Supernatant surrounding the mass is not turbid. Middleright) FBS-BHI (FBS >10 kD and BHI <10 kD fractions) culture displays turbid
growth. Media contains bacteria with clear division septa and a tightly wound
bacterial mass at the bottom of the culture tube. Right) Reconstituted FBS (FBS
>10 kD and FBS <10 kD fractions) culture displays turbid growth typical of dcsaB
in unfractionated FBS. No bacterial mass is present in the culture tube.
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B

A

Figure A2-2. Sterne dcsaB growth in reconstituted BHI and reconstituted
FBS. A) dcsaB grown in reconstituted BHI possesses long chains with multi-chain,

B

A

rope-like structures, resembling growth in unfractionated BHI media. Image
captured at 100X magnification. B) dcsaB grown in reconstituted FBS has shorter
chains and clear division septa, resembling growth in unfractionated FBS. Image
captured at 100X magnification.

C

D
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Figure A2-3. Sterne dcsaB growth in BHI-FBS and FBS-BHI mixed fraction
cultures. A) dcsaB in BHI-FBS (BHI proteins, FBS flow-through) grows in long
chains, however tight, rope-like multi-chain structures are less apparent. Image
captured at 100X magnification. B) and C) dcsaB grown in FBS-BHI (FBS proteins,
BHI flow-through) displays compact, twisted chains with an aberrant morphology
(B), however cells contain clear division septa (C). D) dcsaB grown in FBS-BHI
shows a mix of chain morphologies: 1) rope-like, multi-chain structures without
clear division septa, 2) long chains without apparent division septa, but not
associated with rope-like forms, and 3) shorter chains with clear division septa.
Images in B), C), and D) captured at 1000X, 400X, and 100X magnifications,
respectively.
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These results suggested that multiple components of FBS likely promote different
aspects of dcsaB’s phenotypic switch. Components <10 kD (likely small molecules or
peptide fragments) appear to play a role in breaking-up/unravelling the multi-chain
structures associated with dcsaB growth in BHI, however, cell separation was not
observed in these cultures containing BHI proteins and FBS flow-through. The
formation of multi-chain structures may be due, in part, to increased levels of
SCWP on the dcsaB cell surface (contributing to dcsaB’s “stickiness” and the
propensity of chains to bind together). We find in our RNA-seq data that a number
of the genes associated with SCWP synthesis are upregulated 4-16-fold in dcsaB
grown in BHI vs. FBS, and 4-8-fold in dcsaB BHI as compared to Sterne BHI.
Sterne does not show differential expression of SCWP synthesis genes between BHI
and FBS culture. B. anthracis may therefore respond to components in the FBS <10
kD fraction and downregulate its SCWP synthesis genes to allow for multi-chain
unravelling and in part, cellular dispersion associated with FBS and animal-host
environments. Complementary to the <10 kD FBS fraction, the ability of the FBSBHI cultures (FBS proteins, BHI flow-through) to grow with turbidity while still
containing a dense cellular pellet, suggests that a larger molecular-weight
component of FBS plays a role in cell separation, however likely indirectly as heatkilled FBS cultures were capable of turbid growth. When added together, these
fractions of FBS appear to both unravel the bacterial mass associated with dcsaB
growth in BHI and allow for cell separation and dispersion, critical events in B.
anthracis’s pathogenesis.
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Since multiple components of FBS appear to play different roles in the dcsaB
phenotypic switch, experiments to specifically uncover these compounds will
highlight molecular signals that the pathogen uses to sense its external
environment and precipitate an infectious or non-infectious response. Such work
will allow for a better understanding B. anthracis’s biology, and in addition, may
allow avenues for development of novel approaches to treat infection. Interference of
signaling pathways in B. anthracis may prevent the organism from sensing its
external environment and executing its infection program (i.e., production of
anthrax toxins and PDGA capsule in mammalian environments) and allow better
treatment outcomes.

Follow-up experiments could elucidate the FBS active principles by a variety of
approaches. The approach described above could be expanded to fine-tune molecular
weight cutoffs and find a range in which the active components are found (e.g., the
“rope-unravelling” compound is <3 kD or <1 kD, or the “cell-separation” compound
is >30 kD and <50 kD). Getting a better defined molecular weight range followed by
mass-spectrometry could allow identification of switch signals. In addition,
treatment of the lower molecular weight fractions could remove non-polar (e.g.,
charcoal stripped FBS) or other serum compounds. The absence or presence of
fraction activity could help elucidate the nature of the components integral to
dcsaB’s phenotypic switch.
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A2.2 Uncovering fBACA1-pXO1 crosstalk in B. anthracis

During the course of research conducted for this Thesis, it was discovered that
fBACA1 presents different plaquing efficiency on B. anthracis Sterne compared to
DSterne indicator strains (Figure A2-4). A similar observation was noted with other
B. anthracis-infecting phages but not further explored in (Schuch and Fischetti,
2009). Our result suggests potential fBACA1-pXO1 (and more broadly phage-pXO1)
crosstalk that could allow for successful phage infection. We have observed DSterne
lysis by fBACA1 previously, although at a much lower efficiency.

Figure A2-4. fBACA1 plaquing efficiency on B. anthracis DSterne versus
Sterne strains. fBACA1 stock at 10-4 dilution was added to either DSterne (left) or
Sterne (right) in a BHI soft-agar overlay. DSterne does not display any PFUs,
whereas plaques are apparent on the Sterne plate. DSterne and Sterne displayed
equivalent growth in BHI-only negative controls (not pictured).
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Experimental work to uncover potential phage-plasmid crosstalk and the genes
involved in this event should be a relatively straightforward task. Sterne could be
cured of its pXO1 plasmid to generate a DSterne strain with a similar chromosomal
background to Sterne. Following plasmid curing, pXO1 DNA could be purified and
digested to make a library of ~2-3 kbp fragments hosted in DSterne. This library
could then be tested for clones harboring increased fBACA1 susceptibility and
candidates Sanger sequenced to uncover the gene(s) important for increased phage
sensitivity. Uncovering such phage-plasmid crosstalk would, to our knowledge, be a
rare finding, however it would be of critical importance in understanding the
environmental interactions between B. anthracis and its bacteriophages.

In addition to characterizing this pXO1-driven crosstalk, is also possible that the
dcsaB phenotypic switch is partially (or fully) precipitated by a pXO1-encoded factor
as well, as a number of pXO1 genes are differentially expressed with elevated
temperature and/or CO2/bicarbonate conditions—some of the same conditions which
appear to cause the dcsaB phenotypic switch. Generating a dcsaB mutant in
DSterne and testing its ability to execute a phenotypic switch could identify pXO1
as an integral part of dcsaB’s ability to overcome the limitations associated with
CsaB-deficiency. If DSterne dcsaB cannot execute the phenotypic switch associated
with Sterne dcsaB (or perhaps does so less efficiently), then the same library
screening approach as described above could be undertaken, except in a dcsaB
chromosomal background, and would uncover the pXO1 gene(s) associated with
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dispersion and differential expression in FBS and likely in animal-host
environments. Genes highlighted by this approach would give researchers more
insights into the mechanisms by which B. anthracis executes its multifaceted
lifestyle and deals with the threat and consequences of bacteriophage infection.

232

APPENDIX 3. RNA-SEQUENCING DIFFERENTIAL EXPRESSION DATA
Representative pXO1 differential expression (DE) data comparing dcsaB and Sterne in FBS culture are shown. The
full DE dataset is available at: https://www.dropbox.com/sh/b3alrq7k5y7q6pq/AABh2Usqstjt2MTzHXh2zJoSa?dl=0
Password: bacillusphage
Table A3-1. Differential expression (DE) of pXO1-encoded genes comparing dcsaB and Sterne in FBS
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Gene

Base Mean

Name

AW20_RS

40.28794778

Log2 Fold

Log2 Fold

Wald

P-

Adjusted

Gene

Change

Change

Statistic

value

P-value

Product

(relative to

Standard

dcsaB)

Error

-0.490798703

0.38062251

-1.289463156

0.1972

0.346059833

hypothetical

00005
AW20_RS

37117
95.3907458

-0.099657705

0.29940662

-0.332850705

00010
AW20_RS
00015

0.7392

protein
0.838469831

46981
141.841706

-0.586029343

0.311808046 -1.879455486

0.0601
82326

hypothetical
protein

0.147014984

disulfide
formation
protein

AW20_RS

229.2474758

-0.725721958

0.283674816 -2.558288282

00020

0.0105

0.039266833

18885

ArsR family
transcription
al regulator

AW20_RS

1245.398124

-1.194286171

0.236542347 -5.048931774

00025

4.44E-

9.90E-06

07

RNA
chaperone
Hfq

AW20_RS

98947.27241

-0.863221596

0.249173039 -3.464345896

00030
AW20_RS

319.4364786

0.145773982

0.241252511

0.604238196
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199.28654

0.469822078

0.279286127

1.682224902

215.9477031

0.20666064

0.255799138

0.807902019

1453.391531

-0.547510834

0.219591421 -2.493316143

6715.447841

-0.500661095

0.229506752 -2.181465648

transposase

0.4191

0.579591376

hypothetical

0.0126

protein
0.044947659

0.0291

8512.976489

-0.220167255

0.173325781 -1.270251053

0.2039

0.085439802

-0.47248248

0.268809962 -1.757682177

0.0788

recombinase
XerS

0.354104906

95218
1442.322615

hypothetical
protein

48993

00060
AW20_RS

0.201549057

55611

00055
AW20_RS

0.0925

hypothetical
protein

46989

00050
AW20_RS

0.68695407

25237

00045
AW20_RS

0.5456

hisitidine
kinase

8529

00040
AW20_RS

0.003679375

31523

00035
AW20_RS

0.0005

hypothetical
protein

0.179528642

metal-

00065

01602

binding
protein

AW20_RS

163.2857252

-1.044700058

0.320002774 -3.264659383

00070
AW20_RS

39.80538607

-1.163014458

0.591522954 -1.966135802

263.8019101

-0.336857234

0.247516363 -1.360949356

1077.399961

-0.197305634

0.172224852 -1.145628129
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0.126797388

transposase

0.1735

0.317247877

transposase

0.2519

0.410487689

transposase

0.946964898

hypothetical

49053
6922.346539

0.027366035

0.239721538

0.114157596

00090
AW20_RS

seudo=true

29694

00085
AW20_RS

0.0492

transposase;p

82926

00080
AW20_RS

0.006573442

95958

00075
AW20_RS

0.0010

0.9091
12865

7802.140801

0.124144625

0.216353865

0.573803593

00095

0.5661

protein
0.702329306

00717

type VII
secretion
protein

AW20_RS

880.0068621

-0.051460847

0.261908783 -0.196483853

00100
AW20_RS

00110

0.906698924

3147
505.0798772

-0.514809968

0.32901197

-1.56471501

00105
AW20_RS

0.8442
0.1176

protein
0.240528372

49747
492.6544954

-0.700258148

0.3102765

-2.256884255

0.0240
15308

membrane
membrane
protein

0.07356784

membrane
protein

AW20_RS

3056.12698

-1.462902866

0.367911604 -3.976234643

00115
AW20_RS

657.5803757

-1.405356179

0.440697768 -3.188934185

2474.705448

-0.713182998

0.283225111 -2.518078274

protein
0.008137083

transposase

0.0117

0.042733678

integrase

0.571692744

DNA-binding

9971
81.53620979

-0.320648495

0.390043762 -0.822083381

00130
AW20_RS

0.0014

hypothetical

27984

00125
AW20_RS

0.00072877

05

00120
AW20_RS

7.00E-

0.4110
29443

319.4700036

-0.684821911

0.245562875 -2.788784381

00135

0.0052

protein
0.022672982

90628

transition
state

236

regulator
AW20_RS

145.0826688

-0.736757473

0.298723257 -2.466354578

00140
AW20_RS

0.0136

0.047531989

49614
434.7144813

-0.489971204

0.267041331 -1.834814116

00145

0.0665

hypothetical
protein

0.159121837

33236

ArsR family
transcription
al regulator

AW20_RS

2210.238201

-0.693300265

0.213213075 -3.251678003

00150
AW20_RS

0.006809538

47259
20194.88175

-0.875852984

0.196343904 -4.460810672

00155
AW20_RS

0.0011
8.17E-

ATPase;pseu
do=true

0.000121285

Lethal factor

0.00110746

ribonuclease

06
3900.263686

-0.89332468

0.23216851

-3.847742664

0.0001

00160
AW20_RS

19211
356.9205462

-1.071375415

0.278585925

-3.8457629

00165
AW20_RS

151.4991323

-1.124093446

0.3718195

-3.023223492

12627.33504

-0.521245605

0.282880681 -1.842634159

177591.0628

0.216513963

0.272647886

0.794115688

616.3591551

-0.820528024

0.278724518 -2.943867405

237

493.2485061

-0.784489061

0.218001338 -3.598551591

1020.204571

-0.825115797

0.18572247

-4.442735418

1045.859044

-0.931241648

0.231182458 -4.028167429

00210

0.0032
0.0003
8.88E5.62E-

1157.078063

-0.819698305

0.2377903

-3.447147786

0.0005

protective
antigen

0.015695144

hypothetical
protein

0.002485308

germination
protein XC

0.000127916

germination
protein XA

0.00061308

05

00205
AW20_RS

0.586786753

06

00200
AW20_RS

0.4271

transcription
al regulator

19994

00195
AW20_RS

0.157226583

41388

00190
AW20_RS

0.0653

hypothetical
protein

28085

00185
AW20_RS

0.012737107

82443

00180
AW20_RS

0.0025

hypothetical
protein

00975

00175
AW20_RS

0.001112816

20178

00170
AW20_RS

0.0001

germination
protein

0.003851652

resolvase

0.001240295

transposase

66539
8665.18771

-0.842555367

0.220960437 -3.813150341

0.0001
37207

AW20_RS

518.5022341

-1.125746745

0.193555455 -5.816145804

00215
AW20_RS

2.48E-07

09
3438.27036

-0.423457505

0.302835547 -1.398308455

00220
AW20_RS

6.02E0.1620

protein
0.304001547

2046
20261.22109

-0.450309252

0.22707776

-1.983061887

00225

0.0473

hypothetical
hypothetical
protein

0.12312871

60517

anthrax toxin
expression
trans-acting
positive
regulator

AW20_RS

176.7775063

-0.844698404

0.293542272 -2.877603958

238

00230
AW20_RS

0.018552253

transposase

0.028465221

transposase

0.175379655

adenine

07079
595.4803311

-0.541470943

0.200855493

-2.69582342

00235
AW20_RS

0.0040
0.0070
21488

2622.129431

-0.37688982

0.212521935 -1.773416098

00240

0.0761
59783

phosphoribos
yltransferase

AW20_RS

1113.809566

-0.2635663

0.258193916 -1.020807555

00245

0.3073

0.471770571

45624

adenine
phosphoribos
yltransferase

AW20_RS
00250

8757.074351

-0.002289827

0.254770638 -0.008987798

0.9928
28871

0.997902358

calmodulinsensitive

adenylate
cyclase
AW20_RS

1518.156802

-0.391075267

0.176797609 -2.211994102

00255
AW20_RS

310.7777827

-1.133370892

0.242183205 -4.679807963

13635.594

-0.791363913

0.316270476 -2.502174474

9574.538594

-0.66304155

0.303788351 -2.182577272

239

7284.619741

-0.518508924

0.254467483 -2.037623503

812.2553554

-0.819040841

0.221784207 -3.692962869

1637.819277

-0.300280391

0.181912164 -1.650688909

307.3928467

0.30109773

0.219273018

1.373163616

0.085328024

0.0415
0.0002

hypothetical
protein

0.112211764

hypothetical
protein

0.001821798

transposase

0.0988

0.21186739

transposase

0.1697

0.312755182

transposase

0.032168146

hypothetical

01488
215.4565265

-0.873579346

0.330026485 -2.646997697

00295
AW20_RS

protein

02114

00290
AW20_RS

0.0290

hypothetical

21656

00285
AW20_RS

0.044206248

876

00280
AW20_RS

0.0123

hypothetical
protein

66955

00275
AW20_RS

5.06E-05

43308

00270
AW20_RS

2.87E-

hypothetical
protein

06

00265
AW20_RS

0.080576313

67072

00260
AW20_RS

0.0269

0.0081
20991

1770.796188

-0.48359844

0.157348034 -3.073431729

0.0021

protein
0.011186612

UDP-glucose

00300

16121

6dehydrogena
se

AW20_RS

454.088118

-0.622686332

0.269381354 -2.311542068

00305

0.0208

0.066105808

02932

UTP-glucose-1phosphate
uridylyltrans
ferase

AW20_RS

497.3734375

-0.627760585

0.247675252 -2.534611675

00310
240

AW20_RS

100.3814544

-0.350703856

0.431943747 -0.811920205

0.4168

199.0323073

0.198536822

0.279565505

0.710162084

0.4776

0.577097243

-1.011115458

0.214830698 -4.706568792

00325

2.52E-

hyaluronate
synthase

0.631099917

0363
6632.227967

hyaluronan
synthase

3742

00320
AW20_RS

0.041187358

57204

00315
AW20_RS

0.0112

hypothetical
protein

4.49E-05

06

phosphatidic
acid
phosphatase

AW20_RS

132813.8708

-1.149459047

0.243426884 -4.721988921

00330
AW20_RS
00335

2.34E-

4.23E-05

06
1130.043522

-1.281553467

0.243992371 -5.252432528

1.50E07

S-layer
protein

4.00E-06

hypothetical
protein

AW20_RS

784.5682394

-1.145897466

0.263625121 -4.346692987

00340
AW20_RS

3519.146471

-0.915642326

0.245058324 -3.736426135

2186.763531

-0.275258126

0.197267037 -1.395357939

814.7299149

-0.955540275

0.286402291 -3.336356955

743.2068529

0.223189599

0.223560905

0.998339129

241

206.1556122

1.693143599

0.365591983

4.631238315

524.7986827

1.46946708

0.386466028

3.802318899

960.7375923

1.734194226

0.38203669

4.539339465

00385

0.3181
3.63E0.0001
5.64E-

84.4683098

-0.361137408

0.352321291 -1.025022947

0.3053

0.481946246

-0.162313041

0.274766394 -0.590731049

0.5547
0064

CAAX amino
protease

6.15E-05

hypothetical
protein

0.001281594

hypothetical
protein

8.92E-05

membrane
protein

0.470169342

5236
168.3689169

membrane
protein

06

00380
AW20_RS

0.005361893

43348

00375
AW20_RS

0.0008

hypothetical
protein

06

00370
AW20_RS

0.304964497

1494

00365
AW20_RS

0.1629

cell surface
protein

48841

00360
AW20_RS

0.001595352

07928

00355
AW20_RS

0.0001

hypothetical
protein

86654

00350
AW20_RS

0.000187222

05

00345
AW20_RS

1.38E-

hypothetical
protein

0.694014576

lytic
transglycosyl
ase;pseudo=t

rue
AW20_RS

64.08590631

-0.475284684

0.367571226 -1.293041047

00390
AW20_RS

488.6030874

-0.340623306

0.251091718 -1.356569259

124.5689047

0.092932182

0.281361717

0.330294337

32.40852174

-1.639068861

0.545081378 -3.007016799

36.71061686

-0.466949632

0.447278384 -1.043979877

242

112.3076433

-0.538997506

0.282058888 -1.910939631

115.9115024

-0.829081134

0.397967888 -2.083286511

432.8726726

0.650966577

0.206497592

3.152417276

00435

0.2964
0.0560
0.0372
0.0016

7295.531763

0.478733618

0.192512917

2.486761025

0.0128

hypothetical
protein

0.46119601

hypothetical
protein

0.139700211

hypothetical
protein

0.102923926

hypothetical
protein

0.009037363

19247

00430
AW20_RS

0.013352785

25115

00425
AW20_RS

0.0026

hypothetical
protein

12339

00420
AW20_RS

0.840101031

947

00415
AW20_RS

0.7411

hypothetical
protein

38252

00410
AW20_RS

0.318662704

77571

00405
AW20_RS

0.1749

membrane
protein

18115

00400
AW20_RS

0.344307393

96863

00395
AW20_RS

0.1959

hypothetical
protein

0.045550212

ATPase

0.481058177

hypothetical

91196
440.0056256

0.199374582

0.199300081

1.000373814

0.3171
29637

protein

AW20_RS

492.6717989

-0.82802337

0.325809355 -2.541435224

00440
AW20_RS

3658.777802

-0.89960411

0.321713439 -2.796290114

921.6523179

-1.597642487

0.378006765 -4.226491787

826.1922088

-1.49084136

0.385479522 -3.867498203

176.779715

-0.669301931

0.27807877

-2.406878928

243

201.7778963

-0.368506836

0.284311679 -1.296136821

50.66702448

-1.145931596

0.385036853

-2.97616082

45.07721675

-0.02827616

0.421852199 -0.067028594

79.59185248

-0.611176864

0.334516404 -1.827046016

0.054307157

0.1949
0.0029
0.9465
0.0676

101.6345659

-0.026152655

0.285740261 -0.091525971

0.9270

0.342852703

-0.002027731

0.233443662 -0.008686169

0.9930

membrane
protein

0.014502557

hypothetical
protein

0.96846138

hypothetical
protein

0.160852346

hypothetical
protein

0.956812233

74671
162.4220842

hypothetical
protein

92851

00485
AW20_RS

0.0160

DNA-binding
protein

5894

00480
AW20_RS

0.001048382

18818

00475
AW20_RS

0.0001

hypothetical
protein

28351

00470
AW20_RS

0.000293056

89503

00465
AW20_RS

2.37E-

hypothetical
protein

09958

00460
AW20_RS

0.022286979

05

00455
AW20_RS

0.0051

hypothetical
protein

69297

00450
AW20_RS

0.040631221

3984

00445
AW20_RS

0.0110

membrane
protein

0.99796839

hypothetical

00490
AW20_RS

69527
70.99709979

-0.602435248

0.371383233

-1.62213906

00495

0.1047

protein
0.220088784

73576

chromosome
partitioning
protein ParA

AW20_RS

94.94883553

-0.710453775

0.341511803 -2.080319829

00500

0.0374

0.103522926

96207

pilus
assembly
protein CpaB

AW20_RS

189162.8175

0.458609249

0.1952193

2.34920036

00505
AW20_RS

2876.116883

-1.402875308

0.309396142 -4.534236593

244

1468.567299

-0.473997878

0.223241437 -2.123252223

1132.287783

0.393416163

0.242568552

1.621876206

68.61730551

-0.320398333

0.335741966 -0.954299328

00535

0.095058521

0.1048
0.3399

62.55730685

-0.219726934

0.360343917 -0.609770067

0.5420

0.220088784

-0.344388355

0.303602171 -1.134340883

0.2566
51586

surface layer
protein

0.503760191

hypothetical
protein

0.683851915

14132
128.7867504

hypothetical
protein

32148

00530
AW20_RS

0.0337

hypothetical
protein

29857

00525
AW20_RS

9.11E-05

32722

00520
AW20_RS

5.78E-

hypothetical
protein

06

00515
AW20_RS

0.061147465

1378

00510
AW20_RS

0.0188

hypothetical
protein

0.415420162

hypothetical
protein

AW20_RS

131.6222278

-0.305642313

0.32900264

-0.928996538

00540
AW20_RS

597.1041683

-0.277423122

0.270284961 -1.026409761

284.451115

-0.469900958

0.280925518 -1.672688764

7488.697885

0.374444318

0.198997519

1.8816532

0.0943
0.0598

3528.430114

-0.882808217

0.389671492 -2.265519125

0.0234

0.20463416

245

-0.754429607

0.276207834 -2.731383815

00565

0.0063

hypothetical
protein

0.14648017

hypothetical
protein

0.07224095

80842
25524.10619

hypothetical
protein

83118

00560
AW20_RS

0.469983808

88582

00555
AW20_RS

0.3046

hypothetical
protein

98479

00550
AW20_RS

0.515993228

9088

00545
AW20_RS

0.3528

cell division
protein FtsZ

0.026277197

06897

plasmid
replication
protein RepX

AW20_RS

1646.116972

-0.105217502

0.216224636

-0.486612

00570
AW20_RS

0.753906088

33318
92.52409772

-1.679239447

0.348879697 -4.813233509

00575
AW20_RS

0.6265
1.49E-

protein
2.80E-05

06
1328.829374

-0.796633748

0.206964786 -3.849127007

00580

0.0001

hypothetical
hypothetical
protein

0.001103017

1854

conjugal
transfer
protein TraG

AW20_RS

3238.038611

-0.078864518

0.184602292 -0.427213103

0.6692

0.786194293

hypothetical

00585
AW20_RS

24119
1316.019332

-0.219272398

0.264930039 -0.827661518

00590
AW20_RS

0.4078

protein
0.56909151

62218
457.7892578

-0.12501907

0.276714332 -0.451798318

00595

0.6514

hypothetical
protein

0.773613796

14282

Cro/Cl family
transcription
al regulator

AW20_RS

4360.692625

-0.89089181

0.284410154

-3.13241914

00600
AW20_RS

2126.12283

-0.825788255

0.162850117 -5.070848393

3.96E-

hypothetical
protein

246

8.93E-06

transposase

0.000468746

transposase

0.213657165

GNAT family

07
431.8119866

-1.104354443

0.269210592 -4.102195359

00610
AW20_RS

0.009554733

33722

00605
AW20_RS

0.0017

4.09E05

745.8985858

0.362313561

0.22034256

1.644319466

00615

0.1001
1023

acetyltransfe
rase

AW20_RS

1849.896387

-0.489937105

0.190640452

-2.56995354

00620
AW20_RS

00630

0.038421598

71215
523.884729

-0.212958596

0.234794573 -0.906999652

00625
AW20_RS

0.0101
0.3644

protease
0.526488708

06981
13806.08837

-0.630448414

0.182436468 -3.455714865

0.0005
48836

CAAX amino
hypothetical
protein

0.00376269

hypothetical
protein

AW20_RS

1725.722958

-1.038416902

0.203547818 -5.101586992

00635
AW20_RS

3.37E-

8.04E-06

07
351.2926219

-1.206385028

0.262534762 -4.595143972

00640

4.32E-

transposase;p
seudo=true

7.19E-05

06

TetR family
transcription
al regulator

AW20_RS

540.4027878

-1.108320579

0.221201082 -5.010466348

00645
AW20_RS

5.43E-

1.17E-05

07
285.264997

-0.79133082

0.323717018 -2.444514118

00650

0.0145

nucleotidyltr
ansferase

0.049870427

0474

S1 RNAbinding
domain

247

protein
AW20_RS

766.9210729

-0.949623087

0.232967914 -4.076196888

00655
AW20_RS

1312.69454

-0.924274539

0.170998259 -5.405169283

1635.161057

-0.957246181

0.28974627

-3.303739449

00675

protein
1.92E-06

ATPase AAA

0.0009

0.00588947

hypothetical

54045
2200.986624

-0.758230712

0.209356778 -3.621715622

00670
AW20_RS

6.47E-

hypothetical

08

00665
AW20_RS

0.000514014

05

00660
AW20_RS

4.58E-

0.0002

protein
0.002318484

92656
1033.050265

-1.378027053

0.24758817

-5.565803309

2.61E08

membrane
protein

8.60E-07

membrane
protein

AW20_RS

20.2856091

-1.730175319

0.615633431 -2.810398576

00680
AW20_RS

7263.086719

-0.729172523

0.157136053

-4.6403897

3.48E-

3786.939213

-0.961171431

0.163093283 -5.893384547

3.78E-

5.96E-05

-0.837348194

0.149038178 -5.618346967

00695

1.93E-

nucleotidyltr
ansferase

1.66E-07

09
52483.152

hypothetical
protein

06

00690
AW20_RS

0.021623412

48018

00685
AW20_RS

0.0049

hypothetical
protein

6.62E-07

08

group II
intron
reverse
transcriptase

248

/maturase
AW20_RS

8736.876998

-0.881426782

0.166023351 -5.309053086

00700
AW20_RS

1.10E-

3.05E-06

07
45.88027229

-0.048259142

0.449672991 -0.107320526

00705

0.9145

DNA-binding
protein

0.949837206

34701

phosphoaden
osine
phosphosulfa
te reductase

AW20_RS

1116.189197

0.171158803

0.173263979

0.987849892

00710
AW20_RS
00715

0.3232

0.486976442

26169
3566.035883

1.211678168

0.245553032

4.934486689

8.04E07

hypothetical
protein

1.65E-05

hypothetical
protein

AW20_RS

353.7389678

-0.335889521

0.260766611 -1.288084851

00720
AW20_RS

2105.35779

-0.661692619

0.168105209 -3.936181537

882.1353058

-0.091515005

0.18383418

-0.497812785

protein
0.000831118

integrase

0.6186

0.746001202

hypothetical

16004
3834.727678

-2.529140712

0.365261283 -6.924195994

00735
AW20_RS

8.28E-

hypothetical

05

00730
AW20_RS

0.346474502

16428

00725
AW20_RS

0.1977

4.38E-

protein
4.10E-10

12
10497.36941

-0.395136412

0.227163696 -1.739434688

00740

0.0819

hypothetical
protein

0.184612754

58331

XRE family
transcription
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al regulator
AW20_RS

8200.559172

-0.479011147

0.153314977 -3.124359778

00745
AW20_RS

2158.346426

-1.052783397

0.300234798 -3.506533562

00760

0.0004

59.48491693

-0.309445864

0.358076787 -0.864188565

0.3874

0.003230299

-0.348566649

0.323972567 -1.075914087

0.2819
65681

hypothetical
protein

0.54958796

84313
111.7125042

hypothetical
protein

53984

00755
AW20_RS

0.009782576

81924

00750
AW20_RS

0.0017

hypothetical
protein

0.444905186

SAMdependent
methyltransf
erase

AW20_RS

29.24870795

-0.93937892

0.476151928 -1.972855435

00765
AW20_RS

0.125175222

12035
398.8254697

-0.533092785

0.206360894 -2.583303327

00770
AW20_RS

0.0485
0.0097

protein
0.037287183

85924
361.4242563

-0.305846043

0.254507291 -1.201718196

00775

0.2294

hypothetical
hypothetical
protein

0.384768475

72729

group II
intron
reverse
transcriptase
/maturase

AW20_RS

103.4797797

-0.323014547

0.321680746

-1.00414635

250

00780
AW20_RS

239.9134389

-0.383269169

0.256113657 -1.496480792

59.72288321

-0.411173885

0.387997123 -1.059734366

104.6837238

-0.47100818

0.344429156 -1.367503801

00805

0.265702925

transposase

0.2892

0.452915236

hypothetical

0.1714

protein
0.315398361

67447
2011.023637

-0.534865805

0.205734255 -2.599789737

00800
AW20_RS

protein

65464

00795
AW20_RS

0.1345

hypothetical

2841

00790
AW20_RS

0.479604606

08077

00785
AW20_RS

0.3153

0.0093

protein
0.035757677

2809
2383.688051

-0.465111377

0.17767383

-2.617782137

0.0088
50329

hypothetical
hypothetical
protein

0.034341685

hypothetical
protein

AW20_RS

23.61520445

-0.859429859

0.587438463 -1.463012576

00810
AW20_RS

1154.062111

-0.563658263

0.272288882 -2.070074473

155.482404

-1.100883673

0.290238987 -3.793024793

0.105683082

0.0001

96.89868454

-0.456198971

0.327106294 -1.394650545

0.1631

hypothetical
protein

0.001326388

48823

00825
AW20_RS

0.0384

hypothetical
protein

45371

00820
AW20_RS

0.278244917

63938

00815
AW20_RS

0.1434

hypothetical
protein

0.305163523

transposase

0.023526425

DNA

21245
366.4712863

-0.704037473

0.253854256 -2.773392431

251

00830

0.0055
47518

topoisomeras
eI

AW20_RS

14.18670735

-2.905992942

0.782115575 -3.715554368

00835
AW20_RS
00840

0.0002

0.001709388

02759
81.22748452

-0.171368971

0.334344603 -0.512551929

0.6082
64787

hypothetical
protein

0.736320531

hypothetical
protein
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